AS 2024 年 9 月 27 日に米国証券取引委員会に提出された

登録 いいえ333-282302

 

 

ユナイテッド 州
証券取引委員会
ワシントン D. C. 20549

 

 

 

第2号改訂 TO

フォーム F-1
登録申告書
UNDER
1933 年の証券法

 

 

 

トップ ウェルスグループホールディングス
(登録者の正確な氏名はその定款に記載)

 

 

 

ケイマン諸島   2091   適用されない
(明またはその他の司法管轄権
法人または組織 )
  (主な標準工業
分類コード番号 )
  (税務署の雇用主
識別番号 ) 。

 

単位 714 、 715 、 7F, 香港プラザ
188
コノート · ロード · ウエスト
香港.香港
電話番号: + 85 2 3615 8567
(登録者は主に事務室の住所を実行し、郵便番号と電話番号、市外局番を含む)

 

 

 

c / o コーリンユニバーサル社です。
122 東 42nd ストリート, 18これは…。 フロア
ニューヨークです, ニューヨークです。 10168
+ 1 (800) 221-0102
(サービスエージェントの名前、住所、郵便番号と電話番号、市外局番を含む)

 

 

 

コピーされました

 

ウィリアム S 。ローゼンシュタット、 Esq 。
“Mengyi ” Jason“ Ye, Esq 。
オルトリ · ローゼンシュタット LLP
366 Madison Avenue , 3 番地研究開発フロア.フロア
ニューヨーク州、 NY 10017
電話番号: + 1 212 — 588 — 0022
  ローラ · ヘイマン、エスク。
iTKG 法律 LLC
103 カーネギーセンター、スイート 300
プリンストン州、ニュージャージー州 08540 — 6235
電話番号: + 1 835 — 222 — 4854

 

 

 

近似する. 一般販売の開始日をお勧めします本登録声明の有効日以降、できるだけ早く。

 

If このフォームに登録されている有価証券は、規則 415 の下で遅延または継続的に提供されます。 1933 年の証券法、次のボックスをチェックしてください。」と

 

If このフォームは、証券法第 462 条 ( b ) に基づく募集のための追加有価証券を登録するために提出されます。 ボックスに、同じオファリングの以前の有効な登録申告書の証券法登録申告書番号をリストします。 ↓ ↓

 

もし…。 本表は、証券法第462条(C)条に基づいて提出された発効後修正案ですので、以下のブロックを選択してリストアップしてください 証券法は,同一発行の比較的早く発効した登録宣言番号を登録する

 

もし…。 本表は証券法第462条に基づいて提出された発効後修正案ですので、以下のブロックを選択してリストアップしてください 証券法は,同一発行の比較的早く発効した登録宣言番号を登録する

 

指示する 登録者が 1933 年の証券法規則 405 で定義されている新興成長企業であるかどうかをチェックマークすることによって。

 

この目論見書について募集説明書の概要

 

供物リスク要因

 

特別注釈について 展望的な声明

 

 

 

 

 

収益の使用

 

配当政策    大文字である 

 

薄めにする

 

マネジメントの 財務状況と経営実績の議論と分析

 

会社の歴史と構造

 

商売人

 

監督管理

 

管理する

 

プリンシパル 株主

 

 

 

 

関係者取引株式の説明 資本将来売却する資格のある株

 

配送計画

 

民事責任の実行可能性

 

株主.株主

 

 

 

 

数量

 

普通 オーナー

 

Winwin Development Group Limited

 

   Beyond Gloryユニバーサル株式会社
KINE Sky Global Limited
   国智控股有限公司 
シクマ資本有限公司  $0.99   $26,730,000 
水星環球投資有限公司(1)  $0.0495   $1,336,500 
挨拶調和環球有限公司  $0.9405   $25,393,500 

 

(1) 2024 年 4 月 18 日、当社は最初の営業を閉じた。 普通株式 1 株当たり 4.00 米ドルの公募価格で、 2,000,000 株の普通株式を公募します。2024 年 7 月 2 日、当社は登録を申請しました。 SEC へのフォーム F—1 ( ファイル番号 333 — 280654 ) ( 改正された「再販目論見書」 ) における声明。 2024 年 7 月 23 日に、当社の既存株主 6 名の既存株主総額 684 万普通株式を登録すること 転売目論見書に基づき売却する株式。以下の表は、登録普通株式の内訳を示します。 既存株主による転売目論見書における売却について.”

 

株主名

 

 

 

 

数量

 

普通

 

 

株式

 

 

 

 

登録済み

 

  販売中
他社、他産業、その他の当社のコントロールを超えた事象または要因の営業および株価の業績 ii
1
香港ドル、人民元、米ドル間の為替レートの変動 13
14
当社または当社が事業を展開するキャビア業界に影響を与える一般的な市場状況その他の動向 52
53
業績の実際の変動または予想および業績予想の変更または修正 54
55
証券リサーチアナリストによる財務推計や推薦の変更 56
57
当社、当社のサービス、当社の役員、取締役、主要株主、その他の実益所有者、当社の事業について有害なネガティブな宣伝 パートナーや私たちの業界 65
67
当社または競合他社による新製品提供、買収、戦略的関係、合弁事業、資本調達または資本コミットメントの発表。 81
85
上級管理職の増任や退職 91
92
当社、役員、取締役、主要株主に関する訴訟または規制手続。 94
107
情報技術の発展と業界の技術革新に追いつく能力 113
115
117
私たちの将来の業務発展、財務状況、経営業績 117
117
当社の製品の原材料の価格と入手可能性 118

 

 

収益、コストまたは支出の予想される変化

 

i

 

 

 

当社の製品の需要と市場受け入れに関する期待

 

 

ii

 

 

重要な顧客、サプライヤー、その他のビジネス関係との関係の変化

 

 

私たちの業界の競争は

 

 

  事業戦略の実施とイノベーションの成功に関する不確実性

 

  製品汚染や品質管理の困難など、当社のブランドや評判に重大な悪影響を及ぼす可能性のある事象。

 

  業界の政策や規制について

 

  当社が事業を遂行するために必要なすべての認証、承認、および / またはライセンスを取得、維持、または調達する能力、および当社が事業を展開する関連する管轄区域において。 以下の財務データは、 そして、 2023 年 12 月 31 日を末日とする年度の連結財務諸表と併せて読めます。

 

  当社の業績概要 2023 年 12 月 31 日および 2022 年 12 月 31 日を末日とする年度は以下の通りです。 現在までの年度

 

  12 月 31 日 変わる

 

  ドル ドル

 

  ドル 収益

 

  販売コスト グロス利益

 

  その他の収入 行政費

 

  販売費用 税前利益/(損失)

 

  売上高は 8,43 0,358 米ドル、 99% 増加しました。 2022 年 12 月 31 日に終了した年度の 8,51 2,929 米ドルから 2023 年 12 月 31 日に終了した年度の 16,94 3,287 米ドルとなりました。 キャビア消費の人気の高まりに基づいて、新規顧客と既存の顧客からの注文の増加も 高級ダイニング業界ですまた、 2023 年には高級ワインの取引を開始し、 2022 年のニールと比較して 4,460,092 米ドルの収益を上げました。 分析は以下のとおりです。 現在までの年度

 

12 月 31 日

 

変わる

 

ドル

 

   ドル
ドル
 
   2023   2022 
キャビアからの収入   7.8    7.8 
ワインからの収益   7.8    7.8 

 

1

 

 

販売コスト

 

当社の販売コストは主に購入で構成されています キャビアとワインの費用です2023 年 12 月 31 日に終了した年度の売上高は 11,55 6,006 米ドルで、 7,24 6,259 米ドル増加しました。 2022 年 12 月 31 日に終了した年度の 4,30 9,747 米ドルから 168% 増加しました。この増加は、収益の大幅な増加に沿っています。

 

毛利と利回り

 

この年度までに

 

12 月 31 日年々変化ドル

 

ドル

 

ドル

 

キャビアの総利益

 

ワインの総利益

 

2

 

 

グロス利益

 

キャビアの総利益

 

ワインの総利益毛利率12 月期末の総利益率 2022 年 12 月 31 日期は 49.4% と比較して、 2023 年 31 日は 31.8% でした。粗利益率の低下は主に 特定の顧客によるボリューム購入の増加により、その注文に対してより有利な割引を確保することができました。.”

 

提案されたすべての関連者取引を検討して承認する

 

 

管理職および独立監査員との会議を定期的に開催する

 

 

適切なコンプライアンスを保証するために、私たちの手続きの十分性と有効性を検討することを含む、私たちの商業行為と道徳的基準を監督する。

 

補償 委員会。

 

当社の報酬委員会は、 Feiyong 、 LI 、 Phei Suan 、 HO 、 Wai Chun 、 CHIk で構成されています。ミス。 Wai Chun 、 CHIk は当社の報酬委員会の議長です。補償委員会は、とりわけ、 物事 :

 

 

取締役会が私たちのCEOや他の役員の報酬を承認することを審査または提案します

 

 

取締役の報酬について、株主に対して審査 · 推薦を行うこと

 

 

3

 

  

奨励された報酬または株式計画、計画または同様の計画を定期的に審査し、承認する

 

 

報酬コンサルタント、法律顧問、その他のコンサルタントは、経営陣から個人が独立していることを考慮したすべての要因を考慮してのみ選択することができる。

 

指名委員会。

 

うちの 指名委員会は、 Feiyong 、 LI 、 Phei Suan 、 HO 、 Wai Chun で構成されています。CHIk 李 Feiyong 氏は、私たちの指名委員会の委員長です。 当社は、 Feiyong 、 Li 、 Phei Suan 、 HO 、および Wai Chun 、 CHIk が NASDAQ の「独立性」要件を満たしていると判断しました。 ルール 560 5 。推薦委員会は、取締役会の選定を支援します。 取締役会とその委員会の構成を決定します推薦委員会は、とりわけ以下の事項を担当します。

 

 

株主選挙または取締役会の任命のために、取締役会に指名者を推薦し、選抜し、取締役会に推薦する

 

 

4

 

 

 

このオファー

 

普通株

 

Beneficially

 

即座に所有

 

このオファーの後

 

数量

 

普通

 

  近似値
パーセンテージ
優秀な
普通
 
   20,159,440 
数量    1,727,952 
普通    1,763,951 
   1,763,951 
近似値   899,975 
パーセンテージ    683,981 

 

5

 

 

優秀な

 

普通

 

  役員や行政職:
金寛王、Wong
洪翔
郭権、袁
 
李飛永   20,160,000 
Phei Suan , HO   1,188,000 
Wai Chun , CHIK   1,332,000 
グループとしての全取締役 · 執行役員   1,332,000 
5% 以上の主要株主 :   900,000 
Winwin Development Group Limited   1,224,000 
クワン · キム · キングス、 WONG が 20,160,000 普通を所有 Winwin Development Group Limited を通じて株式を保有する、イギリス領ヴァージン諸島の法律に基づいて法人化された会社。 90% は Wong の Kim Kwan Kings 氏、 10% は CHONG の Kin Fai 氏です。Kim Kwan Kings 氏、 WONG は単独取締役です。 Winwin Development Group Limited 。ウォン氏は、 Winwin Development が保有する普通株式の実質所有者とみなされます。 ウォン氏は、 Winwin Development Group Limited が保有する普通株式の議決権および処分権を有しています。 Winwin Development Group Limited の登録住所は、 Craigmuir Chambers , Road Town , Tortola , VG 1110 , British Virgin Islands です。   864,000 

 

私たちは、可能性のある取り決めを認識していません。 その後の日付で、当社経営陣の変更をもたらします。

 

関係者取引

 

雇用協定と賠償協定  管理 — 雇用を参照 補償契約と補償契約」。
その他関係者との取引
2023 年 12 月 31 日現在、当社は 以下の関係者との残高
名前.名前
金額
関係.関係
注記
 
ウォン · キム · クワン · キングズ   1,188,000 
当社の取締役および支配株主   1,332,000 
無担保無利子ローンの支払、需要に応じて返済   1,332,000 
シクマ資本有限公司   900,000 
当社の株主   1,224,000 
無担保無利子融資に対応して,金を引き出してから1年以内に返済する   864,000 
2022 年 12 月 31 日現在、当社は 以下の関係者との残高   6,840,000 

 

名前.名前

 

金額

 

関係.関係

 

6

 

 

注記

 

大自然母健康(香港)有限会社

 

付属会社創富集団(国際)有限公司の元取締役と、関連会社大自然健康(香港)有限公司の元取締役を経営する。

 

売掛金

 

金輝、創

 

取締役や拓富グループ(国際)有限公司の元主な所有者を務めていた。当社持株株主Win Development Group Limitedの現株主

 

ピーク·フォーチュン·グループ(国際)有限会社が普通株式受取額を発行する

 

金寛王、Wong

 

名前.名前

 

7

 

 

金額

 

関係.関係

 

注記

 

美しさ & ヘルス · インターナショナル株式会社

 

共同管理下の会社

 

  収入 — キャビアの販売 Beauty & Health International E—Commerce Limited ( 顧客 C ) ( 注 b )

 

  共同管理下の会社 収入 — キャビアの販売

 

  マザー ネイチャーヘルス ( 香港 ) リミテッド 同社の元取締役は、同関連会社の元取締役でもあります。

 

8

 

 

  収入 — キャビアの販売 Sky Channel Management Limited

 

  当社の主たる所有者は、同関連会社の元取締役でした。 マーケティング費用

 

  金輝、創 当社の元取締役 · 主席

 

  無担保無利子ローンの支払金、オンデマンド返済金 金輝、創

 

  当社の元取締役 · 主席 2022 年 12 月 31 日時点のトップ · ウェルス · インターナショナルの普通株式発行債権額。支払額は 2023 年 5 月 13 日に行われた。

 

  金寛王、Wong 当社の取締役および支配株主

 

  無担保無利子ローンの支払金、オンデマンド返済金 金輝、創

 

当社の取締役および支配株主

 

  トップ · ウェルス · インターナショナルの無担保無利子ローンの通常株式への転換 2021 年、当社は以下の 関係者取引 :

 

  名前.名前 金額

   

9

 

 

関係.関係

 

注記

 

  金輝、創 当社の元取締役 · 主席

 

  無担保無利子貸付債権の現金前払い、需要に応じて返済 金寛王、Wong

 

当社の取締役および支配株主無担保無利子ローンの支払金、オンデマンド返済金

 

この関連取引 パーティーは 2022 年 8 月 31 日以降に終了しました。買い戻し·買い戻し·引き渡し 普通株

 

  このような条件で株を発行することができます 当該等株式の発行前に、吾等が選択する条項及び方式により、当社が選択することができる 取締役会や私たちの株主の一般的な決議案を採択する。 “会社法”と我々の定款大綱と定款細則 協会は私たちが自分の株を購入することを許可したが、一定の制限と要求を受けなければならない。“会社法”と 特定の種類の株式を保有する株主に付与される権利は、私たちの取締役が行動することができます

 

  われわれの選択権又は当該等の償還可能な株式を保有する株主に基づいて、わが取締役が当該等の株式を発行する前に決定した条項及び方式に従って、償還又は償還しなければならない株式を発行する

 

  ある種類の株式を保有する株主が特別決議案の同意を得て、当該種別の株式に付随する権利を変更し、当該等の株式が取締役が変更を行う際に決定しなければならないことを規定する条項及び方法で、吾等の選択に従って当該等の株式を償還又は償還することができること;及び

 

  取締役が購入時に決定した条項および方法に従って、任意の償還可能株式を含む、私たち自身の任意のカテゴリのすべてまたは任意の株式を購入する。

 

  会社法に基づいて何でも買い戻します 株式は自社の利益から支払うか、株式割増口座から支払うか、または新規発行のものから支払うことができる 株式を買い戻したり資本から購入したりするために。もし買い戻し収益が当社の資本から支払われた場合、 わが社は支払い後すぐに通常業務中に満期になった債務を返済できるようにしなければなりません。はい。 また、“会社法”によると、このような株式は、(1)完全に納付されていない限り、(2)買い戻しがこのような状況になる場合がある。 流通株がない場合には、在庫株として保有する株式を除き、流通株はない。株式の買い戻しはこのような方法で行うことができる 規定の規定に基づいて許可されたり根拠されたりする条項。もし条項に許可がなければ 購入の際、会社は、購入方法及び条項が事前に取得されない限り、自分の任意の株式を買い戻すことができません。 会社の決議です。また、“会社法”と当社の定款大綱と定款細則によると、わが社は受け入れることができます 引渡しによって引き起こされない限り、十分に入金された株式を無償で渡す 無流通株(在庫株として保有している株式を除く)。 株式権利の変動

 

  もしいつでも私たちの株が 別の種類の株式、私たちの任意のカテゴリの株式に付随するすべてのまたは任意の権利(条項が別に規定されていない限り) このカテゴリ株式の発行は,当該カテゴリ株式発行済株式の3分の2を保有する所有者の書面による同意を経て変更しなければならない またはこのカテゴリーの株式保有者が3分の2以上の多数で採択された決議で承認されるか このカテゴリーの株式保有者の単独株主総会に出席するために、自らまたは代表を委任する。 株のクラスの条件がなければ 発行された規定以外の場合、いかなる種類の株式を保有する株主に付与される権利は、創出によって変化するものとはみなさない。 またはそのクラスの既存の株式と同等のランキングの株式を発行します

 

  “資本論”の変化 私たちは時々普通の決議案を採択することができる。 私たちの株主:

 

  この一般決議によって規定される額および一般決議によって規定される権利、優先権、および特権に基づいて、私たちの株式を増加させる

 

  私たちの株式の全部またはすべてを既存の株式よりも大きい株式に分割します

 

  ある限度のある場合を除いて “ケイマン諸島会社法”、ケイマン諸島で会社を構成する株主は、合併や合併に反対する その株式を支払う公正な価値を得る権利がある(双方が合意していなければ、ケイマン諸島によって決定される 裁判所)合併または合併に異議を唱える場合、異なる意見を持つ株主は、規定の手続を厳格に遵守しなければならない 会社法の中で。異なる政見者の権利の行使は、異なる政見者株主が次のいずれかの他の権利を行使することを排除する。 彼や彼女はもともと株式を持っていることでそのような権益を享受する権利があるかもしれないが,その合併をする権利がある 合併が無効であるか違法であるか

 

  関連する法律規定と分離する 合併と合併については,“会社法”には再編や合併を促進する成文法規定も掲載されている 会社は計画を手配する方法であるが、この計画は各種類の株主の過半数の承認を得なければならない。 そして、それと手配する債権者は、これらの債権者は、上記各カテゴリの債権者の価値の4分の3を別途代表しなければならない。 開催された1回以上の会議に出席して投票に参加した株主または債権者を直接または委任する(どのような状況にあるかによる) そのために。会議の開催とその後の計画はケイマン諸島大裁判所の承認を受けなければならない。 異なる意見を持つメンバー/債権者は出席して意見を述べる権利がある。公聴会では,大裁判所は(いかなる反対意見にも基づいて) 否、否 承認する. その計画が合理的かどうか(合理的な会員がそれを承認するかどうか)

 

10

 

 

クラスごとに 会議には公平な代表がいた

 

  多数を占める 誠実に行動し、少数の人に脅迫されず、階級の利益に不利な行為を促進する すべての通知を出します 各時期は守られている

 

  解決策. 必要な多数で通過する。 デラウェア州

 

  ケイマン諸島 株主訴訟

 

  デラウェア州の法律によると、株主は通常、受託責任の違反、会社の浪費、適用法律に従って取られていない行動を含む集団訴訟と派生訴訟を提起することができる。このような訴訟では、裁判所は通常、勝訴側がそのような訴訟に関連する弁護士費を取り戻すことを許可する権利がある。 原則として、私たちは通常適切な原告です 一般的な規則として、派生訴訟は少数の株主によって提起されてはならない。しかしイギリス当局によると ケイマン諸島では、上記の原則は説得力を持つ可能性が高いが、次のような場合を含む例外もある

 

  会社です。 違法または越権的である The Actは文句を言いました 越権ではないが、まだ獲得されていない簡単な多数票の許可を得た場合にのみ、適切に発効することができる。 そして

 

  これを歓迎する. その会社を統制している人たちは少数の人たちに詐欺をしている 会社の記録を調べる

 

デラウェア州法律によると、デラウェア州会社の株主は、通常営業時間内に任意の正当な目的のために検査を行う権利があり、株主リスト(S)の写し及び会社及びその子会社の他の帳簿及び記録(ある場合)を取得し、会社がこれらの子会社の帳簿及び記録を取得することができる限り、これらの子会社の帳簿及び記録を取得することができる。ケイマン諸島の株主は免除された ケイマン諸島の法律によると、会社は株主リストあるいはその他の会社の記録のコピーを閲覧または取得する権利がありません。 (組織定款の大綱及び定款細則の写し及び当該会社が採択したいかなる特別決議及び登録簿を除く 同社等の住宅ローン及び押記)。しかしこのような権利は会社のメモや “会社規約”

 

株主提案会社の会社登録証明書又は定款が規定されていない限り、デラウェア州の法律には、株主が会議で業務を提出する方法を制限する条項は含まれていない。

 

https://www.imperialcristalcaviar.com/ そして

 

Http://ir.Imperialcristancaviar.com.登記申告書及び「設立」に掲げる書類 参考情報」は、当社のウェブサイトにも掲載されています。に含まれる、またはアクセス可能な情報、 当社のウェブサイトは本目論見書の一部ではなく、参照によって組み込まれることはありません。

 

ディーラー、セールスパーソナル、その他は認められません。 この目論見書に含まれない情報を提供したり表現したりします無許可の情報に頼ってはいけません。 表現だ本目論見書は、ここに提供される有価証券のみを売却するためのオファーですが、状況および管轄区域においてのみです。 合法である場所です本目論見書に記載されている情報は、発行日時点でのみ最新です。ピークフォーチュングループホールディングス有限公司

 

  レポートと財務諸表 2023年12月31日まで及び2022年12月31日まで年度

 

  トップウェルスグループホールディングス有限公司 連結財務諸表と指数 情報

 

  2023 年 12 月 31 日期、 2022 年 12 月 31 日期 2021 年と ページ

 

  独立公認会計事務所報告書 ( PCAOb ID : 6732 ) 連結貸借対照表 2022 年 12 月 31 日現在

 

11

 

 

2023 年 12 月 31 日期、 2022 年 12 月 31 日期、 2021 年 12 月 31 日期における営業利益およびその他の総合損益の連結計算書

 

2023 年 12 月 31 日、 2022 年および 2021 年 12 月 31 日を末日とする会計年度における株主資本比率の変更に関する連結報告書

 

2023 年、 2022 年、 2021 年 12 月期連結キャッシュ · フロー決算書

 

2023 年 12 月 31 日、 2022 年および 2021 年 12 月 31 日期連結財務諸表の注釈

 

F—7—F—19

 

独立公認会計士の報告書 FIRM売掛金関係者の売掛金

 

在庫情報

 

繰り上げ返済する支払済預金関係者が当然の金非流動資産財産·工場·設備·純価値

 

使用権資産 — オペレーティングリース繰延税金資産 非流動資産総額

 

12

 

 

総資産

 

経常負債   売掛金
     
計算すべき費用その他は支払わなければならない   レンタル負債を経営しています--流動負債
     
関係者の金額に対応する   借金をする
     
当期所得税を納める   流動負債総額
     
非流動負債  

レンタル負債を経営しています--非流動負債

 

負債総額

 

引受金とその他の事項

 

株主権益

     
普通株、$   パーバル;
     
株式認可、   ) * 発行済株式 · 発行済株式
     
追加実収資本  

留保利益

 

株主権益総額

 

13

 

 

負債と資本総額

 

すべてに遡及効果を与えること 2023 年 10 月 12 日のプロ · ラタ株式発行後の発行済 · 発行済株式 2700 万株 ( 株式として扱われている ) 分裂、最も早い時期から提示されます。

 

添付ノートはこれらの不可欠な部分を形成します。 連結財務諸表。

 

ピークフォーチュングループホールディングス有限公司

 

連結営業決算書等 総合利益 ( 損失 )

 

( 米ドル ( 「 $」 ) で表される金額 ) 株数と額面価額を除く )

 

12月31日までの年度

 

14

 

 

販売 ( 関係者への販売を含む

 

ゼロ

 

  2023 年、 $ 2022 年と

 

  ゼロ 2021 年 )

 

  販売コスト 総利益

 

  その他の収入 販売費用 ( 関係者へのマーケティング費用を含む )

 

  ゼロ 2023 年、 $

 

2022 年と

 

ゼロ

 

2021 年 )

 

行政費

 

15

 

 

所得税引前利益 ( 損失 )

 

所得税 ( 経費 ) 控除

 

当期利益と総合利益

 

1 株当たり利益 :

 

普通株式、 — ベーシックおよび希釈

 

16

 

 

1 株当たり基本利益および希釈利益の算出に使用される加重平均残高株式

 

普通株式、基本株式および希釈株式 *

 

すべてに遡及効果を与えること 2023 年 10 月 12 日のプロ · ラタ株式発行後の発行済 · 発行済株式 2700 万株 ( 株式として扱われている ) 分裂、最も早い時期から提示された。

 

添付ノートはこれらの不可欠な部分を形成します。 連結財務諸表。

 

ピークフォーチュングループホールディングス有限公司

 

合併権益変動表

 

17

 

 

( 米ドル ( 「 $」 ) で表される金額 ) 株数と額面価額を除く )

 

ごく普通である

 

ストック

  

優秀 *

 

金額

 

その他の内容

 

18

 

 

支払済み

 

資本金

 

(累計)

 

19

 

 

損失 )

 

保持

 

収益

 

総額2021年1月1日現在の残高

 

トップ · ウェルス · インターナショナルの普通株式発行について損失と総合損失額

 

2021年12月31日現在の残高トップ · ウェルス · インターナショナルの普通株式発行について

 

当期利益と総合利益2022年12月31日現在の残高

 

株式分割とみなす Pro Rata 株式発行

 

20

 

 

組織再編による資本削減

 

当期利益と総合利益

 

2023年12月31日現在の残高

 

すべてに遡及効果を与えること 2023 年 10 月 12 日のプロ · ラタ株式発行後の発行済 · 発行済株式 2700 万株 ( 株式として扱われている ) 分裂、最も早い時期から提示されます。

 

添付ノートは、 連結財務諸表。

 

ピークフォーチュングループホールディングス有限公司

 

統合現金フロー表

 

21

 

 

( 米ドル ( 「 $」 ) で表される金額 ) 株数と額面価額を除く )

 

12月31日までの年度

 

経営活動のキャッシュフロー

 

純利益(赤字)

 

調整 : — 。

 

財産·工場·設備の減価償却

 

繰延税額相殺

 

  営業資産 · 負債の変動 売掛金

 

  在庫情報 繰り上げ返済する

 

22

 

  

  支払済預金 売掛金

 

  計算すべき費用その他は支払わなければならない 関係者への支払額

 

  当期所得税を納める 経営活動が提供する現金純額

 

  投資活動によるキャッシュフロー 財産·工場·設備を購入する

 

  投資活動に使用された純現金 融資活動によるキャッシュフロー

 

借入金収益

 

組織再編による資本削減

 

株式分割とみなされるプロ · ラタ株式発行の収益

 

トップ · ウェルス · インターナショナルの株式発行収益

 

融資活動が提供する現金純額

 

23

 

 

現金及び現金等価物 ( 死亡 ) の増加

 

年初現金および現金等価物

 

年末現金および現金等価物

 

現金残高及び現金等価物の分析

 

銀行残高

 

添付ノートは、 連結財務諸表。

 

24

 

 

トップ · ウェルス · グループホールディングス 限定

 

連結財務諸表付記

 

2023年12月31日まで及び2022年12月31日まで年度

 

概要情報と運用基盤

 

トップウェルスグループホールディングス有限公司 ケイマン諸島で設立された有限責任会社ですトップ · ウェルス · グループ · ホールディング · リミテッドとその子会社 「会社」と定義されます。本報告書の執筆時点において、当社の直接かつ最終的な親会社は Winwin Development です。 グループ · リミテッド ( 「 Winwin 」 ) 。このレポートの日付時点で、 Winwin は

 

ウォン · キム · クワン · キングス氏が所有する%

 

氏所有の% 。 チョン · キン · ファイ。

 

25

 

 

本報告書の作成日現在、当社およびその子会社の詳細は以下のとおりです。

 

実体名

 

登録成立日

 

  持株会社 業務的性質

 

  ピークフォーチュングループホールディングス有限公司 2023年2月1日

 

  Winwin Development Group Limited 投資持株

 

トップ · ウェルス · グループ · リミテッド

 

2023年1月18日

 

26

 

 

ピークフォーチュングループホールディングス有限公司

 

投資持株

 

  トップ · ウェルス · グループ ( インターナショナル ) リミテッド 2009 年 9 月 22 日

 

  トップ · ウェルス · グループ · リミテッド キャビアの貿易

 

  2023 年 3 月 21 日、当社は イギリス領ヴァージン諸島で法人化された Top Wealth ( BVI ) Group Limited ( 以下「 Top Wealth BVI 」 ) の株式% 、 名目価値は US ドルです。

 

  Winwin の株主から。2023 年 3 月 24 日、 Top Wealth BVI を通じて買収。 利子率 トップ · ウェルス · グループ ( インターナショナル ) Limited ( 「トップ · ウェルス · インターナショナル」 ) は香港で設立され事業を展開する会社です。 Kong 、 US ドルという名目対価で

 

  Winwin の株主から。 2023 年 4 月 28 日。

 

  普通株 名額で発行されました 2023 年 10 月 12 日、考察中 株式会社の新規公募により、同社はさらに

 

  普通株式を株主に総額で 株主の既存持分 ( 総称して「 Pro 」 ) に比例した比率で定価 株式分割 ( 分割 ) 」と表現された。プロ · ラタ株式発行後、 普通株式は 発行され、未払いの。

 

  十二月三十一日 完成品

 

  手当 支払済預金

 

  主に払い戻しに関連する預金 香港のイタメ農場のサプライヤーへの保証金と役員と加工工場のリース契約。預金は 当社がサプライヤー契約を終了し、リース契約満了時に回収しました。 不動産 · 設備

 

  十二月三十一日 装備

 

  賃借権改善 不動産 · 設備

 

  減価償却累計 減価償却額 :

 

  十二月三十一日までの年度 行政費

 

計算すべき費用その他は支払わなければならない

 

経費その他の買掛金 主に給与やその他の専門手数料の支払額を表しています

 

借金をする

 

27

 

 

2023 年 12 月 31 日に終了した年度は、 当社は、 2 つの無担保無利子スタンバイブリッジローンファシリティを設立しました。1 つは、少数株主から取得した、 施設制限は US $です。

 

, of which US$

 

独立した第三者から現在まで描かれています 設定は US $です

 

, of which US$

 

引き下げられた両施設の返済は、日付から 1 年以内に支払われます。 最初の引き下げです

 

リース事業

 

28

 

  

当社は、事業リースを オフィスと倉庫の保管。会社の賃貸借契約は、

 

トゥ

 

何年か

 

2022 年 12 月 31 日現在、当社 まだ開始されていない追加の材料の運営リースはありません

 

以下の表で説明します。 会社の運営契約について。

 

12月31日まで

 

  使用権資産 — オペレーティングリース 費用

 

  累計償却する 総賃貸コスト

 

  その他の情報 十二月三十一日までの年度

 

  新規使用権資産 — オペレーティングリースおよびリース負債の認識 レンタル負債の金額を計上するために支払った現金

 

29

 

  

加重平均残余賃貸期間--レンタルを経営します

 

年間

 

年間

 

加重平均割引率-レンタル経営

 

オペレーティングリース債務の満期 ( 割引外キャッシュフロー ) は以下の通りです。

 

期日まで

 

30

 

  

リース支払総額を経営する

 

計上された利息を差し引く

 

リース負債総額を経営する

 

所得税

 

当社およびその子会社は 各事業体が居住している場所から得られる所得について事業体単位で所得税の対象となります

 

当社とその子会社 Top ウェルス · ビルジア諸島は、ケイマン諸島とイギリス領ヴァージン諸島にそれぞれ本拠を置いています。両社は現在常設。 所得税の休暇なので両社は所得税を発生しません

 

当社の事業子会社、 香港で法人化された Top Wealth International は、以下の所得税率の対象となります。

 

最初の HK $%

 

31

 

 

評価可能な利益 and

 

その後の評価可能な利益の% 。

 

  十二月三十一日までの年度 所得税支給

 

  現在の 香港.香港

 

  過去数年間の超過引当額 延期する

 

  香港.香港 前年の引当下

 

  総額 所得税の数値調整 一見の課税に対する費用 :

 

十二月三十一日までの年度

 

所得税引前利益 ( 損失 )

 

香港の所得税率における税制効果

 

優遇税率の税制効果

 

未認識の税金損失の税金効果

 

非控除支出

 

32

 

 

過去数年間の超過引当額

 

減税の税制効果

 

総額

 

有効所得税率(%)

 

十二月三十一日までの年度

 

実効所得税率 — 香港

 

認識されていない資料はなかった 一時的な違い

 

繰延税金資産の構成要素 負債とその動きは以下の通りでした

 

33

 

 

税損

 

減価償却

 

手当

 

利子

 

所得税

 

関係者取引

 

2023 年、同社は以下の 関係者取引 :

 

名前.名前

 

34

 

 

金額

 

関係.関係

 

注記

 

チョン · キン · ファイ

 

当社の元取締役 · 主席

 

無担保無利子ローンの返済支払、需要に応じて返済

 

  ウォン · キム · クワン · キングズ 当社の取締役および支配株主

 

  無担保無利子ローンの返済支払、需要に応じて返済 シクマ資本有限公司

 

  当社の株主 無担保無利子ローンからの支払金、引き下げから 1 年以内に返済されます。

 

  2022 年、同社は以下の 関係者取引 : 名前.名前

 

  金額 関係.関係

 

  注記 ビューティー & ヘルスインターナショナル有限公司 ( お客様 B ) ( 注釈 a )

 

  共同管理下の会社 収入 — キャビアの販売

 

  Beauty & Health International E—Commerce Limited ( 顧客 C ) ( 注 b ) 共同管理下の会社

 

35

 

 

収入 — キャビアの販売

 

マザーネイチャーヘルス ( 香港 ) リミテッド ( 顧客 E ) ( 注 b )

 

同社の元取締役は、同関連会社の元取締役でもあります。

 

収入 — キャビアの販売

 

Sky Channel Management Limited ( 注 d )

 

当社の主たる所有者は、同関連会社の元取締役でした。

 

マーケティング費用

 

チョン · キン · ファイ

 

当社の元取締役 · 主席

 

無担保無利子ローンの支払金、オンデマンド返済金

 

チョン · キン · ファイ

 

36

 

 

当社の元取締役 · 主席

 

2022 年 12 月 31 日時点のトップ · ウェルス · インターナショナルの普通株式発行債権額。支払額は 2023 年 5 月 13 日に行われた。

 

ウォン · キム · クワン · キングズ

 

当社の取締役および支配株主

 

無担保無利子ローンの支払金、オンデマンド返済金

 

ウォン · キム · クワン · キングズ

 

当社の取締役および支配株主

 

37

 

 

トップ · ウェルス · インターナショナルの無担保無利子ローンの通常株式への転換

 

2021 年、当社は以下の 関係者取引 :

 

  名前.名前 金額

 

  関係.関係 注記

 

  チョン · キン · ファイ 当社の元取締役 · 主席

 

  無担保無利子貸付債権の現金前払い、需要に応じて返済 ウォン · キム · クワン · キングズ

 

  当社の取締役および支配株主 無担保無利子ローンの支払金、オンデマンド返済金

 

  2023 年 12 月 31 日現在、当社 関係者との残高は以下の通りでした 名前.名前

 

  金額 関係.関係

 

  注記 ウォン · キム · クワン · キングズ

 

  当社の取締役および支配株主 無担保無利子ローンの支払、需要に応じて返済

 

  シクマ資本有限公司 当社の株主

 

無担保無利子融資に対応して,金を引き出してから1年以内に返済する

 

2022 年 12 月 31 日現在、当社 関係者との残高は以下の通りでした

 

名前.名前

 

金額

 

関係.関係

 

38

 

 

注記

 

マザーネイチャーヘルス ( 香港 ) リミテッド ( 顧客 E ) ( 注 c )

 

同社の元取締役は、同関連会社の元取締役でもあります。

 

売掛金

 

チョン · キン · ファイ

 

当社の元取締役 · 主席

 

無担保無利子債権、需要に応じて返済可能

 

ウォン · キム · クワン · キングズ

 

当社の取締役および支配株主

 

39

 

 

無担保無利子ローンの支払、需要に応じて返済

 

注:

 

この関係者との取引は、 2022 年 8 月 31 日以降に停止しました。

 

この関係者との取引は、 2022 年 9 月 3 日に開始されました。支配株主は、 2022 年 8 月 28 日にこの関係者に対するすべての持分を処分しました。これらの取引は、 2023 年 12 月 31 日期における関係者取引とはみなされていません。

 

この関係者との取引は、 2022 年 1 月 27 日に開始されました。元取締役は 2022 年 2 月 10 日に辞任しました。これらの取引は、 2023 年 12 月 31 日期における関係者取引とはみなされません。

 

この関係者との取引は、 2022 年 12 月 31 日以降に終了しました。

 

濃度とリスク

 

当社は重大な影響を受けていません。 集中リスク以外の財務リスクは、以下のように分析されます。

 

40

 

 

顧客

 

10% 以上の顧客 当社の収益または重要な売掛金の残高は、以下のように分析されます。

 

  終了年度の収入 12 月 31 日

 

  締め切りの残高 12 月 31 日

 

顧客A

 

  (a) 顧客B

 

  (b) 顧客C

 

  (c) 顧客D

 

  (d) 顧客E

 

  (e) 普通

 

  (f)

 

発表されました

 

Winwin Development Group Limited

 

Beyond Gloryユニバーサル株式会社

 

41

 

 

KINE Sky Global Limited

 

国智控股有限公司

 

シクマ資本有限公司

 

水星環球投資有限公司

 

株を比例して発行した後、Top Win Development Group LimitedはWealth Group Holding Limited 74.67%(20,160,000株普通株に相当),6.40%(相当)を保有している Beyond Glory Worldwide Limitedは1,728,000株の普通株を持ち,Ken Sky Globalは6.53%(1,764,000株の普通株に相当)を持つ. 国智控股有限公司は6.53%(176.4万株普通株に相当)、3.33%(90万株普通株に相当)を保有している それぞれシクマ資本有限会社と水星環球投資有限公司が2.53%(684,000株の普通株に相当)を保有している。 株主が株式を保有する割合は株式を比例して発行する前後で変わらない。

 

2023年10月16日、国家智恵控股有限公司 KINE Sky Global Limitedは432,000株と432,000株の普通株を314,685香港ドルでHarmony Global Limitedに譲渡した それぞれ314,685香港ドル(約40,344ドル)と314,685香港ドル(約40,344ドル)だった。当日Beyond Global Worldwide Limitedは 540,000株の普通株は墨丘利環球投資有限公司に与えられ、代償は香港ドル393,356元(約50,430ドル)である。

 

コンサルティング会社株式オプション

 

42

 

 

頂上フォーチュン·グループ(国際)有限公司 当該子会社の経営者は、海通証券さんとの企業開発コンサルタント委任契約(“顧問”)を締結する 協議“)は,その中でピークフォーチュングループ(国際)有限会社にMr.Chenを委任し,任期10カ月,8月から発効した 2022年6月1日から2023年6月30日まで、企業発展、プロジェクト管理、資本融資に関するコンサルティングサービスを提供します。 同社の米国での初公募株。コンサルタント協定によると、創富グループ(国際)有限公司は ピークフォーチュン·グループ·ホールディングスにMr.Chenに株式オプションを付与して合計108万株を買収するよう促しました ピーク富集団持株有限公司は会社が初めて公募した後、ピーク富集団持株有限公司の普通株の4%を占めた。 初公募前に発行され、発行された(“顧問株式購入”)。Mr.Chenに付与されたオプションが授与され 3年以内に3回の均等額に分けて行使することができ,それぞれ会社にある ナスダック資本市場に看板を掲げて上場します。すべての選択権は会社設立3周年後60ヶ月以内に行使しなければならない 列挙してください。そうでなければ、行使されなかったオプションは無効になります。顧問株式オプションの適用行権価格 Mr.Chenは当社の普通株式1株当たり株価の50%(50%)を付与する。

 

私たちは発行と取引のたびに 証券法の下の条例D又は第2条に基づく 証券法第4(2)項公開に触れない又はSに依存した証券条例による取引について 発行者がオフショア取引で販売する行為について。これらの証券の発行には引受業者が参加していない。 

 

プロジェクト8.証拠品および財務諸表の添付表

 

(A)展示品。

 

証拠品番号:

 

説明する

 

配給代理プロトコルフォーマット

 

会社規約(ここでは表F-1登録説明書の添付ファイル3.1(書類番号333-275684)を引用し、改訂され、最初は2023年11月21日に米国証券取引委員会に提出された)

 

ディレクター

 

43

 

 

2024 年 9 月 27 日

 

名前: Feiyong 、李

 

/ s / Phei Suan, HO

 

ディレクター

 

2024 年 9 月 27 日

 

名前: Phei Suan, HO

 

/ s / Wai Chun, CHIK

 

ディレクター

 

2024 年 9 月 27 日

 

44

 

 

名前: ワイチュン、チック

 

代理人による署名 アメリカ合衆国の

 

1933 年の証券法に基づき、 アメリカ合衆国における正当な権限を与えられた代表者は、この登録声明に署名しました 2024 年 9 月 27 日にニューヨーク州ニューヨークで開催された。

 

コーリンユニバーサル社です。

 

許可されたアメリカ代表

 

  投稿者: /S/コリン·A·ド·フリーズ

 

  名前: コーリン·A·デフリーズ

 

  タイトル: 上級副総裁

 

  II-7 F-1/A

 

  本当だよ デイ: ビジネスコンタクトメンバー

 

  米国-公認会計基準:関連側メンバー 米国-公認会計基準:関連側メンバー

 

  米国-公認会計基準:関連側メンバー 米国-公認会計基準:関連側メンバー

 

45

 

 

  米国-公認会計基準:関連側メンバー アメリカ-アメリカ公認会計基準:普通株式メンバー

 

  US-GAAP:AdditionalPaidInCapitalMembers アメリカ-公認会計基準:前払いメンバーを保留

 

  アメリカ-アメリカ公認会計基準:普通株式メンバー US-GAAP:AdditionalPaidInCapitalMembers

 

  アメリカ-公認会計基準:前払いメンバーを保留 アメリカ-アメリカ公認会計基準:普通株式メンバー

 

  US-GAAP:AdditionalPaidInCapitalMembers アメリカ-公認会計基準:前払いメンバーを保留

 

  アメリカ-アメリカ公認会計基準:普通株式メンバー US-GAAP:AdditionalPaidInCapitalMembers

 

  アメリカ-公認会計基準:前払いメンバーを保留 アメリカ-アメリカ公認会計基準:普通株式メンバー

 

  US-GAAP:AdditionalPaidInCapitalMembers アメリカ-公認会計基準:前払いメンバーを保留

 

  アメリカ-アメリカ公認会計基準:普通株式メンバー US-GAAP:AdditionalPaidInCapitalMembers

 

  アメリカ-公認会計基準:前払いメンバーを保留 アメリカ-アメリカ公認会計基準:普通株式メンバー

 

US-GAAP:AdditionalPaidInCapitalMembers

 

アメリカ-公認会計基準:前払いメンバーを保留

 

twg: MrWongKimKwanKings メンバー

 

twg : MrChongKinFai メンバー

 

46

 

 

twg: TopWealthBVIGroupLimited メンバー

 

twg: TopWealthGroupInternationalLimited メンバー

 

米国-GAAP:IPOメンバー

 

米国-GAAP:IPOメンバー

 

アメリカ-アメリカ公認会計基準:普通株式メンバー

 

米国-GAAP:IPOメンバー

 

twg: TopWealthGroupHoldingLimitedMember

 

twg: TopWealthBVIGroupLimited メンバー

 

47

 

 

twg: TopWealthGroupInternationalLimited メンバー

 

twg: WinwinDevelopmentGroupLimited メンバー

 

twg : BeyondGloryWorldwideLimitedMembertwg: KeenSkyGlobalLimitedMembertwg: StateWisdomHoldingsLimited メンバーtwg: SnowBearCapitalLimited メンバーtwg: MercuryUniversalInvestmentLimited メンバー

 

twg: GreetHarmonyGlobalLimited メンバー

 

  SRT:最小メンバ数 SRT:最大メンバ数

 

  twg: 販売のキャビア製品メンバー twg: 販売のキャビア製品メンバー

 

  twg: 販売のキャビア製品メンバー twg: SaleOfWineMember

 

  twg: SaleOfWineMember twg: SaleOfWineMember

 

  twg: USDToHKYearEndMember twg: USDToHKYearEndMember

 

twg: USDToHKYearEndMember

 

twg: USDToHK 平均レートメンバー

 

twg: USDToHK 平均レートメンバー

 

twg: USDToHK 平均レートメンバー

 

twg: ThirdPartiesMember

 

48

 

 

twg: ThirdPartiesMember

 

米国-公認会計基準:関連側メンバー

 

米国-公認会計基準:関連側メンバー

 

米国-GAAP:デバイス構成員

 

米国-GAAP:デバイス構成員

 

アメリカ-公認会計基準:リース改善メンバー

 

アメリカ-公認会計基準:リース改善メンバー

 

  twg: ThirdPartiesMember SRT:最小メンバ数

 

  SRT:最大メンバ数 国:香港

 

  twg: TopWealthGroupInternationalLimited メンバー twg: HongKongMember

 

  twg: HongKongMember twg: HongKongMember

 

  twg: OverProvisionInPreviousYearsMember twg: OverProvisionInPreviousYearsMember

 

49

 

 

twg: OverProvisionInPreviousYearsMember

 

twg: UnderProvisionInPreviousYearsMember

 

twg: UnderProvisionInPreviousYearsMember

 

twg: UnderProvisionInPreviousYearsMember

 

国:香港

 

国:香港

 

twg: 税金損失メンバー

 

50

 

 

twg: 減価償却手当会員

 

twg: 税金損失メンバー

 

twg: 減価償却手当会員

 

twg: 税金損失メンバー

 

twg: 減価償却手当会員

 

twg: 税金損失メンバー

 

twg: 減価償却手当会員

 

twg: 税金損失メンバー

 

51

 

 

twg: 減価償却手当会員

 

SRT:シーン予測メンバ

 

  twg: ChongKinFai メンバー twg: WongKimKwanKings メンバー

 

  twg: SnowBearCapitalLimited メンバー twg: BeautyHealthInternationalCompanyLimited お客様 B メンバー

 

  twg: ビューティーヘルスインターナショナル ECommerceLimited お客様 CMember twg: MotherNatureHealthHKLimited お客様メンバー

 

  twg: SkyChannelManagementLimited 会員 twg: ChongKinFai メンバー

 

  twg: ChongKinFaiOneMember twg: WongKimKwanKings メンバー

 

  twg: ワンキムクワンキングズワンメンバー twg: ChongKinFai メンバー

 

  twg: WongKimKwanKings メンバー twg: WongKimKwanKings メンバー

 

  米国-公認会計基準:関連側メンバー twg: SnowBearCapitalLimited メンバー

 

  米国-公認会計基準:関連側メンバー twg: MotherNatureHealthHKLimited お客様メンバー

 

  米国-公認会計基準:関連側メンバー twg: ChongKinFai メンバー

 

  米国-公認会計基準:関連側メンバー twg: WongKimKwanKings メンバー

 

  米国-公認会計基準:関連側メンバー twg: 顧客メンバー

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

twg: 顧客メンバー

 

アメリカ公認会計基準:売掛金メンバー

 

52

 

 

US-GAAP:顧客集中度リスクメンバー

 

twg: 顧客メンバー

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー


twg: 顧客メンバー

 

53

 

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: 顧客メンバー

 

アメリカ公認会計基準:売掛金メンバー

 

54

 

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerBMember

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

  twg: CustomerBMember アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

   twg: CustomerBMember 
   アメリカ公認会計基準:売掛金メンバー   US-GAAP:顧客集中度リスクメンバー
twg: CustomerBMember(1)
 
   アメリカ公認会計基準:売掛金メンバー   US-GAAP:顧客集中度リスクメンバー 
twg: CustomerBMember        
アメリカ公認会計基準:売掛金メンバー  $2,700    5,400 
US-GAAP:顧客集中度リスクメンバー  $641,015    25,637,869 
twg: CustomerCMember  $4,308,921    4,308,921 
アメリカ公認会計基準:売掛金メンバー  $4,952,636   $29,952,190 
US-GAAP:顧客集中度リスクメンバー  $4,952,636   $29,952,190 

 

 

(1)twg: CustomerCMember

 

アメリカ公認会計基準:売掛金メンバー

 

55

 

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerCMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerCMember

 

   アメリカ公認会計基準:売掛金メンバー
US-GAAP:顧客集中度リスクメンバー(1)
 
twg: CustomerCMember  $        0.99 
アメリカ公認会計基準:売掛金メンバー  $0.18 
US-GAAP:顧客集中度リスクメンバー  $0.37 
twg: CustomerDMember  $0.55 
アメリカ公認会計基準:売掛金メンバー  $0.44 

 

(1)US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerDMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

56

 

 

twg: CustomerDMember
アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerDMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerDMember

 

アメリカ公認会計基準:売掛金メンバーUS-GAAP:顧客集中度リスクメンバーtwg: 顧客メンバー

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

  twg: 顧客メンバー アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: 顧客メンバー

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

57

 

 

twg: 顧客メンバー

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

  twg: 顧客メンバー アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: CustomerFMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

  twg: CustomerFMember アメリカ公認会計基準:売掛金メンバーUS-GAAP:顧客集中度リスクメンバー

 

twg: CustomerFMember

 

アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: CustomerFMemberアメリカ公認会計基準:売掛金メンバーUS-GAAP:顧客集中度リスクメンバーtwg: CustomerFMember

 

58

 

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバーtwg: CustomerGMember

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

  twg: CustomerGMember アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: CustomerGMember

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

  twg: CustomerGMember アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: CustomerGMember

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

  twg: CustomerHMember アメリカ公認会計基準:売掛金メンバー

 

  US-GAAP:顧客集中度リスクメンバー twg: CustomerHMember

 

  アメリカ公認会計基準:売掛金メンバー US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerHMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerHMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerHMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

59

 

 

twg: CustomerIMember

 

   アメリカ公認会計基準:売掛金メンバー
US-GAAP:顧客集中度リスクメンバー
         
   2023   2022   twg: CustomerIMember 
   アメリカ公認会計基準:売掛金メンバー   US-GAAP:顧客集中度リスクメンバー   twg: CustomerIMember   % 
アメリカ公認会計基準:売掛金メンバー   16,943,287    8,512,929    8,430,358    99.0 
US-GAAP:顧客集中度リスクメンバー   (11,556,006)   (4,309,747)   (7,246,259)   168.1 
twg: CustomerIMember   5,387,281    4,203,182    1,184,099    28.2 
アメリカ公認会計基準:売掛金メンバー   2        2    100.0 
US-GAAP:顧客集中度リスクメンバー   (1,846,759)   (466,477)   (1,170,282)   250.9 
twg: CustomerIMember   (495,276)   (1,456,347)   961,071    (66.0)
アメリカ公認会計基準:売掛金メンバー   3,045,248    2,280,358    974,890    42.75 

 

US-GAAP:顧客集中度リスクメンバー

 

   twg: CustomerJMember
アメリカ公認会計基準:売掛金メンバー
         
   2023   2022   US-GAAP:顧客集中度リスクメンバー 
   twg: CustomerJMember   アメリカ公認会計基準:売掛金メンバー   US-GAAP:顧客集中度リスクメンバー   % 
twg: CustomerJMember   12,483,195    8,512,929    3,970,266    46.64 
アメリカ公認会計基準:売掛金メンバー   4,460,092        4,460,092    100.0 
    16,943,287    8,512,929    8,430,358    99.0 

 

US-GAAP:顧客集中度リスクメンバー

 

twg: CustomerJMember

 

アメリカ公認会計基準:売掛金メンバー

 

   US-GAAP:顧客集中度リスクメンバー
twg: CustomerJMember
         
   2023   2022   アメリカ公認会計基準:売掛金メンバー 
   US-GAAP:顧客集中度リスクメンバー   twg: CustomerMember   アメリカ公認会計基準:売掛金メンバー   % 
US-GAAP:顧客集中度リスクメンバー   4,957,157    4,203,182    753,975    17.9 
twg: CustomerMember   430,124        430,124    100.0 
アメリカ公認会計基準:売掛金メンバー   5,387,281    4,203,182    1,184,099    28.2 
US-GAAP:顧客集中度リスクメンバー   39.7%   49.4%       9.7%
twg: CustomerMember   9.64%              
アメリカ公認会計基準:売掛金メンバー   31.8%   49.4%        (17.6)%

 

US-GAAP:顧客集中度リスクメンバー

 

60

 

 

twg: CustomerMember

 

アメリカ公認会計基準:売掛金メンバー

 

US-GAAP:顧客集中度リスクメンバー

 

   twg: CustomerMember
アメリカ公認会計基準:売掛金メンバー
 
   2023   2022 
   US-GAAP:顧客集中度リスクメンバー   %   アメリカ-公認会計基準:帳簿を支払うべきメンバー   % 
米国-GAAP:サプライヤー集中度リスクメンバー   444,388    24.1    110,024    23.6 
twg: SupplierAMember   233,659    12.7    173,215    37.1 
アメリカ-公認会計基準:帳簿を支払うべきメンバー   86,038    4.7    53,282    11.4 
米国-GAAP:サプライヤー集中度リスクメンバー   9,793    0.5    29,997    6.4 
twg: SupplierAMember   921,110    49.9    35,322    7.6 
アメリカ-公認会計基準:帳簿を支払うべきメンバー   76,342    4.1    20,072    4.3 
米国-GAAP:サプライヤー集中度リスクメンバー   36,545    1.9    18,142    3.9 
twg: SupplierAMember   14,977    0.8    11,440    2.5 
アメリカ-公認会計基準:帳簿を支払うべきメンバー   23,907    1.3    14,983    3.2 
    1,846,759    100.0    466,477    100.0 

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

twg: SupplierAMember

 

   アメリカ-公認会計基準:帳簿を支払うべきメンバー
米国-GAAP:サプライヤー集中度リスクメンバー
 
   2023   2022 
   twg: SupplierAMember   %   アメリカ-公認会計基準:帳簿を支払うべきメンバー   % 
米国-GAAP:サプライヤー集中度リスクメンバー   495,276    100    1,456,347    100 

 

twg: SupplierBMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

twg: SupplierBMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

   米国-GAAP:サプライヤー集中度リスクメンバー
twg: SupplierBMember
 
   2023   2022 
   アメリカ-公認会計基準:帳簿を支払うべきメンバー   米国-GAAP:サプライヤー集中度リスクメンバー 
twg: SupplierBMember   217,384    1,385 
アメリカ-公認会計基準:帳簿を支払うべきメンバー   (863,616)   120,260 
米国-GAAP:サプライヤー集中度リスクメンバー       (481,173)
twg: SupplierBMember   780,582    576,912 
アメリカ-公認会計基準:帳簿を支払うべきメンバー   (83,034)   215,999 
米国-GAAP:サプライヤー集中度リスクメンバー   134,350    217,384 

 

61

 

 

twg: SupplierMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

twg: SupplierMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

twg: SupplierMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

twg: SupplierMember

 

アメリカ-公認会計基準:帳簿を支払うべきメンバー

 

米国-GAAP:サプライヤー集中度リスクメンバー

 

62

 

 

twg: SupplierMember

 

アメリカ-アメリカ公認会計基準:普通株式メンバー

 

アメリカ-アメリカ公認会計基準:普通株式メンバー

 

アメリカ-アメリカ公認会計基準:普通株式メンバー

 

米国-GAAP:IPOメンバー

 

アメリカ-アメリカ公認会計基準:普通株式メンバー

 

米国-GAAP:IPOメンバー

 

iso4217: USD

 

iso4217: USD

 

xbrli: 株式

 

   xbrli: 株式
2023
   xbrli: 純粋
2022
 
ISO 4217:香港ドル   7.8    7.8 

 

   December 31, 
   2023   2022 
USD to HK$ Average Rate   7.8    7.8 

 

63

 

 

Fair Value MeasurementsFair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Inputs used to measure fair value are classified using the following hierarchy:

 

  Level 1. Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

  Level 2. Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly through corroboration with observable market data.

 

  Level 3. Inputs are unobservable for the asset or liability and include situations in which there is little, if any, market activity for the asset or liability. The inputs used in the determination of fair value are based on the best information available under the circumstances and may require significant management judgment or estimation.

 

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses reflected as current assets and current liabilities. Due to the short-term nature of these instruments, management considers their carrying value to approximate their fair value.

 

New accounting standards

 

Financial Instruments —Credit Losses

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (Topic 326), Financial Instruments — Credit Losses: Measurement of Credit Losses on Financial Instruments, which replaces the existing incurred loss impairment model with an expected credit loss model and requires an asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance became effective for the Company beginning January 1, 2023. The adoption did not have a material impact on the Company’s consolidated financial statements.

 

Accounts receivables are reviewed for impairment on a quarterly basis and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company’s analysis of amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions. The allowance for expected credit losses is recognized in net income (loss) and any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of accounts receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs. As of June 30, 2023 and December 31, 2021, the total allowance for expected credit losses on the Company’s accounts receivable were Nil and Nil.

 

On December 14, 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures. The amendments require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). In addition, public business entities are required to provide certain qualitative disclosures about the rate reconciliation and the amount of income taxes paid (net of refunds received) disaggregated (1) by federal (national), state, and foreign taxes and (2) by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). For public business entities, the standard is effective for annual periods beginning after December 15, 2024. The amendments in this ASU require a cumulative effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company is evaluating the impact of this standard on the Company’s consolidated financial statements.

 

We have evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the Financial Accounting Standards Board or other standards-setting bodies through the date of this report and do not believe the future adoption of any such standards will have a material impact on our consolidated financial statements.

 

64

 

 

Corporate History and Structure

 

Top Wealth Group Holding Limited is a holding company with no operations of its own. We conduct our operations in Hong Kong primarily through, Top Wealth Group (International Limited), our Operating Subsidiary in Hong Kong. The ordinary shares offered in this prospectus are those of Top Wealth Group Holding Limited.

 

The following diagram illustrates the corporate structure of Top Wealth Group Holding Limited and its subsidiary as of the date of this prospectus.

 

A group of money in a chart  Description automatically generated with medium confidence

 

Top Wealth Group Holding Limited was incorporated as a limited liability company on February 1, 2023 under law of the Cayman Islands. It is a holding company and is not actively engaged in any business. Under its memorandum of association, Top Wealth Group Holding Limited is authorized to issue 500,000,000 Ordinary Shares, par value US$0.0001 per share, of which 29,000,000 Ordinary Shares are issued and outstanding. The registered office of Top Wealth Group Holding Limited is at the office of Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands.

 

Top Wealth (BVI) Holding Limited was incorporated under the law of the British Virgin Islands as the intermediate holding company of Top Wealth Group (International) Limited, on January 18, 2023 as part of the reorganization. Top Wealth (BVI) Holding Limited is wholly-owned by Top Wealth Group Holding Limited.

 

Top Wealth Group (International) Limited was incorporated on September 22, 2009 under the laws of Hong Kong. Top Wealth Group (International) Limited is our operating entity and is indirectly wholly-owned by Top Wealth Group Holding Limited through Top Wealth (BVI) Holding Limited.

 

History of Shares

 

On February 1, 2023, the date of the incorporation of Top Wealth Group Holding Limited, 1 Ordinary Share was issued to Ogier Global Subscriber (Cayman) Limited. On March 1, 2023, the 1 Ordinary Share was transferred from Ogier Global Subscriber (Cayman) Limited to Winwin Development Group Limited and the Top Wealth Group Holding Limited further issued 99 Ordinary Shares to Winwin Development Group Limited on the same date.

 

On April 18, 2023, 650 Ordinary Shares were further issued to Winwin Development Group Limited, whereby Top Wealth Group Holding Limited was then solely owned by Winwin Development Group Limited as to 750 Ordinary Shares.

 

Furthermore, on the same date, April 18, 2023, Winwin Development Group Limited entered into Sale and Purchase Agreements with: Keen Sky Global Limited, State Wisdom Holdings Limited, Beyond Glory Worldwide Limited, Snow Bear Capital Limited and Mercury Universal Investment Limited, respectively. Pursuant to the Sales and Purchase Agreements, Winwin Development Group Limited is to sell, and Beyond Glory Worldwide Limited, Keen Sky Global Limited, State Wisdom Holdings Limited, Snow Bear Capital Limited, and Mercury Universal Investment Limited are to acquire, 6.40%, 6.53%, 6.53%, 3.33%, 2.53% equity interests in Top Wealth Group Holding Limited, at the consideration of HK$1,424,000 (approximately US$182,564), HK$1,453,000 (approximately US$186,282), HK$1,453,000 (approximately US$186,282), HK$742,000 (approximately US$95,128), and HK$565,000(approximately US$72,436), respectively. On the same date, Winwin Development Group Limited executed the instrument of transfers whereby Winwin Development Group Limited have transferred 48, 49, 49, 25, and 19 Ordinary Shares, out of its 750 Ordinary Shares, to Beyond Glory Worldwide Limited, Keen Sky Global Limited, State Wisdom Holdings Limited, Snow Bear Capital Limited and Mercury Universal Investment Limited, respectively.

65

 

 

On October 12, 2023, in contemplation of Company’s initial public offering, Top Wealth Group Holding Limited further issued 26,999,250 Ordinary Shares in aggregate to its shareholders at par value, on a pro rata basis proportional to the shareholders’ existing equity interests (collectively refers as the “Pro Rata Share Issuance”), which has been treated as a share split. All references to the number of ordinary shares and per-share data in the accompanying consolidated financial statements have been retroactively adjusted to reflect such issuance of shares. After the Pro Rata Share Issuance, 27,000,000 Ordinary Shares were issued and outstanding. The following table sets forth the breakdown of the Pro Rata Share Issuance to each shareholder:

 

Shareholders  Number of
Ordinary
Shares
Issued
 
Winwin Development Group Limited   20,159,440 
Beyond Glory Worldwide Limited   1,727,952 
Keen Sky Global Limited   1,763,951 
State Wisdom Holdings Limited   1,763,951 
Snow Bear Capital Limited   899,975 
Mercury Universal Investment Limited   683,981 

 

Subsequent to the Pro Rata Share Issuance, Top Wealth Group Holding Limited was 74.67% (representing 20,160,000 Ordinary Shares) owned by Winwin Development Group Limited, 6.40% (representing 1,728,000 Ordinary Shares) owned by Beyond Glory Worldwide Limited, 6.53% (representing 1,764,000 Ordinary Shares) owned by Keen Sky Global Limited, 6.53% (representing 1,764,000 Ordinary Shares) owned by State Wisdom Holdings Limited, 3.33% (representing 900,000 Ordinary Shares) owned by Snow Bear Capital Limited, and 2.53% (representing 684,000 Ordinary Shares) owned by Mercury Universal Investment Limited, respectively. The percentage of the ownership of equity interests held by the shareholders remained the same before and after the Pro Rata Share Issuance.

 

On October 16, 2023, State Wisdom Holdings Limited and Keen Sky Global Limited transferred 432,000 and 432,000 Ordinary Shares to Greet Harmony Global Limited at the consideration of HK$314,685 (approximately US$40,344) and HK$314,685 (approximately US$40,344), respectively. On the same day, Beyond Global Worldwide Limited transferred 540,000 Ordinary Shares to Mercury Universal Investment Limited at the consideration of HK$393,356 (approximately US$50,430). The following table sets forth the breakdown of equity ownership of the Company after the series of transactions in October 16, 2023:

 

Shareholders  Number of
Ordinary
Shares
Owned
 
Winwin Development Group Limited   20,160,000 
Beyond Glory Worldwide Limited   1,188,000 
Keen Sky Global Limited   1,332,000 
State Wisdom Holdings Limited   1,332,000 
Snow Bear Capital Limited   900,000 
Mercury Universal Investment Limited   1,224,000 
Greet Harmony Global Limited   864,000 

 

On April 18, 2024, the Company closed its initial public offering of 2,000,000 Ordinary Shares at a public offering price of US$4.00 per Ordinary Share.

 

On July 2, 2024, the Company filed the registration statement on Form F-1 with the SEC (File No. 333-280654) (as amended, the “Resale Prospectus”), which was declared effective on July 23, 2024, for 6 existing shareholders of the Company to register their existing shareholding of an aggregate of 6,840,000 Ordinary Shares to be sold pursuant to the Resale Prospectus. The following table sets forth the breakdown of number of ordinary shares registered for sale in the resale prospectus by the existing shareholders:

 

Name of Shareholders  Number of
Ordinary
Shares
Registered for
Sale in
the Resale
Prospectus
 
Beyond Glory Worldwide Limited   1,188,000 
Keen Sky Global Limited   1,332,000 
State Wisdom Holdings Limited   1,332,000 
Snow Bear Capital Limited   900,000 
Mercury Universal Investment Limited   1,224,000 
Greet Harmony Global Limited   864,000 
Total   6,840,000 

 

As of the date of this prospectus, 29,000,000 Ordinary Shares were issued and outstanding.

 

66

 

 

BUSINESS

 

Overview

 

Our mission is to become a world-renowned supplier of the finest selection of caviar and offer caviar-based gourmet products around the globe with unparalleled gastronomical experience.

 

Headquartered in Hong Kong, we are a fast-growing supplier of caviar products. We are currently specialized in supplying high-quality sturgeons caviar. Our caviar is endorsed with the Convention on International Trade in Endangered Species of Wild Fauna and Flora (“CITES”) permits, which certifies that our caviar is legally traded. We are one of the major suppliers of caviar in Hong Kong. We have secured a long-term and exclusive supply of caviar raw products from a PRC sturgeon farm.

 

Since we established our caviar business in August 2021, we had supplied caviar to our customers under their brand labels (i.e. private labeling) or without brand labels. Subsequently in November 2021, we established our own caviar brand, “Imperial Cristal Caviar”, and started selling caviar under our own brand as well. With its exquisite package design, we consider our branded caviar is ideal to be presented as both culinary delights and festive gifts. Imperial Cristal Caviar has continuously achieved tremendous sales growth since its launch in the market.

 

In March 2023, as the addition to the gastronomical experience of our caviar, we have commenced our wine trading business line, to complement our caviar business. For the fiscal year ended December 31, 2023, our wine trading business line contributed revenue of US$4,460,092, compared to Nil for the fiscal year ended December 31, 2022. The fine wine we distribute include white wine, red wine, and Champagne, from various countries including France, Greek, and Spain, etc. Our wine trading business only involves the distribution of fine wine within Hong Kong on business-to-business (B2B) sales, primarily to our F&B related distributor customers, in particular, the F&B related distributor customers who we supply our caviar product. We do not import or manufacture the wine we distribute, instead, we source the wines from our wine suppliers in Hong Kong on an as-demand per order basis. Therefore, we are not subject to the relevant licensing requirements that apply to sale of alcoholic beverages in Hong Kong.

 

We take pride in our well-tested, reliable caviar supply chain management module, which helps ensure the palatability and freshness of our products when they reach our customers. We believe we are among one of the few Hong Kong caviar suppliers being able to secure a long-term and exclusive supply of caviar raw products from a PRC sturgeon farm. In April 2022, we entered into an exclusive supply agreement with the agent and distributor of a well-established sturgeon farm in Fujian, the PRC, which appointed us as its exclusive distributor in Hong Kong and Macau for conducting overseas distribution and granted us the rights to procure caviar directly from it for a term of 10 years. This sturgeon farm is one of the six existing PRC sturgeon farms which are officially permitted to export locally-bred roe. We have engaged a Hong Kong-based supply chain management company to handle the logistics, warehousing and packaging workflows in our supply chain, so we can strategically focus on brand-building and product quality assurance.

 

We are dedicated to enhancing our brand awareness. As part of our sales and marketing efforts, we have proactively participated in food expo and set up pop-up stores across the world. We have also collaborated with famous food bloggers and used different online platforms and media coverage to promote and strengthen the publicity of our products. We regularly invite chefs of notable hotels and restaurants to our tasting events.

 

We generate all of our revenues, through our Operating Subsidiary, from trading of caviar products and wine. Our revenues for the years ended December 31, 2023, 2022 and 2021 were US$16.9 million, US$8.5 million and US$19,615, respectively. We have turned around from a loss before tax of approximately US$16,888 for the year ended December 31, 2021 to a profit before tax of approximately US$2.3 million for the year ended December 31, 2022, and we have maintained a profit before tax of approximately US$3.3 million for the year ended December 31, 2023.

 

Our top five customers accounted for 92.0% and 91.1% of our total revenues for the years ended December 31, 2023 and 2022. Our customers, including our top five customers, primarily include food and beverage (“F&B”) related distributors. We have strategically focused on business-to-business sales (B2B) which would allow us access to our customers’ sales network and consumer base that helps us maximize the reach of our products swiftly and effectively. As our caviar products gain popularity worldwide, our customer base has continuously expanded as a result of customers’ referral and our marketing efforts. Our caviar products are mainly sold to customers based in Hong Kong and a substantial portion are exported overseas by our customers. As our products gradually become more well-known in the international market, we aspire to expand our sales channels from only selling through distributors to selling our products directly to overseas customers.

 

67

 

 

Our major suppliers include (i) a distributor and agent of a sturgeon farm in the PRC, Fujian Aoxuanlaisi Biotechnology Co., Ltd (“Fujian Aoxuanlaisi”), which supplies caviar raw product to us; (ii) a Hong Kong supply chain management company, Sunfun (China) Limited (“Sunfun China”), which handles the logistics, warehousing and packaging workflows in our supply chain; (iii) a Hong Kong wine distributor, which supplies fine wine to us; and (iv) other suppliers which supply packaging materials and printing services to us. We materially rely on Fujian Aoxuanlaisi as our supplier for caviar raw product. Fujian Aoxuanlaisi is the agent and ppointed distributor of a well-established PRC sturgeon farm, operated by Fujian Longhuang Biotech Co. Limited (“Fujian Longhuang”). Fujian Aoxuanlaisi and Fujian Longhuang currently maintain a long-term exclusive sales agreement for 15 years, from December 2020 to December 2035. Historically, before April 2022, we obtained the supply of caviar raw product from Fujian Aoxuanlaisi on an as-demand per order basis, without any long-term agreements. In April 2022, our Operating Subsidiary, Top Wealth Group (International) Limited, has entered into the Caviar Sales Agreement with Fujian Aoxuanlaisi, appointed us as its exclusive distributor in Hong Kong and Macau. We do not have any direct supply agreement with Fujian Longhuang, the PRC sturgeon farm.

 

For the years ended December 31, 2023, 2022 and 2021, our procurement from Fujian Aoxuanlaisi amounted to approximately US$6.2 million, US$5.3 million, and US$0.3 million respectively, representing approximately 64.3%, 90% and 100% of our total purchases for the corresponding year. Our material reliance on Fujian Aoxuanlaisi as the supplier of our caviar raw product exposes us to unique and significant risk, for detailed discussion, please see “Risk Factors Risks related to our Business and Industry — We materially rely on Fujian Aoxuanlaisi Biotechnology Co., Ltd (“Fujian Aoxuanlaisi”), the exclusive distributor of a PRC sturgeon farm, as our supplier for the supply of caviar raw product. Such arrangement materially and adversely exposes us to unique risk. Any disruption in the supplier’s relationships, either between Fujian Aoxuanlaisi and the PRC sturgeon farm, or between Fujian Aoxuanlaisi and us, could have a material adverse effect on our business. Any disruption in the provision of caviar from Fujian Aoxuanlaisi or PRC sturgeon farm and our inability to identify alternative caviar supplier may materially and adversely affect our business operations and financial results.”

 

Competitive Strengths

 

A fast-growing luxury caviar products supplier with a premier brand image

 

We position ourselves as a luxury caviar products supplier aiming to supply the finest selection of luxury caviar products and offer gourmet products around the globe with unparalleled gastronomical experience. We are currently specialized in supplying high quality sturgeons caviar. In November 2021, we established our own caviar brand, “Imperial Cristal Caviar”. From the feedback of our distbributors and customers, our Imperial Cristal Caviar is highly recognized by the end-consumers in terms of its tastiness, texture, palatability, appearance and packaging. Our packaging carries a delicate design that conveys elegance and exclusivity and is ideal to be presented as both culinary delights and festive gifts. We also gladly learned from our distributor customers and market survey that our caviar products are also well-received by chefs of restaurants who serve our caviar products on their menus.

 

An extensive distribution network which allows us to stay abreast of the latest trend and development of consumers’ taste

 

We have access to an extensive distribution network through our distributors customers which allows us to connect with a broad range of consumers around the world and to stay abreast of the latest trend and development of consumers’ taste. Our caviar products are mainly sold to F&B related distributors in Hong Kong, which then export and resell such goods to downstream customers such as supermarket, retail stores, F&B chain and consumers across the world. Leveraging the sales network and consumer base of our distributors, our caviar products have been exported overseas to different countries. Through sales channels that cover extensive points of sale across countries and regions, we serve a variety of consumer groups with diversified demands, which deepens our market penetration and extends our geographical coverage.

 

A strict and comprehensive quality control system to effectively control our product safety and quality

 

Food safety and quality control are of paramount importance to our reputation and business. To ensure food safety and quality, we have established a comprehensive standards and requirements regarding our supply chain, ranging from procurement, logistics, warehousing to packaging.

 

We carefully select the source of caviar supplies. We have reviewed all certifications required from our caviar supplier in the PRC for, among other things, the operation of sturgeon farm in the PRC and exporting caviar products overseas. Our caviar products are endorsed with the CITES permits, which certifies that our caviar is legally traded. We conduct sample inspection on each incoming batch of caviar.

 

68

 

 

Our food processing factory is operated by the supply chain management company and we require its staff to follow a comprehensive set of operation manual and technical protocols prescribed by us. We provide instruction and regular on-the-job training to the processing staff to ensure their work standard and efficiency. In order to maintain the quality and freshness of our caviar, our food processing factory is equipped with temperature control system that mandates a prescribed temperature range. We implement strict and comprehensive measures in our food processing factory to ensure sanitation and hygiene at the premises, such as mandating the processing staff to wear standardized clothing, conducting regular inspection on the packaging equipment and performing routine maintenance and cleaning.

 

The supply chain management company has designated a quality control staff at our food processing factory to inspect and monitor the processing procedures. The quality control staff will conduct quality control testing and inspection throughout the packaging process and ensure the taste, size, quality and packaging of our caviar products conform with our quality standards and requirements.

 

Since the establishment of our caviar business and up to the date of this prospectus, we did not encounter any material food safety incidents and we had not experienced any product liability claims.

 

A stable and exclusive procurement source of caviar

 

We take pride in our well-tested, reliable caviar supply chain management module, which helps ensure the palatability and freshness of our products when they reach our customers. We believe we are among one of the few Hong Kong caviar suppliers being able to secure long-term and exclusive supply of caviar from sturgeon farm. We have entered into an exclusive supply agreement with the distributor of a well-established sturgeon farm in the PRC in April 2022, which appointed us as its exclusive distributor in Hong Kong and Macau for conducting overseas distribution and granted us the rights to procure caviar directly from it for a term of 10 years. This sturgeon farm is one of the six existing PRC sturgeon farms which are officially permitted to export locally-bred roe. Our end-to-end supply chain business model not only improves cost efficiency, it also promotes consumers’ confidence in our caviar products as well as facilitate our sales and marketing plans.

 

Growth Strategies

 

Expand the global market reach of our caviar product

 

We strive to strengthen the global market reach of our caviar product in developed markets with a strong consumer base, such as Europe, the United States, Japan, Dubai, Australia and Southeast Asia (collectively, the “Target Regions”). We intend to establish representative offices at each of the Target Regions to access the local consumers. We currently plan to recruit local sales and marketing staff to conduct marketing activities in such regions, ranging from (i) conducting product promotion; (ii) brand building; (iii) maintaining regular communication with local customers; (iv) collecting feedbacks from local consumers on our products; and (v) maintaining regular communication and interaction with different industry players, so we can stay abreast of the latest trend and development of local consumers’ tastes.

 

As our products gradually become more well-known in the international market, we aspire to expand our sales channels from only selling through distributors to selling our products directly to overseas customers. Material obstacles that we have to overcome include (i) the competition for high-quality sales and distribution partners is intense and we may not be able to offer more favorable arrangement than our competitors; (ii) there may not be suitable distribution channels or overseas customers in the markets that we planned to expand; (iii) we may not be able to hire, train and retain skilled local sales and marketing staffs; and (iv) we may encounter difficulties in adapting our logistics and management systems to an expanded distribution network. However, leveraging our competitive strengths described in the paragraph headed “Competitive Strengths” above, we are confident that we will be able to expand our sales channels to overseas customers three years after the Offering.

 

Strengthen our sales and marketing activities

 

We plan to strengthen our sales and marketing activities and increase our market exposure and brand awareness by participating in food-expo and collaborating with luxurious restaurants, hotels and private clubs to host tasting events in different countries and regions. Further, we plan to invite the media and chefs from notable restaurants and hotels to visit the sturgeon farm which supplies caviar raw products to us. We believe we can provide the participants with a better understanding of our procurement source and give them stronger assurance with respect to our product safety, quality and hygienic conditions, thereby enhancing the brand image of our products.

 

69

 

 

Expand our procurement source and broaden our product portfolio

 

We are committed to sourcing top-quality caviar from the best sturgeon farms around the world. We currently plan to expand our procurement source and broaden our product portfolio by exploring potential co-operations with sturgeon farms located in Europe and/or the United States. In identifying suitable caviar suppliers, we will conduct on-site inspection at the selected sturgeon farms and conduct legal and business due diligence on their background and operations. We would also verify that the caviar supplied by the selected sturgeon farms complies with the Convention on International Trade in Endangered Species of Wild Fauna and Flora. We believe that expansion in our product portfolio will provide a wider selection of caviar for our customers in terms of places of origin, as well as species and ages of sturgeon.

 

Depending on the availability of potential acquisition targets, we also plan to carry out vertical expansion by acquiring non-controlling stakes in suitable sturgeon farms in Europe and/or the United States. We believe that through integration with upstream sturgeon farms, we can guarantee a stable supply of caviar with consistent high quality.

 

Our Caviar Products and Our Own Brand

 

Headquartered in Hong Kong, we are a fast-growing supplier of luxury caviar products. We are currently specialized in supplying premium class sturgeons caviar. Our caviar is endorsed with the CITES permits, which certifies that our caviar is legally traded. We are one of the major suppliers of caviar in Hong Kong being able to secure a long-term and exclusive supply of caviar raw products from sturgeon farm.

 

Since we established our caviar business in August 2021, we had supplied caviar to our customers under their brand labels (i.e. private labelling) or without brand labels. Subsequently in November 2021, we established our own caviar brand, “Imperial Cristal Caviar”, and started selling caviar under our own brand as well. With its exquisite package design, our branded caviar is ideal to be presented as both culinary delights and festive gifts. Imperial Cristal Caviar has continuously achieved tremendous sales growth since its launch in the market.

 

The table below sets forth details of our own brand caviar products:

 

Product Line   :   Imperial  
Sturgeon Species   :   Huso Dauricus
Roe Size   :   3.2mm – 3.4mm
Packaging Size   :   10/30/50/100/250 gram

 

Product Line   :   Osietra  
Sturgeon Species   :   Acipenser Schrenckii and Huso Dauricus
Roe Size   :   2.9mm – 3.1mm
Packaging Size   :   10/30/50/100/250 gram

 

70

 

 

Operation Flow

 

The diagram below illustrates the operation flow of our product supply chain:

 

 

(a) Receipt of purchase order from customer

 

Our customers place orders with us on an as-needed basis and their purchase orders generally set forth the key terms including species of sturgeon, roe size, quantity and unit price per kilogram.

 

(b) Procurement of caviar from sturgeon farm

 

Depending on our inventory level and customers’ orders on hand, our sales and marketing staff will place purchase orders with the agent and exclusive distributor of a sturgeon farm in the PRC. The quantity that we order from the supplier is typically slightly in excess of the quantity ordered by our customers such that we could maintain certain inventory to meet any ad-hoc orders from our customers.

 

(c) Importation from the PRC

 

Our supplier will arrange for the transportation of caviar from the PRC to Hong Kong by air cargo. Our supplier is responsible for obtaining CITES permit in the PRC and handling the required documentation for the export of goods to Hong Kong. The supply chain management company engaged by us will handle the customs clearance procedures in Hong Kong and collect our goods at the designated port.

 

(d) Packaging at the Hong Kong food processing factory

 

We engage a Hong Kong-based supply chain management company to handle the processing of our products. The supply chain management company deploys labor to perform food packaging and labelling at our food processing factory located in Hong Kong. Depending on the purchase order and requirements of our customers, our caviar products are packaged in different sizes of containers and labelled with our own brand or our customers’ brands (i.e. private labelling) or without brand labels. We provide instruction and regular on-the-job training to the processing staff to ensure their work standard and efficiency. In order to maintain the quality and freshness of our caviar, our food processing factory is equipped with temperature control system that mandates a prescribed temperature range.

 

(e) Quality inspection

 

The supply chain management company has designated a quality control staff at our food processing factory to inspect and monitor the processing procedures. The quality control staff will conduct quality control testing and inspection throughout the packaging process and ensure the taste, size, quality and packaging of our caviar products conform with our quality standards and requirements.

 

71

 

 

(f) Local delivery/Exportation to foreign countries

 

The supply chain management company engaged by us will also provide logistics, transportation and customs clearance services for delivering our caviar products to the destination specified by our customers on or before our prescribed time. Our products are mainly sold free on board (“FOB”) in Hong Kong. Depending on our customers’ requirements, our caviar products are either delivered to specified locations in Hong Kong or exported overseas. The supply chain management company is responsible for applying for re-export license for the re-exportation of our caviar products to foreign countries on our behalf.

 

Our Customers

 

Our customers primarily and substantially include F&B-related distributors. We have strategically focused on business-to-business sales (B2B) which would allow us access to our customers’ sales network and consumer base that helps us maximize the reach of our products swiftly and effectively. As our caviar products gain popularity worldwide, our customer base has continuously expanded as a result of customers’ referral and our marketing efforts.

 

Furthermore, to complement our caviar business, in March 2023, we have commenced our wine trading business line.

 

Our wine trading business only involves the distribution of fine wine within Hong Kong on business-to-business (B2B) sales, primarily to our F&B related distributor customers, in particular, the F&B related distributor customers who we supply our caviar product.

 

For the year ended December 31, 2022, there were four customers each generated over 10% of our total revenue for the year, and they in aggregate accounted for approximately 82.6% of our total revenue for the year. One of these four customers is our related party and all of our transactions with such related party have been ceased after December 31, 2022. Our top five customers are Sunfun (China) Limited, accounting for 37.4% of our sales volume, Channel Power Limited, accounting for 17.7% of sales volume, Beauty and Health International Company Limited, accounting for 15% of sales volume, Beauty and Health International E-Commerce Limited, accounting for 12.5% of our sales volume, and Mother Nature Health (HK) Limited, accounting for 9.4% of our sales volume. For the year ended December 31, 2023, there were three customers each generated over 10% of our total revenue for the period, and they in aggregate accounted for approximately 75.5% of our sales volume. Our top 3 customers for the year ended December 31, 2023 are, Mother Nature Health (HK) Limited, accounting for 34.5 % of our sales volume in the period, Sunfun (China) Limited, accounting for 25.0% of our sales volume, A One Marketing Limited accounting for 16.5% of our sales volume.

 

Geographical coverage

 

Our caviar products are mainly sold to customers based in Hong Kong and a substantial portion are exported overseas by our customers. As our caviar products gradually become more well-known in the international market, we aspire to expand our sales channels from only selling through distributors to selling our products directly to overseas customers.

 

Substantially all of the fine wine we distributed are sold to F&B distributors customers based in Hong Kong.

 

General terms with customers

 

Our customers place purchase orders for our caviar products and wine with us on an as-needed basis. For our caviar product, we entered into distributorship agreements with our F&B related distributor customers.

 

72

 

 

The material terms of our distributorship agreements for our caviar product with our F&B related distributor customers are summarized as follows:

 

Principal term       Description
Product description   :   The distributorship agreements set out the type of caviar products to be supplied by us and other product specifications such as sturgeon species, place of origin, roe size, quality standards, shelf life and annual procurement amount.
         
Pricing   :   The distributorship agreements set out the unit price for each of our products to be supplied, which is typically agreed at a fixed price per kilogram.
         
Term   :   Generally one year and may be renewed upon mutual agreement and negotiation.
         
Delivery arrangements   :   We are responsible for the transportation of products to the destination specified by our customers on or before the date as stipulated in the purchase orders. The transportation costs and other related expenses are borne by us.
         
Rights and responsibilities of us   :    Our rights and responsibilities under the distributorship agreements mainly include the following:
         
        (i) to be informed and supervise the sales and marketing activities conducted by our F&B related distributor customers in relation to our products;
           
        (ii) review the sales and marketing materials prepared by our F&B related distributor customers in relation to our products;
           
        (iii) provide copies of quality inspection report, production approvals, corporate licences and other relevant documentation in relation to our products to our F&B related distributor customers;
           
        (iv) products supplied by us shall comply with applicable quality standards; and
           
        (v) any increase in price of our products shall not exceed a certain prescribed percentage upon renewal of the distributorship agreement.
           
Rights and responsibilities of our F&B related distributor customers   :   The rights and responsibilities of our F&B related distributor customers under the distributorship agreements mainly include the following:
           
        (i) achieve a certain percentage of annual sales growth, which shall be a condition for the renewal of the distributorship agreement;
           
        (ii) refrain from engaging in any activities which result in damages to our brand image;
           
        (iii) only engage in sales and marketing activities of our products within designated region(s) or territory(ies) and prescribed sales channel;
           
        (iv) keep our products, business, sales strategies and other information confidential; and
           
        (v) provide all sales and marketing materials in relation to our products to us for approval.

 

73

 

 

Product return

 

Due to the perishable nature of caviar, we generally do not accept any product return from our customers except under certain limited circumstances, such as when products are defective, poorly packaged or damaged or the quantity delivered was inconsistent with the purchase order. Our customers are normally required to report any quality issue to us within three business days upon their receipt of our products. We have not experienced any material product return so far.

 

Credit and payment terms

 

We generally grant our customers a credit period ranging from 30 to 60 days from the invoice date. Our customers generally settle their payments in Hong Kong dollars by telegraphic transfer.

 

Seasonality

 

Up to the date of this prospectus, we have not experienced any pronounced seasonality, but such fluctuations may have been masked by our rapid growth.

 

Pricing Strategies

 

The selling prices of our caviar products are determined on a cost-plus pricing approach with reference to, among other things, cost of sales which mainly represents procurement costs and costs incurred in relation to our supply chain management and a percentage of mark-up over our estimated cost of sales. The percentage of mark-up may vary based on factors such as (i) prevailing market prices for different caviar products; (ii) size of purchase order; (iii) type of customer; (iv) length of relationship with the customer; (v) supply and demand mechanism in our target markets; (vi) consumer preference; and (vii) any positive impact on our brand reputation.

 

Sales and Marketing

 

We have strategically focused on business-to-business sales (B2B) which would allow us access to our customers’ sales network and consumer base that helps us maximize the reach of our products swiftly and effectively. As our caviar products gain popularity worldwide, our customer base has gradually expanded as a result of customers’ referral and our marketing efforts.

 

We are dedicated to enhancing our brand awareness. Our sales and marketing representatives are primarily responsible for conducting business development and marketing activities. They are responsible for (i) enhancing our promotion and sales efforts; (ii) actively approaching and liaising with our existing and potential customers; and (iii) collecting feedbacks and handling any queries on our products from customers.

 

As part of our sales and marketing efforts, we have proactively participated in food expo and set up pop-up stores across the world. We have also collaborated with famous food bloggers and used different online platforms and media coverage to promote and strengthen the publicity of our products. We regularly invite chefs of notable hotels and restaurants to our tasting events.

 

74

 

 

Our Suppliers

 

Our major suppliers include (i) a exclusive distributor and agent of a sturgeon farm in the PRC, Fujian Aoxuanlaisi Biotechnology Co., Ltd (“Fujian Aoxuanlaisi”), which supplies caviar raw product to us; (ii) a Hong Kong supply chain management company, Sunfun (China) Limited (“Sunfun China”), which handles the logistics, warehousing and packaging workflows in our supply chain; (iii) a Hong Kong wine distributor, which supplies fine wine to us; and (iv) other suppliers which supply packaging materials and printing services to us.

 

We materially rely on Fujian Aoxuanlaisi as our supplier for caviar raw product. Fujian Aoxuanlaisi is the agent and appointed distributor of a well-established PRC sturgeon farm, operated by Fujian Longhuang Biotech Co. Limited (“Fujian Longhuang”). Fujian Aoxuanlaisi and Fujian Longhuang currently maintain a long-term exclusive sales agreement for 15 years, from December 2020 to December 2035. Historically, before April 2022, we obtained the supply of caviar raw product from Fujian Aoxuanlaisi on an as-demand per order basis, without any long-term agreements. In April 2022, our Operating Subsidiary, Top Wealth Group (International) Limited, has entered into the Caviar Sales Agreement with Fujian Aoxuanlaisi, appointed us as its exclusive distributor in Hong Kong and Macau. We do not have any direct supply agreement with Fujian Longhuang, the PRC sturgeon farm.

 

For the years ended December 31, 2023, 2022 and 2021, our procurement from Fujian Aoxuanlaisi amounted to approximately US$6.2 million, US$5.3 million, and US$0.3 million respectively, representing approximately 64.3%, 90% and 100% of our total purchases for the corresponding year.

 

For fiscal ended December 31, 2023, Hong Kong wine distributor and importer, Silver Fame International (HK) Limited, supplies fine wine to us. We have not entered any agreement with Silver Fame International (HK) Limited, we obtain the supply of the fine wine from which on an as-demand per order basis. For the years ended December 31, 2023, 2022 and 2021, our procurement from Silver Fame International (HK) Limited amounted to approximately US$3.4 million, US$0.6 million, and nil respectively, representing approximately 35.6%, 10% and 0% of our total purchases for the corresponding year.

 

Fujian Aoxuanlaisi, the distributor of the PRC sturgeon farm

 

In April 2022, our Operating Subsidiary, Top Wealth Group (International) Limited, has entered into the Caviar Sales Agreement with Fujian Aoxuanlaisi, the agent and the distributor of Fujian Longhuang, a PRC sturgeon farm. Pursuant to the Caviar Sales Agreement between Fujian Aoxuanlaisi and Top Wealth Group (International) Limited, by way of Power of Attorney, Fujian Aoxuanlaisi appointed Top Wealth Group (International) Limited as its exclusive distributor in Hong Kong and Macau for conducting overseas distribution and granted Top Wealth Group (International) Limited the rights to procure caviar directly for a term of 10 years, from 30 April 2022 to 30 April 2032. The Caviar Sales Agreement between our Operating Subsidiary and Fujian Aoxuanlaisi and the Power of Attorney granted by Fujian Aoxuanlaisi are collectively referred as the “Exclusive Supply Agreement.”

 

75

 

 

The principal terms of the Exclusive Supply Agreement are summarized as follows:

 

Principal term       Description
Product description   :   The agreement sets out the type of caviar to be supplied and other product specifications such as roe size and quality standards.
         
Pricing   :   The unit price for each type of caviar is typically agreed at a fixed price per kilogram, which is set out in the purchase orders. The unit pricing of caviar shall be determined based on the prevailing market price at the time when we place purchase orders, provided that the average unit price of caviar in any year shall not fluctuate by more than a certain percentage compared to the previous year.
         
Term   :   10 years; from 30 April 2022 to 30 April 2032
         
Minimum annual procurement/supply commitment   :   We and the Fujian Aoxuanlaisi are committed to minimum annual procurement/supply commitment, which is subject to pre-agreed increase in quantity from year to year.
         
Failure to fulfil the minimum annual procurement/supply commitment   :  

In the event the Fujian Aoxuanlaisi fails to adhere to the minimum annual supply commitment in any year during the term of the exclusive supply agreement, the Fujian Aoxuanlaisi shall make up the shortfall by increasing the volume of supply in the following year and the unit price attributable to such volume shall be reduced by a certain percentage.

 

In the event we fail to adhere to the minimum annual procurement commitment in any year during the term of the exclusive supply agreement, we shall make up the shortfall by increasing the volume of procurement in the following year and the unit price attributable to such volume shall increase by a certain percentage.

         
Exclusivity   :   Fujian Aoxuanlaisi appointed Top Wealth Group (International) Limited as its exclusive distributor in Hong Kong and Macau for conducting overseas distribution.
         
Warranty   :   The caviar supplied shall have a shell life of 12 months provided that it remains unopened and is maintained at a temperature of -20°C.
         
Credit and payment terms   :   Fujian Aoxuanlaisi grants us certain credit period after shipment. We generally settle payments in HKD by telegraphic transfer
         
Delivery arrangements   :   Fujian Aoxuanlaisi is responsible for arranging the transportation of caviar from the PRC to Hong Kong by air cargo as well as obtaining CITES permit in the PRC and handling the required documentation for the exportation of caviar from the PRC to Hong Kong.
         
Amendment and termination   :   No amendment or termination of the exclusive supply agreement shall be effective unless agreed in writing.
         
Rights and responsibilities of the supplier   :   The rights and responsibilities of the Fujian Aoxuanlaisi under the exclusive supply agreement mainly include the following:
           
        (i) provide inspection reports, production reports, business licenses and other information relevant to their caviar products;
           
        (ii) maintain long-term stable supply of caviar to us; and
           
        (iii) in the event the caviar products supplied by Fujian Aoxuanlaisi fails to fulfil the quality tests conducted by a third party inspection agency, Fujian Aoxuanlaisi shall arrange for a refund or replacement of the defected products for us and shall bear all the direct costs incurred by us as a result.

 

There are no limitations on our business or ability to enter contracts with other caviar producers. There are no obligations for us to distribute caviar in Macau and we currently do not have plans to expand our business to Macau. To the best of our management’s understanding, the Fujian Aoxuanlaisi also supplies its caviar to other distributors in the PRC, Japan and various European countries. According to the exclusive supply agreement, Fujian Aoxuanlaisi has obligation to maintain long-term stable supply of caviar to us, even in the event of limited supply. According to the exclusive supply agreement, in the event Fujian Aoxuanlaisi fails to adhere to the minimum annual supply commitment in any year during the term of the exclusive supply agreement, Fujian Aoxuanlaisi shall make up the shortfall by increasing the volume of supply in the following year and the unit price attributable to such volume shall be reduced by a certain percentage.

 

76

 

 

Supply chain management company

 

Historically and as of the date of this prospectus, we have engaged a Hong Kong-based supply chain management company, Sunfun China Limited (“Sunfun China”), to handle the logistics, warehousing and packaging workflows in our supply chain, so we can strategically focus on brand-building and product quality assurance. On July 31, 2021, our Operating Subsidiary, Top Wealth Group (International) Limited has entered into a Food Processing Factory Leasing and Service Project Agreement (“Leasing and Service Agreement”) with Sunfun China, and such agreement is subsequently renewed on September 10, 2024, until March 31, 2026.

 

Pursuant to Leasing and Service Agreement, in respect of logistics services, Sunfun China is responsible for handling the customs clearance procedures and applying for import license in Hong Kong and collecting our goods at the designated delivery port. The supply chain management company is also responsible for the transportation of our caviar through cold-chain to the places designated by our customers and handling the application procedures for re-export license for delivery to foreign countries. Furthermore, Sunfun China has also leased a food processing factory located in Tsuen Wan, Hong Kong, to Top Wealth Group (International) Limited, for carrying out the packaging and labelling of our caviar products. The food processing factory has obtained a food factory license from the Food and Environmental Hygiene Department of Hong Kong which is essential for food business involving the preparation of food for sale for human consumption off the premises. The license is valid for one year from April 18, 2024 to April 17, 2025. To safeguard the palatability and freshness of our caviar products, the food processing factory is equipped with temperature control system that mandates a prescribed temperature range. Upon our requests, the Sunfun China will deploy labor for food packaging and labelling at our food processing factory located in Hong Kong.

 

The principal terms of Leasing and Service Agreement are summarized as follows:

 

Principal term       Description
    Term   :   18 months
             
(A)   Leasing of food processing factory premises
     
    License   :   Food factory license
             
    Facility and storage capacity   :   The premises shall have the capacity to store a specified volume of caviar and be equipped with cold storage facility which is maintained at the temperature between -18°C to -5°C
             
    Rental   :   Fixed monthly rental
             
(B)   Packaging services
     
    Pricing   :   Subject to quotation based on packaging size and quantity
             
(C)   Logistics services
     
    Local delivery   :   Fixed price which varies by delivery location
             
    National delivery   :   Subject to separate quotation

 

As of the date of this prospectus, we have not experienced any material dispute with our suppliers and we do not foresee any material circumstances which would result in early termination of the supply agreement with our suppliers.

 

Inventory Management

 

Our inventory is mainly comprised of caviar. Depending on our inventory level and customers’ orders on hand, our sales and marketing staff will place purchase orders with our caviar supplier in the PRC. The quantity that we order from the supplier is generally slightly in excess of the quantity ordered by our customers such that we could maintain certain inventory to meet any ad-hoc orders from our customers.

 

77

 

 

We have implemented inventory management policies to monitor and control our inventory level at an optimal level to avoid obsolescence. We adopt a “first-in-first-out” policy to preserve the freshness of our caviar and reduce our loss rate. We maintain an inventory register which clearly records each inflow and outflow of our inventory. Periodic stock-take is conducted to ensure the accuracy of stock-in and stock-out information on record. To safeguard the palatability and freshness of our caviar products, they are stored at our food processing factory which is equipped with temperature control system that mandates a prescribed temperature range.

 

Quality Control

 

Food safety and quality control are of paramount importance to our reputation and business. To ensure food safety and quality, we have established a comprehensive set of standards and requirements covering each facet of our supply chain, ranging from procurement, logistics, warehousing to packaging.

 

We have adopted a stringent policy and procedure on selecting the source of caviar supply. Due to the perishable nature of caviar, we strictly require the caviar processing procedures which involve over 10 works steps covering roe removal from sturgeons, washing and salting of caviar, to be completed over a timeframe of 15 minutes. We have reviewed all certifications required from our caviar supplier in the PRC for, among other things, the operation of sturgeon farm in the PRC and exporting caviar products overseas. Our caviar products are endorsed with the CITES permits, which certifies that our caviar is legally traded. We conduct sample inspection on each incoming batch of caviar.

 

The supply chain management company has designated a quality control staff at our food processing factory to inspect and monitor the processing procedures. The quality control staff will conduct quality control testing and inspection throughout the packaging process and ensure the taste, size, quality and packaging of our caviar products conform with our quality standards and requirements.

 

Our caviar products are transported through cold-chain from the PRC sturgeon farm to the places designated by our customers in order to ensure their palatability and freshness.

 

Since the establishment of our caviar business and up to the date of this prospectus, we have not encountered any material food safety incidents and we had not experienced any product liability claims.

 

Environmental Protection

 

Both the PRC and Hong Kong are parties to the CITES. Pursuant to the Protection of Endangered Species of Animals and Plants Ordinance (Chapter 586 of the Laws of Hong Kong) (the “PESO”), the importation, introduction from the sea, exportation, re-exportation and possession or control of specified endangered species of animals and plants, along with parts and derivatives of those species, are regulated under the PESO. Schedule 1 to the PESO sets out a list of species and categorizes them into different appendices which are regulated with varying degrees of control under the PESO. Sturgeons are included as regulated species under the PESO. In compliance with the PESO, our caviar is endorsed with the Convention on International Trade in Endangered Species of Wild Fauna and Flora (“CITES”) permits, which certifies that our caviar is legally traded. For further details, please refer to the paragraph headed “Licenses and Permits” in this section below.

 

Due to the nature of our business, our operational activities do not directly generate industrial pollutants. As such, we have not directly incurred any cost of compliance with applicable environmental protection rules and regulations as of the date of this prospectus and do not expect that we will directly incur significant costs for such compliance in the future.

 

As of the date of this prospectus, we have not come across any material non-compliance issues in respect of any applicable laws and regulations on environmental protection. We have not been subject to any administrative sanctions or penalties that have a material and adverse effect on our financial condition or business operation.

 

78

 

 

Insurance

 

We maintain employees’ compensation insurance for our directors and employees at our office with AXA General Insurance Hong Kong Limited, which covers the liability to make payment in the case of death, injury or disability of all our employees under the Employees’ Compensation Ordinance (Chapter 282 of the Laws of Hong Kong) and at common law for injuries sustained at work. We believe that our current insurance policies are sufficient for our operations.

 

Employees

 

We had 9 full-time employees as of the date of the prospectus. All of our employees are stationed in Hong Kong. The following table sets forth the number of our full-time employees categorized by function:

 

Function  Number of
Employees
 
General management             2 
Sales and Marketing   3 
Administrative   2 
Accounting and Finance   2 
Total   9 

 

We consider that we have maintained a good relationship with our employees and have not experienced any significant disputes with our employees or any disruption to our operations due to any labor disputes. In addition, we have not experienced any difficulties in the recruitment and retention of experienced core staff or skilled personnel.

 

Our remuneration package includes salary and discretionary bonuses. In general, we determine employees’ salaries based on their qualifications, position and seniority. In order to attract and retain valuable employees, we review the performance of our employees annually which will be taken into account in annual salary review and promotion appraisal. We provide a defined contribution to the Mandatory Provident Fund as required under the Mandatory Provident Fund Schemes Ordinance (Chapter 485 of the Laws of Hong Kong) for our eligible employees in Hong Kong.

 

Facilities

 

As of the date of this prospectus, we entered into the following lease agreements:

 

Location   Term of Lease   Usage
Units 714 & 715, 7/F
Hong Kong Plaza
188 Connaught Road West
Sai Wan, Hong Kong
  May 10, 2024 to May 9, 2026   Principal executive office
Flat E, 8/F
Golden Bear Industrial Centre
66 Chai Wan Kok Street
Tsuen Wan, New Territories
Hong Kong
  September 11, 2024 to March 11, 2026   Food processing factory and transportation supplier

 

We believe that we will be able to obtain adequate facilities on reasonable terms principally through leasing, to accommodate our future expansion plans.

 

Licenses and Permits

 

CITES permits

 

Both the PRC and Hong Kong are parties to the CITES. Pursuant to the Protection of Endangered Species of Animals and Plants Ordinance (Chapter 586 of the Laws of Hong Kong) (the “PESO”), the importation, introduction from the sea, exportation, re-exportation and possession or control of specified endangered species of animals and plants, along with parts and derivatives of those species, are regulated under the PESO. Schedule 1 to the PESO sets out a list of species and categorizes them into different appendices which are regulated with varying degrees of control under the PESO. Sturgeons are included as regulated species under the PESO.

 

79

 

 

Importation from the PRC to Hong Kong

 

Under the PESO, an importer may import caviar into Hong Kong from any other jurisdiction (including the PRC) only if the importer (i) obtains an import license issued by the Director of Agriculture, Fisheries and Conservation Department of Hong Kong and produces such import license to an authorized officer of the Customs and Excise Department; and (ii) produces and surrenders the CITES permit issued by the relevant authorities of the exporting country to the authorized officer, for retention and cancellation.

 

In compliance with the PESO, the sturgeon farm or its agent is responsible for applying for CITES permit from the relevant regulatory authority in the PRC, while the supply chain management company is responsible for applying for import license from the Director of Agriculture, Fisheries and Conservation Department of Hong Kong on behalf of us.

 

Exportation from Hong Kong to foreign countries

 

Pursuant to the PESO, prior to the re-exportation of caviar out of Hong Kong, the re-exporter shall, pursuant to the PESO, apply for a re-export license from the Director of Agriculture, Fisheries and Conservation, which may be issued with or without conditions as the director considers appropriate. Any such re-export license obtained by the re-exporter shall be produced to an authorized officer of the Customs and Excise Department before the caviar is re-exported from Hong Kong.

 

In compliance with the PESO, we have engaged the supply chain management company to apply for re-export license from the Director of Agriculture, Fisheries and Conservation Department of Hong Kong on behalf of us when our caviar products are to be exported to foreign countries.

 

Food factory license

 

Pursuant to section 31(1) of the Food Business Regulation (Chapter 132X of the Laws of Hong Kong) (“FBR”), no person shall carry on or cause, permit or suffer to be carried on any food factory business except under and in accordance with a food factory license from the Food and Environmental Hygiene Department of Hong Kong (the “FEHD”), which is required for the food business involving the preparation of food for sale for human consumption off the premises.

 

The FEHD may grant a provisional food factory license to a new applicant who has fulfilled the basic requirements in accordance with the FBR pending fulfilment of all outstanding requirements for the issue of a full food factory license. A provisional food factory licenses is valid for a period of six months or lesser and a full food factory license is valid generally for a period of one year, both subject to payment of the prescribed license fees and continuous compliance with the requirements under the relevant legislation and regulations. A provisional food factory license is renewable once and a full food factory license is renewable annually.

 

In compliance with the FBR, the supply chain management company, being the landlord of our food processing factory premises, has obtained a food factory license from the FEHD for the operation of our food processing factory, which is valid for one year from April 18, 2024 to April 17, 2025, subject to further renewal.

 

Intellectual Property

 

As of the date of this prospectus, we have registered the following trademarks:

 

Place of registration   Trademark   Status   Trademark Number   Classes   Expiry Date
Hong Kong       Registered, August 24, 2022   306044355   29, 35   August 23, 2032
Hong Kong     Registered, October 20, 2021   305776886   29   October 19, 2031
The PRC       Registered, October 7, 2022   59662676   29   October 6, 2032
Macau     Registered, August 10, 2022   N/194408   29   August 10, 2029

 

Legal Proceedings

 

We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business. During the years ended December 31, 2023 and 2022 and as of the date hereof, neither we nor any of our subsidiaries have been involved in any litigation, claim, administrative action or arbitration which had a material adverse effect on the operations or financial condition of the Company.

80

 

 

REGULATION

 

Our business operations are conducted in Hong Kong and are subject to Hong Kong laws and regulations. This section summarizes the most significant rules and regulations that affect our business activities in Hong Kong.

 

Public Health and Municipal Services Ordinance

 

The legal framework for food safety control in Hong Kong is set out in Part V of the Public Health and Municipal Services Ordinance (Chapter 132 of the Laws of Hong Kong) (the “Public Health Ordinance”) and the relevant sub-legislations thereunder. The Public Health Ordinance requires the manufacturers and sellers of food to ensure that their products are fit for human consumption and comply with the requirements in respect of food safety, food standards and labeling.

 

As the business of our Group principally involves retail of natural and organic foods in Hong Kong, our Group is subject to the Public Health Ordinance.

 

Section 50 of the Public Health Ordinance prohibits the manufacturing, advertising and sale in Hong Kong of food or drugs that are injurious to health. Anyone who fails to comply with this section commits an offence which carries a maximum penalty of HK$10,000 and imprisonment for three months.

 

Section 52 of the Public Health Ordinance provides that, subject to a number of defenses in section 53 of the same ordinance, if a seller sells to the prejudice of a purchaser any food or drug which is not of the nature, substance or quality of the food or drug demanded by the purchaser, the seller shall be guilty of an offence which carries a maximum penalty of HK$10,000 and imprisonment for three months.

 

According to section 54 of the Public Health Ordinance, any person who sells or offers or exposes for sale or has in his possession for the purpose of sale or preparation for sale or deposits with, or consigns to, any person for the purpose of sale or of preparation for sale, any food intended for, but unfit for, human consumption, or any drug intended for use by human but unfit for that purpose, shall be guilty of an offence. The maximum penalty for contravention of section 54 is a fine of HK$50,000 and imprisonment for six months.

 

Section 61 of the Public Health Ordinance provides that it shall be an offense for any person to give with any food or drug sold by him/her, or to display with any food or drug offered for sale by him/her, any label which falsely describes the food or drug or which is calculated to mislead as to its nature, substance or quality. Further, it shall also be an offense if any person publishes, or is a party to the publication of, an advertisement falsely describing any food or drug or that is likely to mislead as to the nature, substance or quality of any food or drug. However, the offender can rely on warranty as a defense.

 

Section 71(2) of the Public Health Ordinance specifies that if a warranty is given by a person resident outside Hong Kong, it shall only be a defense if the company (i) has, not later than three clear days before the date of the hearing, sent to the prosecutor a copy of the warranty with a notice stating that he/she intends to rely on it and specifying the name and address of the person from whom he/she received it; and (ii) has also sent a like notice to that person. In addition, the company has to prove that it had taken reasonable steps to ascertain, and did in fact believe in, the accuracy of the statement contained therein.

 

Import and Export Ordinance

 

The Import and Export Ordinance (Chapter 60 of the Laws of Hong Kong) provides for the regulation and control of, amongst other things, the import and export of articles into or out of Hong Kong. According to the Import and Export (Registration) Regulations (Chapter 60E of the Laws of Hong Kong), a subsidiary legislation of the Import and Export Ordinance, an importer is under an obligation to lodge with the Customs and Excise Department an accurate and complete import declaration through a specified “Government Electronic Trading Services” provider. Further, a similar obligation is imposed on an exporter by the same Regulations.

 

81

 

 

Food Safety Ordinance

 

Food Safety Ordinance (Chapter 612 of the Laws of Hong Kong) (the “Food Safety Ordinance”) establishes a registration scheme for food importers and food distributors to require the keeping of records by persons who acquire, capture, import or supply food and to enable food import controls to be imposed.

 

Registration as food importer or distributor

 

Sections 4 and 5 of the Food Safety Ordinance require any person who carries on a food importation business or food distribution business to register with the Food and Environmental Hygiene Department as a food importer or food distributor.

 

Any person who does not register but carries on a food importation or distribution business, without reasonable excuse, commits an offence and is liable to a maximum fine of HK$50,000 and imprisonment for six months.

 

Record-keeping requirement relating to movement of food

 

Section 22 of the Food Safety Ordinance provides that a person who, in the course of business, imports food must record the following information about the acquisition of the food:

 

the date the food was acquired;

 

the name and contact details of the person from whom the food was acquired;

 

the place from where the food was imported;

 

the total quantity of the food; and

 

a description of the food.

 

A record must be made under this section at or before the time the food is imported. Any person who fails to comply with the record-keeping requirement, without reasonable excuse, commits an offence and is liable to a maximum fine of HK$10,000 and imprisonment for three months.

 

Section 24 of the Food Safety Ordinance provides that a person who, in the course of business, supplies food in Hong Kong by wholesale must record the following information about the supply:

 

the date the food was supplied;

 

the name and contact details of the person to whom the food was supplied;

 

the total quantity of the food; and

 

a description of the food.

 

A record must be made under this section within 72 hours after the time the supply took place. Any person who fails to comply with the record-keeping requirement, without reasonable excuse, commits an offence and is liable to a maximum fine of HK$10,000 and imprisonment for three months.

 

Protection of Endangered Species of Animals and Plants Ordinance

 

Both China and Hong Kong are parties to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (“CITES”). The Protection of Endangered Species of Animals and Plants Ordinance (Chapter 586 of the Laws of Hong Kong) (the “PESO”) came into effect on 1 December 2006 to give effect to the CITES in Hong Kong. The importation, introduction from the sea, exportation, re-exportation and possession or control of specified endangered species of animals and plants, along with parts and derivatives of those species, are thus regulated under the PESO. Schedule 1 to the PESO sets out a list of species and categorizes them into different appendices which are regulated with varying degrees of control under the PESO. Sturgeons (except the species included in Appendix I) are included as an “Appendix II species”.

 

Under the PESO, an importer may import into Hong Kong from any other jurisdiction (including the PRC) caviar if (i) the importer produces the CITES permit issued by the relevant authorities of the exporting country to an authorized officer of the Customs and Excise Department; (ii) an authorized officer has inspected the caviar to compare it with the particulars on the CITES permit and is satisfied that the particulars tally; and (iii) the importer surrenders to the authorized officer the CITES permit for retention and cancellation.

 

82

 

 

Prior to the re-exportation of caviar out of Hong Kong, the re-exporter shall, pursuant to the PESO, apply for a re-export license from the Director of Agriculture, Fisheries and Conservation, which may be issued with or without conditions as the director considers appropriate. Any such re-export license obtained by the re-exporter shall be produced to an authorized officer of the Customs and Excise Department before the caviar is re-exported from Hong Kong.

 

As stipulated in the PESO, a person commits an offence if he or she imports caviar without an import license or re-exports caviar without a re-export license. A person guilty of an offence above is liable on conviction to a fine and imprisonment. Higher penalties can be imposed by the court if the offence is committed for commercial purposes.

 

Consumer Goods Safety Ordinance

 

The Consumer Goods Safety Ordinance (Chapter 456 of the Laws of Hong Kong) (the “Consumer Goods Safety Ordinance”) imposes a duty on manufacturers, importers and suppliers of certain consumer goods to ensure that the consumer goods they supply are safe and for incidental purposes.

 

Our products, other than food (which are specifically excluded under the schedule of the Consumer Goods Safety Ordinance), are regulated by the Consumer Goods Safety Ordinance and the Consumer Goods Safety Regulation (Chapter 456A of the Laws of Hong Kong) (the “Consumer Goods Safety Regulation”).

 

Section 4(1) of the Consumer Goods Safety Ordinance requires consumer goods to be reasonably safe having regard to all of the circumstances including (a) the manner in which, and the purpose for which the products are presented, promoted or marketed; (b) the use of any mark in relation to the consumer goods, instructions or warnings given for the keeping, use or consumption of the consumer goods; (c) reasonable safety standards published by a standards institute or similar bodies for consumer goods of the description which applies to the consumer goods or for matters relating to consumer goods of that description; and (d) the existence of any reasonable means to make the consumer goods safer.

 

According to section 2(1) of the Consumer Goods Safety Regulation, where consumer goods on their packages are marked with, or where any labels affixed to or any documents enclosed in their packages contain, any warning or caution regarding the safe keeping, use, consumption or disposal, such warning or caution shall be in both the English and the Chinese languages. Such warnings and cautions, as required by section 2(2) of the Consumer Goods Safety Regulation, shall be legible and be placed in a conspicuous position on (a) the consumer goods; (b) any package of the consumer goods; (c) a label securely affixed to the package; or (d) a document enclosed in the package.

 

Food and Drugs (Composition and Labelling) Regulations

 

Food and Drugs (Composition and Labelling) Regulations (Chapter 132W of the Laws of Hong Kong) (the “Food and Drugs Regulations”), which are under the Public Health Ordinance, contains provisions governing the advertising and labeling of food.

 

Regulation 3 of the Food and Drugs Regulations provides that the composition of foods and drugs specified in Schedule 1 shall be up to the standards as specified in that schedule. The applicability of individual standards specified thereunder depends on whether the individual product in question is considered “drug” as defined in the Public Health Ordinance.

 

Pursuant to Regulation 5 of the Food and Drugs Regulations, any person who advertises for sale, sells or manufactures for sale any food or drug which does not conform to the relevant requirements as to the composition prescribed in Schedule 1 to the Food and Drugs Regulations commits an offence and is liable to a fine of HK$50,000 and imprisonment for six months.

 

Regulation 4A of the Food and Drugs Regulations requires all pre-packaged food and products sold by our Group (except for those listed in Schedule 4 thereto) to be marked and labeled in the manner prescribed in Schedule 3 to the Food and Drugs Regulations. Schedule 3 contains labeling requirements in respect of stating the product’s name or designation, ingredients, “best before” or “use by” date, special conditions for storage or instructions for use, manufacturer’s or packer’s name and address and count, weight or volume. Additionally, Schedule 3 also includes requirements on the appropriate language or languages for marking or labelling pre-packaged food. Contravention of those requirements may result in a conviction carrying a maximum penalty of HK$50,000 and imprisonment for six months.

 

In accordance with Regulation 4B of the Food and Drugs Regulations, generally pre-packaged food sold by our Group should be marked or labeled with its energy value and nutrient content in the manner prescribed in Part 1 of Schedule 5, and nutrition claims, if any, made on the label of the product or in any advertisement for the product should comply with Part 2 of Schedule 5. Contravention of those requirements may result in a conviction carrying a maximum penalty of HK$50,000 and imprisonment for six months.

 

83

 

 

Food Business Regulation

 

Regulation 31 of the Food Business Regulation (Chapter 132X of the Laws of Hong Kong) (the “Food Business Regulation”) provides that, except under and in accordance with a license granted under the Food Business Regulation, no person shall carry on or cause or permit or suffer to be carried on any food business including a food factory. “Food factory” is defined as any food business which involves the preparation of food for sale for human consumption off the premises.

 

Trade Descriptions Ordinance

 

The Trade Descriptions Ordinance (Chapter 362 of the Laws of Hong Kong) makes it an offence for any person, in the course of trade or business, to (i) apply for a false trade description to any goods; (ii) supply or offer to supply any goods to which a false trade description is applied; or (iii) has in his possession for sale or for any purpose of trade or manufacture any goods to which a false trade description is applied. Furthermore, pursuant to the same legislation, it is an offence for a person to import or export any goods to which a false trade description is applied.

 

Employment Ordinance

 

The Employment Ordinance (Chapter 57 of the Laws of Hong Kong) (the “EO”) provides for the protection of the wages of employees and regulates the general conditions of employment and employment agencies. Under the EO, an employee is generally entitled to, amongst other things, notice of termination of his or her employment contract; payment in lieu of notice; maternity protection in the case of a pregnant employee; not less than one rest day in every period of seven days; severance payments or long service payments; sickness allowance; statutory holidays or alternative holidays; and paid annual leave of up to 14 days depending on the period of employment.

 

Employees’ Compensation Ordinance

 

The Employees’ Compensation Ordinance (Chapter 282 of the Laws of Hong Kong) (the “ECO”) is provides for the payment of compensation to employees injured in the course of employment. As stipulated by the ECO, an employer is required to take out an insurance policy to insure against the injury risk of his or her employees. Any employer who contravenes this requirement commits a criminal offence and is liable on conviction to a fine and imprisonment. An employer who has taken out an insurance policy under the ECO is required to display a prescribed notice of insurance in a conspicuous place on each of its premises where any employee is employed.

 

Minimum Wage Ordinance (Chapter 608 of the Laws of Hong Kong)

 

The Minimum Wage Ordinance provides for a prescribed minimum hourly wage rate (set at HK$40 per hour as at the date of this prospectus) during the wage period for every employee engaged under a contract of employment under the Employment Ordinance. Any provision of the employment contract which purports to extinguish or reduce the right, benefit or protection conferred on the employee by the Minimum Wage Ordinance is void.

 

Mandatory Provident Fund Schemes Ordinance (Chapter 485 of the Laws of Hong Kong) (“MPF Schemes Ordinance”)

 

Employers are required to enroll their regular employees (except for certain exempt persons) aged between at least 18 but under 65 years of age and employed for 60 days or more in a Mandatory Provident Fund (“MPF”) scheme within the first 60 days of employment.

 

For both employees and employers, it is mandatory to make regular contributions into a MPF scheme. For an employee, subject to the maximum and minimum levels of income (set at HK$30,000 and HK$7,100 per month, respectively, as at the date of this prospectus), an employer will deduct 5% of the relevant income on behalf of an employee as mandatory contributions to a registered MPF scheme with a ceiling (set at HK$1,500 as at the date of this prospectus). Employer will also be required to contribute an amount equivalent to 5% of an employee’s relevant income to the MPF scheme, subject only to the maximum level of income (set at HK$30,000 as at the date of this prospectus).

 

84

 

 

MANAGEMENT

 

Directors and Executive Officers

 

The following table provides information regarding our executive officers and directors as of the date hereof:

 

Name   Age   Position(s)
Kim Kwan Kings, WONG   53   Chief Executive Officer, Chairman of the board, and Director
Hung, CHEUNG   55   Director
Kwok Kuen, YUEN   39   Chief Financial Officer
Feiyong, LI   41   Director
Phei Suan, HO   44   Director
Wai Chun, CHIK   39   Director

 

Kim Kwan Kings, WONG  is the chief executive officer, Director, and the Chairman of the board of the Company, overseeing the general corporate strategy and brand promotion management and business expansion. Mr. Wong is one of the founders of the Company, and has committed to expanding and promoting the Company’s business and international market for caviar products. Mr. Wong has extensive experience in market promotion, brand promotion, sales channel expansion, business planning in industries including new retail, health supplement, biotechnology, artificial intelligence. In the past five years, Mr. Wong has been the chief executive officer of TW HK.

 

Kwok Kuen, YUEN has served as our chief financial officer since December 1, 2022. Mr. Yuen has more than 20 years of experience of handling financial and audit operation in companies. From February 2004 to January 2008, Mr. Yuen worked in PricewaterhouseCoopers, with his last position as manager of the assurance department and from February 2008 to March 2015, he worked at PKF Hong Kong Limited with his last position as senior audit manager. Mr. Yuen has extensive experience in providing consulting services to reverse acquisition projects, merger and acquisition, due diligence, corporate reorganization, internal control and system inspection. Mr. Yuen is familiar with Hong Kong audit principals, corporation laws, listing rules, corporate audit, public offering and private placement. Mr. Yuen received a Bachelor degree of business from Monash University in September 1998. He is also member of CPA Australia and Hong Kong Institute of Certified Public Accountants. Since August 2016, Mr. Yuen has been an independent non-executive director of China Tian Yuan Healthcare Group Limited (HKEx: 557), a company listed on the Hong Kong Stock Exchange.

 

Feiyong, LI is our director and the chairman of the nominating committee and the member of the compensation committee and audit committee. Mr. Li has served as an independent director and the chairman of Nominating and Corporate Governance Committee of Jayud Global Logistics Limited (NASDAQ: JYD) since March 31, 2023. Mr. Li has extensive experience in advising equity investment projects in the Hong Kong and U.S. market and served a number of licensed corporations under the Securities and Futures Ordinance of Hong Kong. Mr. Li has been serving as the investment manager at Koala Securities Limited since 2019. Mr. Li previously served as the general manager of Zen Corporate Consulting Limited from 2012 to 2021, where he focused on providing public relations processing services, listing consulting services, and corporate investment and financing services. From 2013 to 2020, Mr. Li also served as the chief investment officer of CNI Securities Group Limited, where he was responsible for project investment and financing. From 2009 to 2011, Mr. Li consecutively served as the investment consultant of Kingston Securities Limited and Guoyuan Securities Brokerage (Hong Kong) Limited. Mr. Li received an advanced diploma in business studies from the Windsor Management College of Singapore in 2021.

 

85

 

 

Phei Suan, HO is our director and the chairwoman of the audit committee and the member of the nominating committee and the compensation committee. Ms. Ho has over 20 years’ experience in accounting, audit and corporate financing experience. Since October 2017, Ms. Ho served as the chief financial officer of Furniweb Holdings Limited (HKEx: 8480), a company listed on GEM of the Stock Exchange of Hong Kong Limited. From May 2014 to September 2017, Ms. Ho served as the group financial controller of PRG Holdings Berhad, a company listed on the main market of Busa Malaysia Securities Berhad. From April 2012 to April 2014, Ms. Ho served as the head of corporate finance of Encorp Berhad, a company listed on the main market of Busa Malaysia Securities Berhad. From April 2011 to March 2012, Ms. Ho served as the financial business consultant of Hewlett-Packard (Malaysia) Sdn Bhd. From March 2008 to October 2010, Ms. Ho served as an audit manager of KPMG China. From August 2002 to February 2008, Ms. Ho served as an audit manager of Ernst & Young in Malaysia. Ms. Ho obtained a bachelor degree of Accountancy from the University of Malaya in Malaysia in 2002. She has been a Chartered Accountant under the Malaysian Institute of Accountants since 2006 and a Certified Public Accountant of the Malaysian Institute of Certified Public Accountants since 2007.

 

Wai Chun, CHIK is our director and the chair of our compensation committee and the member of the nominating committee and audit committee. Ms. Chik has over 15 years of experience in the auditing, accounting, corporate governance and company secretarial matters. She currently serves as the company secretary of P.B. Group Limited, a company that is listed on the Hong Kong Stock Exchange (HKEx: 8331) since August 2019, and FingerTango Inc., a company that is listed on the Hong Kong Stock Exchange (HKEx: 6860) since July 2023. She also currently serves as the independent non-executive director at Boltek Holdings Limited, a company that is listed on the Hong Kong Stock Exchange (HKEx: 8601), since September 2021. Furthermore, Ms. Chik is currently the head of company secretarial department of P.B. Advisory Limited. Ms. Chik obtained the master of corporate governance degree from the Hong Kong Polytechnic University in 2015. She was admitted as a member of CPA Australia in June 2011. Ms. Chik was also certified as a certified public accountant by the Hong Kong Institute of Certified Public Accountants in September 2011, and was admitted as an associate of both the Hong Kong Chartered Governance Institute (formerly known as the Hong Kong Institute of Chartered Secretaries) and the Chartered Governance Institute (formerly known as the Institute of Chartered Secretaries and Administrators) in March 2016.

 

Family Relationships

 

None of the directors or executive officers has a family relationship as defined in Item 401 of Regulation S-K.

 

Board of Directors

 

Our board of directors consists of five directors. A director is not required to hold any shares in our company to qualify to serve as a director. Subject to the rules of the relevant stock exchange and disqualification by the chairman of the board of directors, a director may vote with respect to any contract, proposed contract, or arrangement in which he or she is materially interested. A director may exercise all the powers of the company to borrow money, mortgage its business, property and uncalled capital and issue debentures or other securities whenever money is borrowed or as security for any obligation of the company or of any third party. There are no directors’ service contracts with the Company or its subsidiaries providing for benefits upon termination of employment.

 

Committees of the Board of Directors

 

Our board of directors has established an audit committee, a compensation committee, and a nominating committee under the board of directors, and an investment committee under the management. Our board of directors has adopted a charter for the audit committee, the compensation committee, and the nominating committee. Each committee’s members and functions are described below.

 

86

 

 

Audit Committee. Our audit committee consists of Feiyong, LI, Phei Suan, HO, Wai Chun, CHIK. Ms. Phei Suan, HO is the chair of our audit committee. The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things:

 

  appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;

 

  reviewing with the independent auditors any audit problems or difficulties and management’s response;

 

  discussing the annual audited financial statements with management and the independent auditors;

 

  reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures;

 

  reviewing and approving all proposed related party transactions;

 

  meeting separately and periodically with management and the independent auditors; and

 

  monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.

 

Compensation Committee. Our compensation committee consists of Feiyong, LI, Phei Suan, HO, Wai Chun, CHIK. Ms. Wai Chun, CHIK is the chair of our compensation committee. The compensation committee will be responsible for, among other things:

 

  reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers;

 

  reviewing and recommending to the shareholders for determination with respect to the compensation of our directors;

 

  reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and

 

  selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person’s independence from management.

 

Nominating Committee. Our nominating committee consists of Feiyong, LI, Phei Suan, HO, Wai Chun. CHIK Mr. Feiyong, LI is the chair of our nominating committee. We have determined that Feiyong, LI, Phei Suan, HO, and Wai Chun, CHIK satisfy the “independence” requirements under NASDAQ Rule 5605. The nominating committee will assist the board of directors in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating committee will be responsible for, among other things:

 

  selecting and recommending to the board nominees for election by the shareholders or appointment by the board;

 

  reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity;

 

  making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and

 

  advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken.

 

87

 

 

Duties of Directors

 

Under Cayman Islands law, our directors owe fiduciary duties to us, including a duty of loyalty, a duty to act honestly, in good faith and with a view to our best interests. Our directors must also exercise their powers only for a proper purpose. Our directors also owe to our company a duty to act with skill and care. English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum and articles of association (as may be amended from time to time) and the class rights vested thereunder in the holders of the shares. Our company has a right to seek damages against any director who breaches a duty owed to us. A shareholder may in certain limited exceptional circumstances have the right to seek damages in our name if a duty owed by our directors is breached.

 

Our board of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers of our board of directors include, among others:

 

  convening shareholders’ annual general meetings and reporting its work to shareholders at such meetings;

 

  declaring dividends and distributions;

 

  appointing officers and determining the term of office of the officers;

 

  exercising the borrowing powers of our company and mortgaging the property of our company; and

 

  approving the transfer of shares in our company, including the registration of such shares in our share register.

 

Terms of Directors and Officers

 

Our officers are elected by and serve at the discretion of the board of directors. Our directors are not subject to a term of office and hold office until their resignation, death or incapacity, or until their respective successors have been elected and qualified or until his or her office is otherwise vacated in accordance with our articles of association as may be amended from time to time.

 

A director will also be removed from office automatically if, among other things, the director (i) becomes bankrupt or makes any arrangement or composition with his creditors, (ii) dies or is found to be or becomes of unsound mind, (iii) resigns his office by notice in writing, (iv) without special leave of absence from our board, is absent from meetings of our board for a continuous period of six months, or (v) is removed from office pursuant to any other provisions of our memorandum and articles of association (as may be amended from time to time).

 

Limitation on Liability and Other Indemnification Matters

 

Cayman Islands law allows us to indemnify our directors, officers and auditors acting in relation to any of our affairs against actions, costs, charges, losses, damages and expenses incurred by reason of any act done or omitted in the execution of their duties as our directors, officers and auditors.

 

Under our memorandum and articles of association, we may indemnify our directors and officers, among other persons, from and against all actions, costs, charges, losses, damages and expenses which they or any of them may incur or sustain by reason of any act done, concurred in or omitted in or about the execution of their duty or supposed duty in their respective offices or trusts, except such (if any) as they shall incur or sustain through their own fraud or dishonesty.

 

Board Diversity

 

Board Diversity Matrix
 
Country of Principal Executive Offices:   Hong Kong
Foreign Private Issuer   Yes
Disclosure Prohibited Under Home Country Law   No
Total Number of Directors   5
     
    Female   Male   Non-Binary   Did Not
Disclose
Gender
Part I: Gender Identity
Directors   2   3   0   0
Part II: Demographic Background
Underrepresented Individual in Home Country Jurisdiction  
LGBTQ+  

 

88

 

 

Agreements with Executive Officers and/or Directors

 

We have entered into employment agreements with our senior executive officers and/or Directors.

 

Mr. Kim Kwan Kings, WONG and Mr. Hung, CHEUNG

 

TW Cayman entered into separate employment agreements with: (a) Mr. Kim Kwan Kings, WONG, the Director, Chief Executive Officer, and the Chairman of the Board, on May 16, 2023; and (b) Mr. Mr. Hung, CHEUNG, the Director, on October 27, 2023, respectively (collectively, the Directors Employment Agreements).

 

The initial term of employment under the Directors Employment Agreements is for a term of one year unless terminated earlier. Upon expiration of the initial-year term, the Employment Agreements shall be automatically extended for successive one-year terms unless a three-months prior written notice to terminate the Directors Employment Agreement or unless terminated earlier pursuant to the terms of the Directors Employment Agreements.

 

Pursuant to the Directors Employment Agreements, Mr. Wong and Mr. Cheung will receive a nominal cash compensation of salary US$ 1 annually, each, for their capacities with TW Cayman. TW Cayman is entitled to terminate their agreement for cause at any time without remuneration for certain acts of Mr. Wong and Mr. Cheung, as being convicted of any criminal conduct, any act of gross or willful misconduct, or any severe, willful, grossly negligent, or persistent breach of any employment agreement provision, or engaging in any conduct which may make the continued employment of such officer detrimental to our company. Mr. Wong and Mr. Cheung have agreed to hold, both during and after the terms of his or her agreement, in confidence and not to use for the officer’s benefit or the benefit of any third party, any trade secrets, other information of a confidential nature or non-public information of or relating to us in respect of which we owe a duty of confidentiality to a third party. In addition, each Mr. Wong and Mr. Cheung has agreed not to, for a period of one year following the termination of his employment, carry on any business in direct competition with the business of the Top Wealth group of companies, solicit or seek or endeavor to entice away any customers, clients, representative, or agent of the Top Wealth group of companies or in the habit of dealing with the Top Wealth group of companies who is or shall at any time within two years prior to such cessation have been a customer, client, representative, or agent of the Top Wealth group of companies, and use a name including the words used by the Top Wealth group of companies in its name or in the name of any of its products, services or their derivative terms, or Chinese or English equivalent in such a way as to be capable of or likely to be confused with the name of the Top Wealth group of companies.

 

Furthermore, TW HK, our Operating Subsidiary, has entered letter of employment with Mr. Hung, CHEUNG on June 25, 2022. Pursuant to the letter of employment, commenced on July 1, 2022, Mr. Cheung have been employed as the Manager of TW HK, for a base monthly salary of HK$ 20,000 (approximately US$2,650) and Mandatory Provident Fund (MPF) pension contribution. As provided by the letter of employment, Mr. Cheung is required to refrain from servicing other company or business which will conflict with TW HK’s interest and from infringing the confidentiality principal of TW HK. Either Mr. Cheung or TW HK may terminate employment of Mr. Cheung with TW HK, by giving one month notice in writing.

 

Mr. Cheung will continue to receive compensation, in the form of salary and pension, from the Operating Subsidiary.

 

Mr. Kwok Kuen, YUEN

 

On May 16, 2023, TW Cayman entered into employment agreement with Mr. Kwok Kuen, YUEN, the Chief Financial Officer. This employment agreement shall continue to be effect until or unless terminated by either Mr. Yuen or TW Cayman by giving not less than three (3) months’ notice in writing or payment in lieu, or terminated earlier pursuant to the terms of the employment agreement. TW Cayman may terminate the Mr. Yuen’s employment immediately without notice or payment in lieu if Mr. Yuen: willfully disobeys a lawful and reasonable order, misconducts himself such conduct being inconsistent with the due and faithful discharge of his duties, commits a fraudulent or dishonest acts, is habitually neglectful in his duties; or on any other ground on which the TW Cayman would be entitled to terminate Mr. Yuen’s employment without notice at common law.

 

Pursuant to his employment agreements, Mr. Yuen receive cash compensation of salary HK$35,000 (approximately US$4,490) monthly.

 

89

 

 

Mr. Yuen further undertook to maintain in strict confidence any and all information of Top Wealth group of companies or of any other third parties to which he may have access. During and for a period of two (2) years after Mr. Yuen’s employment, Mr. Yuen will not use for his own account or divulge or disclose to any person, firm or company any trade secret, intellectual property or any other confidential information of the Top Wealth group of companies, include but shall not be limited to all information not in the public domain concerning the business, products, customer and client lists and contact details, procedures, processes and management strategies know-how, technology, accounts, finances, business and marketing plans, contracts, suppliers and business affairs of Top Wealth group of companies.

 

Both during and after a further period of six (6) months following the termination of his employment, Mr. Yuen has agreed not to, approach, canvass, solicit or otherwise endeavor to entice away from any person who at any time during the twelve (12) months preceding the termination of Mr. Yuen’s employment that has been a customer or supplier of the Top Wealth group of companies and during such period he shall not use his knowledge of or influence over any such customer or supplier to or for his own benefit or the benefit of any other person carrying on business in competition with the Company or otherwise use his knowledge of or influence over any such customer or supplier to the detriment of the Company, and not to solicit or entice or endeavor to solicit or entice away from Top Wealth group of companies any person who at the date of termination is employed or engaged by the Top Wealth group of companies in a managerial, executive or sales capacity and with whom Mr. Yuen has had material dealings or was directly managed by or reported to Mr. Yuen within the period of twelve (12) months immediately prior to the date of termination.

 

Furthermore, TW HK, our Operating Subsidiary, has entered letter of employment with Mr. Yuen on November 20, 2022. Pursuant to the letter of employment, commenced on December 1, 2022, Mr. Yuen have been employed as the Chief Financial Officer of TW HK, for a base monthly salary of HK$ 35,000 (approximately US$4,490) and Mandatory Provident Fund (MPF) pension contribution.

 

Compensation of Directors and Executive Officers

 

For the fiscal year ended December 31, 2023, we paid an aggregate of HK$ 876,000 (US$ 112,308) as compensation to our directors and executive officers as well as an aggregate of HK$36,000 (US$4,615) contributions to the Mandatory Provident Fund (“MPF”), a statutory retirement scheme introduced after the enactment of the Mandatory Provident Fund Schemes Ordinance in Hong Kong.

 

For the fiscal year ended December 31,2022 we paid an aggregate of HK$153,000 (US$19,615) as compensation to our directors and executive officers as well as an aggregate of HK$6,000 (US$769) contributions to the MPF.

 

As the appointments of our independent directors was effective on March 29, 2024, for the fiscal year ended December 31, 2023 and 2022, we did not have any non-executive directors and therefore have not paid any compensation to any non-executive directors.

 

Except our contribution to the MPF, we have not set aside or accrued any amount to provide pension, retirement, or other similar benefits to our directors and executive officers. We do not have any equity incentive plan in place as of the date of this prospectus.

 

Code of Conduct and Ethics and Executive Compensation Recovery Policy

 

We have adopted (i) a written code of business conduct and ethics and (ii) Executive Compensation Recovery Policy that applies to our officers, and employees, including our chief executive officer, chief financial officer, principal accounting officer or controller or persons performing similar functions, (collectively the “Policies”). We intend to disclose any amendments to the Policies, and any waivers of the Policies for our Directors, executive officers and senior finance executives, on our website to the extent required by applicable U.S. federal securities laws and the corporate governance rules of Nasdaq.

 

90

 

 

PRINCIPAL SHAREHOLDERS

 

The following table sets forth information regarding the beneficial ownership of our share capital by:

 

each person, or group of affiliated persons, known by us to beneficially own more than 5% of our shares;
   
each of our named Executive Officers;
   
each of our Directors and Director nominees; and
   
all of our current Executive Officers, Directors and Director nominees as a group.

 

The calculations in the table below are based on 29,000,000 Ordinary Shares outstanding as of the date of this prospectus, and 56,000,000 Ordinary Shares issued and outstanding immediately after the completion of this offering. All of our shareholders who own our Ordinary Shares have the same voting rights.

 

The information presented below regarding beneficial ownership of our voting securities has been presented in accordance with the rules of the SEC and is not necessarily indicative of ownership for any other purpose. Under these rules, a person is deemed to be a “beneficial owner” of a security if that person has or shares the power to vote or direct the voting of the security or the power to dispose or direct the disposition of the security. A person is deemed to own beneficially any security as to which such person has the right to acquire sole or shared voting or investment power within sixty (60) days through the conversion or exercise of any convertible security, warrant, option or other right. More than one (1) person may be deemed to be a beneficial owner of the same securities. The percentage of beneficial ownership by any person as of a particular date is calculated by dividing the number of shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting or investment power within sixty (60) days, by the sum of the number of shares outstanding as of such date, plus the number of shares as to which such person has the right to acquire voting or investment power within sixty (60) days. Consequently, the denominator used for calculating such percentage may be different for each beneficial owner. Except as otherwise indicated below and under applicable community property laws, we believe that the beneficial owners of our shares listed below have sole voting and investment power with respect to the shares shown.

 

   Ordinary Shares
Beneficially
Owned Prior to
This Offering
   Ordinary Shares
Beneficially
Owned Immediately
after This Offering
 
   Number of
Ordinary
Shares
   Approximate
percentage of
outstanding
Ordinary
Shares
   Number of
Ordinary
Shares
   Approximate
percentage of
outstanding
Ordinary
Shares
 
Directors and Executive Officers:                
Kim Kwan Kings, WONG(1)   20,160,000    69.52%   20,160,000    36%
Hung, CHEUNG                
Kwok Kuen, YUEN                
Feiyong, LI                
Phei Suan, HO                
Wai Chun, CHIK                
All Directors and Executive Officers as a Group   20,160,000    69.52%   20,160,000    36%
                     
Principal Shareholders holding 5% or more:                    
Winwin Development Group Limited(1)   20,160,000    69.52%   20,160,000    36%

 

 

(1)Kim Kwan Kings, WONG beneficially owns 20,160,000 Ordinary Shares through Winwin Development Group Limited, a company incorporated under the laws of the British Virgin Islands, which is owned as to 90% by Mr. Kim Kwan Kings, WONG and 10% by Mr. Kin Fai, CHONG. Mr. Kim Kwan Kings, WONG is the sole director of Winwin Development Group Limited. Mr. Wong may be deemed the beneficial owners of the Ordinary Shares held by Winwin Development Group Limited, and Mr. Wong holds the voting and dispositive power over the Ordinary Shares held by Winwin Development Group Limited. The registered address of Winwin Development Group Limited is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands.

 

We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.

 

91

 

 

RELATED PARTY TRANSACTIONS

 

Employment Agreements and Indemnification Agreements

 

See “Management — Employment Agreements and Indemnification Agreements.”

 

Other Transactions with Related Parties

 

As of December 31, 2023, the Company had the following balances due with related parties:

 

Name  Amount   Relationship  Note
Wong Kim Kwan Kings  $160,089   Director and controlling shareholder of the Company  Unsecured interest free loan payable, repayable on demand
Snow Bear Capital Limited  $429,065   Shareholder of the Company  Unsecured interest free loan payable, repayable within one year from draw down

 

As of December 31, 2022, the Company had the following balances due with related parties:

 

Name  Amount   Relationship  Note
Mother Nature Health (HK) Limited  $5,436   The former director of Top Wealth Group (International) Limited, the Operating Subsidiary, and the former director of the related company, Mother Nature Health (HK) Limited.  Account receivable
Kin Fai, CHONG  $63,735   A former director and the former principal owner of Top Wealth Group (International) Limited. The current shareholder of Winwin Development Group Limited, the Company’s controlling shareholder  Amount receivable for common stock issued in Top Wealth Group (International) Limited
Kim Kwan Kings, WONG  $(217,779)  Director and controlling shareholder of the Company  Unsecured interest free loan payable, repayable on demand

 

Mother Nature Health (HK) Limited has ceased to be a related party after December 31, 2022. On August 9, 2022, Mother Nature Health (HK) Limited entered into the trade transaction with the Operating Subsidiary, Top Wealth Group (International) Limited, from which the account receivables of the amount of $5,436 was incurred. The $5,436 account receivable have been fully paid by Mother Nature Health (HK) Limited as of the date of the prospectus. These transactions with Mother Nature Health (HK) Limited were not considered as related party transactions in the year ended December 31, 2023.

 

Kin Fai, CHONG, the former director and the former principal owner of Top Wealth Group (International) Limited prior to the reorganization of the group, currently a 10% shareholder of Winwin Development Group Limited, the Company’s controlling shareholder, received from the Company cash advance in the form of interest-free loans, which was to pay for his expenses generated from his business trip on July 14, 2021. The advance has been fully repaid as of the date of the this report.

 

Kim Kwan Kings, WONG is a director and CEO of the Company. On July 14, 2022 and December 31, 2021, Mr. Wong has lent cash to the Top Wealth Group (International) Limited, the Operating Subsidiary, in the form of interest-free loan, with the purpose of solidifying the its work capital. The outstanding amount due to Mr. Wong as of the date of the prospectus is $160,089.

 

92

 

 

During the fiscal year ended December 31, 2023, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Kin Fai, CHONG  $63,735   A former director and principal owner of the Company  Repayment of unsecured interest free loan payable, repayable on demand
Kim Kwan Kings, WONG  $57,690   Director and controlling shareholder of the Company  Repayment of unsecured interest free loan payable, repayable on demand
Snow Bear Capital Limited  $429,065   Shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable within one year from drawdown.

 

During the fiscal year ended December 31, 2022, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Beauty & Health International Company Limited (1)  $1,281,077   A company under common control  Revenue - sale of caviar
Beauty & Health International E-Commerce Limited (Customer C) (note b)  $1,063,334   A company under common control  Revenue - sale of caviar
Mother Nature Health (HK) Limited (2)  $797,872   The Company’s former director  was also this related company’s former director  Revenue - sale of caviar
Sky Channel Management Limited (3)  $1,418,141   The Company’s principal owner was a former director of this related company  Marketing expense
Kin Fai, CHONG  $(898)  A former director and principal owner of the Company  Proceeds from unsecured interest free loan payable, repayable on demand
Kin Fai, CHONG  $64,101   A former director and principal owner of the Company  Amount receivable for issuance of common stock in Top Wealth International as of December 31, 2022. The amount was paid on May 13, 2023.
Kim Kwan Kings, WONG  $(467,315)  Director and controlling shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable on demand
Kin Fai, CHONG  $576,912   Director and controlling shareholder of the Company  Conversion of unsecured interest free loan payable, repayable on demand into common stock in Top Wealth International

 

During 2021, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Kin Fai, CHONG   532   A former director and principal owner of the Company  Cash advanced for unsecured interest free loan receivable, repayable on demand
Kim Kwan Kings, WONG   (293,410)  Director and controlling shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable on demand

 

(1)The transaction with this related party was ceased after August 31, 2022.

 

(2)The transaction with this related party started on September 3, 2022. The controlling shareholder disposed all of his interest in this related party on 28 August 2022. These transactions were not considered as related party transactions in the year ended December 31, 2023

 

(3)The transaction with this related party was ceased after December 31, 2022.

 

93

 

 

DESCRIPTION OF SHARE CAPITAL

 

Top Wealth Group Holding Limited is an exempted company incorporated in the Cayman Islands and our corporate affairs are governed by our articles of association, the Companies Act, and the common law of the Cayman Islands.

 

At incorporation, our authorized share capital is US$50,000, divided into 500,000,000 ordinary shares, par value US$0.0001 per share. Upon incorporation, 1 ordinary share of US$0.0001 was issued a par. On March 1, 2023, 99 ordinary shares of US$0.0001 each were issued at par. All these ordinary shares rank pari-passu with the exiting share in all respect.

 

Thereafter, on April 28, 2023, 650 ordinary shares of US$0.0001 each were issued to the Company’s then-sole owner at par. All these ordinary shares rank pari-passu with the exiting shares in all respect.

 

Furthermore, on the same date, April 18, 2023, the then-sole owner of the Company sold a total of 190 Ordinary Shares, out of its 750 Ordinary Shares, to five shareholders.

 

On October 12, 2023, in contemplation of Company’s initial public offering, the Company further issued 26,999,250 ordinary shares in aggregate to its existing shareholders at par value, on a pro rata basis proportional to the shareholders’ existing equity interests (collectively refers as the “Pro Rata Share Issuance”). After the Pro Rata Share Issuance, 27,000,000 Ordinary Shares were issued and outstanding. All these ordinary shares rank pari-passu with the exiting shares in all respect. This Pro Rata Share Issuance has treated as share split.

 

On April 18, 2024, the Company closed its initial public offering of 2,000,000 Ordinary Shares at a public offering price of US$4.00 per Ordinary Share.

 

As of the date of this prospectus, 29,000,000 Ordinary Shares were issued and outstanding.

 

Ordinary Shares

 

General

 

Our ordinary shares are issued in registered form, and are issued when registered in our register of members. Unless the board of directors determine otherwise, each holder of our ordinary shares will not receive a certificate in respect of such ordinary shares. Our shareholders who are non-residents of the Cayman Islands may freely hold and vote their ordinary shares. We may not issue shares or warrants to bearer.

 

As at the date of this Prospectus, the Company has no outstanding options, warrants and other convertible securities.

 

Subject to the provisions of the Companies Act and our articles regarding redemption and purchase of the shares, the directors have general and unconditional authority to allot (with or without confirming rights of renunciation), grant options over or otherwise deal with any unissued shares to such persons, at such times and on such terms and conditions as they may decide. The directors may deal with unissued shares either at a premium or at par, or with or without preferred, deferred or other special rights or restrictions, whether in regard to dividend, voting, return of capital or otherwise. No share may be issued at a discount except in accordance with the provisions of the Companies Act. The directors may refuse to accept any application for shares, and may accept any application in whole or in part, for any reason or for no reason.

 

Listing

 

Our Ordinary Share are traded on the Nasdaq Capital Market under the ticker symbol “TWG.”

 

Transfer Agent and Registrar

 

The transfer agent and registrar for the Ordinary Shares is VStock Transfer, LLC. The transfer agent and registrar’s address is 18 Lafayette Place, Woodmere, NY 11598.

 

94

 

 

Dividends

 

The holders of our Ordinary Shares are entitled to such dividends as may be declared by our Board of Directors, subject to the Companies Act. Subject to the provisions of the Companies Act and any rights attaching to any class or classes of shares under and in accordance with the articles, our articles provide that the directors may from time to time declare dividends (including interim dividends) and other distributions on shares of the Company in issue and authorize payment of the same out of the funds of the Company lawfully available therefor. Our shareholders may, by ordinary resolution, declare dividends but no such dividend shall exceed the amount recommended by the directors. No dividend shall be paid otherwise than out of profits or, subject to the restrictions of the Companies Act regarding the application of a company’s share premium account and with the sanction of an ordinary resolution, the share premium account. The directors when paying dividends to shareholders may make such payment either in cash or in specie.

 

Unless provided by the rights attached to a share, no dividend shall bear interest.

 

Voting Rights

 

Subject to any rights or restrictions for the time being attached to any class or classes of shares, on a show of hands every shareholder of record present in person or by proxy at a general meeting shall have one vote and on a poll every shareholder of record present in person or by proxy shall have one (1) vote for each share registered in his name in the register of Members.

 

An ordinary resolution to be passed by the shareholders requires the affirmative vote of a simple majority of the votes attached to the Ordinary Shares cast by those shareholders entitled to vote who are present in person or by proxy (or, in the case of corporations, by their duly authorized representatives) at a general meeting, while a special resolution requires the affirmative vote of a majority of not less than two-thirds of the votes attached to the Ordinary Shares cast by those shareholders who are present in person or by proxy (or, in the case of corporations, by their duly authorized representatives) at a general meeting. Both ordinary resolutions and special resolutions may also be passed by a unanimous written resolution signed by all the shareholders of our company, as permitted by the Companies Act and our amended and restated memorandum and articles of association. A special resolution will be required for important matters such as a change of name or making changes to our amended and restated memorandum and articles of association.

 

Cumulative Voting

 

Delaware law permits cumulative voting for the election of directors only if expressly authorized in the certificate of incorporation. There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands but our amended and restated memorandum and articles of association do not provide for cumulative voting.

 

Pre-emptive Rights

 

There are no pre-emptive rights applicable to the issue by us of Ordinary Shares under our amended and restated memorandum and articles of association.

 

Options Grants

 

Effective on August 1, 2022, Top Wealth (International) Limited (“TW HK”), the Operating Subsidiary, entered into a Corporate Development Consultant Appointment Agreement with Mr. Haitong, CHEN (the “Consultancy Agreement”), in which TW HK appointed Mr. Chen for a term of 10 months commencing from August 1, 2022 to June 30, 2023, subject to extension or early termination, to provide corporate development, project management, and capital financing consultancy services in connection to the Company’s IPO in the United States. Pursuant to the Consultancy Agreement, in addition to a fixed cash remuneration to Mr. Chen, TW HK will also cause TW Cayman to grant stock options to Mr. Chen to acquire an aggregate of 1,080,000 Ordinary Shares of TW Cayman after Company’s IPO, representing 4% of the Ordinary Shares of TW Cayman issued and outstanding prior to the IPO (the “Consultancy Stock Option”). The options granted to Mr. Chen will vest and become exercisable over a period of three years in three equal tranches, on the first, second, and third anniversary of the date of Company’s listing on Nasdaq capital market. All options shall be exercised after three anniversaries and within 60 months of Company’s listing, otherwise the unexercised options will be null and void. The applicable exercise price for the Consultancy Stock Option that to be granted to Mr. Chen is fifty percent (50%) of the IPO Price per Ordinary Shares offered by the Company.

 

Upon the expiration of the term of the Consultancy Agreement, Mr. Chen and the Company mutually agreed not to extend Consultancy Agreement.

 

95

 

 

Our Memorandum and Articles of Association

 

The following are summaries of the material provisions of our amended and restated memorandum and articles of association and the Companies Act, insofar as they relate to the material terms of our Ordinary Shares. They do not purport to be complete. Reference is made to our amended and restated memorandum and articles of association, a copy of which is filed as an exhibit to the registration statement of which this prospectus is a part (and which is referred to in this section as, respectively, the “memorandum” and the “articles”).

 

Meetings of Shareholders

 

As a Cayman Islands exempted company, we are not obligated by the Companies Act to call shareholders’ annual general meetings; accordingly, we may, but shall not be obliged to, in each year hold a general meeting as an annual general meeting. Any annual general meeting held shall be held at such time and place as may be determined by our board of directors. All general meetings other than annual general meetings shall be called extraordinary general meetings.

 

The directors may convene a meeting of shareholders whenever they think necessary or desirable. At least 5 clear days’ notice of a general meeting shall be given to shareholders entitled to attend and vote at such meeting. The notice shall specify the place, the day and the hour of the meeting and the general nature of that business. In addition, if a resolution is proposed as a special resolution, the text of that resolution shall be given to all shareholders. Notice of every general meeting shall also be given to the directors. Subject to the Cayman Companies Act and with the consent of the shareholders who, individually or collectively, hold at least 90 percent of the voting rights of all those who have a right to vote at a general meeting, a general meeting may be convened on shorter notice.

 

Our board of directors must convene a general meeting upon the written requisition of one or more shareholders entitled to attend and vote at a general meeting of the Company holding not less than 10% of the rights to vote at such general meeting in respect to the matter for which the meeting is requested, specifying the purpose of the meeting and signed by each of the shareholders making the requisition. If the directors do not convene such meeting within 21 clear days’ from the date of receipt of the written requisition, those shareholders who requested the meeting or any of them may convene the general meeting themselves within three months after the end of such period of 21 clear days in which case reasonable expenses incurred by them as a result of the directors failing to convene a meeting shall be reimbursed by us.

 

No business may be transacted at any general meeting unless a quorum is present at the time the meeting proceeds to business. A quorum shall consist of the presence (whether in person or represented by proxy) of one shareholder if the Company has one shareholder and two shareholders if the Company has more than one shareholder. If, within fifteen minutes from the time appointed for the meeting, a quorum is not present, the meeting, if convened upon the requisition of shareholders, shall be dissolved. In any other case, it shall stand adjourned to the same time and place seven days hence or to such other time or place as is determined by the directors, and if, at the adjourned meeting, a quorum is not present within fifteen minutes from the time appointed for the meeting, the shareholders present in person or by proxy at the meeting shall be a quorum. Subject to the articles, at every meeting, the shareholders present in person or by proxy may choose someone of their number to be the chairman.

 

A corporation that is a shareholder shall be deemed for the purpose of our memorandum and articles of association to be present at a general meeting in person if represented by its duly authorized representative. Where a duly authorized representative is present at a meeting that shareholder who is a corporate is deemed to be present in person; and the acts of the duly authorized representative are personal acts of that shareholder.

 

96

 

 

At any general meeting a resolution put to the vote of the meeting shall be decided on a show of hands, unless a poll is (before, or on, the declaration of the result of the show of hands) demanded by the chairman of the meeting or by one or more shareholders present who together hold not less than ten percent of the voting rights of all those who are entitled to vote on the resolution. Unless a poll is so demanded, a declaration by the chairman as to the result of a resolution and an entry to that effect in the minutes of the meeting, shall be conclusive evidence of the outcome of a show of hands, without proof of the number or proportion of the votes recorded in favor of, or against, that resolution.

 

If a poll is duly demanded it shall be taken in such manner as the chairman directs and the result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded.

 

In the case of an equality of votes, whether on a show of hands or on a poll, the chairman of the meeting at which the show of hands takes place or at which the poll is demanded, may, if he wishes, cast a second or casting vote.

 

Meetings of Directors

 

The business of our company is managed by the directors. Our directors are free to meet at such times and in such manner and places within or outside the Cayman Islands as the directors determine to be necessary or desirable. The quorum for the transaction of business at a meeting of directors shall be two unless the directors fix some other number. An action that may be taken by the directors at a meeting may also be taken by a resolution of directors consented to in writing by all of the directors.

 

Winding Up

 

If we are wound up, the shareholders may, subject to the articles and any other sanction required by the Companies Act, pass a special resolution allowing the liquidator to do either or both of the following:

 

  to divide in specie among the shareholders the whole or any part of our assets and, for that purpose, to value any assets and to determine how the division shall be carried out as between the shareholders or different classes of shareholders; and

 

  to vest the whole or any part of the assets in trustees for the benefit of shareholders and those liable to contribute to the winding up.

 

Calls on Ordinary Shares and forfeiture of Ordinary Shares

 

Subject to the terms of allotment, the directors may make calls on the shareholders in respect of any monies unpaid on their shares including any premium and each shareholder shall (subject to receiving at least 14 clear days’ notice specifying when and where payment is to be made), pay to us the amount called on his shares. Shareholders registered as the joint holders of a share shall be jointly and severally liable to pay all calls in respect of the share. If a call remains unpaid after it has become due and payable the person from whom it is due and payable shall pay interest on the amount unpaid from the day it became due and payable until it is paid at the rate fixed by the terms of allotment of the share or in the notice of the call or if no rate is fixed, at the rate of ten percent per annum. The directors may waive payment of the interest wholly or in part.

 

We have a first and paramount lien on all shares (whether fully paid up or not) registered in the name of a shareholder (whether solely or jointly with others). The lien is for all monies payable to us by the shareholder or the shareholder’s estate:

 

  either alone or jointly with any other person, whether or not that other person is a shareholder; and

 

  whether or not those monies are presently payable.

 

At any time the directors may declare any share to be wholly or partly exempt from the lien on shares provisions of the articles.

 

97

 

 

We may sell, in such manner as the directors may determine, any share on which the sum in respect of which the lien exists is presently payable, if due notice that such sum is payable has been given (as prescribed by the articles) and, within 14 clear days of the date on which the notice is deemed to be given under the articles, such notice has not been complied with.

 

Redemption, Repurchase and Surrender of Ordinary Shares

 

We may issue shares on terms that such shares are subject to redemption, at our option, on such terms and in such manner as may be determined, before the issue of such shares, by our board of directors or by an ordinary resolution of our shareholders.

 

The Companies Act and our memorandum and articles of association permits us to purchase our own shares, subject to certain restrictions and requirements. Subject to the Companies Act and any rights for the time being conferred on the shareholders holding a particular class of shares, we may by action of our directors:

 

  issue shares that are to be redeemed or liable to be redeemed, at our option or the shareholder holding those redeemable shares, on the terms and in the manner our directors determine before the issue of those shares;

 

  with the consent by special resolution of the shareholders holding shares of a particular class, vary the rights attaching to that class of shares so as to provide that those shares are to be redeemed or are liable to be redeemed at our option on the terms and in the manner which the directors determine at the time of such variation; and

 

  purchase all or any of our own shares of any class including any redeemable shares on the terms and in the manner which the directors determine at the time of such purchase.

 

Under the Companies Act, the repurchase of any share may be paid out of our Company’s profits, or out of the share premium account, or out of the proceeds of a fresh issue of shares made for the purpose of such repurchase, or out of capital. If the repurchase proceeds are paid out of our Company’s capital, our Company must, immediately following such payment, be able to pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act, no such share may be repurchased (1) unless it is fully paid up, and (2) if such repurchase would result in there being no shares outstanding other than shares held as treasury shares. The repurchase of shares may be effected in such manner and upon such terms as may be authorized by or pursuant to the articles. If the articles do not authorize the manner and terms of the purchase, a company shall not repurchase any of its own shares unless the manner and terms of purchase have first been authorized by a resolution of the company. In addition, under the Companies Act and our memorandum and articles of association, our Company may accept the surrender of any fully paid share for no consideration unless, as a result of the surrender, the surrender would result in there being no shares outstanding (other than shares held as treasury shares).

 

Variations of Rights of Shares

 

If at any time, our share capital is divided into different classes of shares, all or any of the rights attached to any class of our shares may (unless otherwise provided by the terms of issue of the shares of that class) be varied with the consent in writing of the holders of two-thirds of the issued shares of that class or with the sanction of a resolution passed by a majority of not less than two-thirds of holders of shares of that class as may be present in person or by proxy at a separate general meeting of the holders of shares of that class.

 

Unless the terms on which a class of shares was issued state otherwise, the rights conferred on the shareholder holding shares of any class shall not be deemed to be varied by the creation or issue of further shares ranking pari passu with the existing shares of that class.

 

Changes in Capital

 

We may from time to time by an ordinary resolution of our shareholders:

 

  increase our share capital by new shares of the amount fixed by that ordinary resolution and with the attached rights, priorities and privileges set out in that ordinary resolution;

 

  consolidate and divide all or any of our share capital into shares of larger amount than our existing shares;

 

98

 

 

  convert all or any of our paid-up shares into stock, and reconvert that stock into paid up shares of any denomination;

 

  subdivide our existing shares, or any of them, into shares of a smaller amount than that fixed by the memorandum, provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived; and

 

  cancel any shares that, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of our share capital by the amount of the shares so cancelled, or, in the case of shares without nominal par value, diminish the number of shares into which our capital is divided.

 

Our shareholders may by special resolution, subject to confirmation by the Grand Court of the Cayman Islands on an application by our company for an order confirming such reduction, reduce its share capital in any manner authorized by the Companies Act.

 

Inspection of Books and Records

 

Holders of our Ordinary Shares will have no general right under Cayman Islands law to inspect any account or book or document of the Company except as conferred by the Companies Act or authorized by the Directors or by the Company in general meeting. However, we will provide our shareholders with annual audited financial statements. See “Where You Can Find Additional Information” on page 118.

 

Rights of Non-Resident or Foreign Shareholders

 

There are no limitations imposed by our memorandum and articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our memorandum and articles of association governing the ownership threshold above which shareholder ownership must be disclosed.

 

Issuance of additional Ordinary Shares

 

Our articles of association authorizes our Board of Directors to issue additional Ordinary Shares from authorized but unissued shares, to the extent available, from time to time as our board of directors shall determine.

 

Exempted Company

 

We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except that an exempted company:

 

  does not have to file an annual return of its shareholders with the Registrar of Companies;

 

  is not required to open its register of members for inspection;

 

  does not have to hold an annual general meeting;

 

  may issue negotiable or bearer shares or shares with no par value;

 

  may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance);

 

  may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;

 

  may register as a limited duration company; and

 

  may register as a segregated portfolio company.

 

99

 

 

“Limited liability” means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

 

Differences in Corporate Law

 

The Companies Act and the laws of the Cayman Islands affecting Cayman Islands companies like us and our shareholders differ from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the material differences between the provisions of the laws of the Cayman Islands applicable to us and the laws applicable to companies incorporated in the United States and their shareholders. Set forth below is a summary of certain significant differences between the provisions of the Companies Act applicable to us and the comparable laws applicable to companies incorporated in the State of Delaware in the United States.

 

    Delaware   Cayman Islands
Title of Organizational Documents   Certificate of Incorporation and Bylaws  

Certificate of Incorporation and Memorandum and Articles of Association
 

Duties of Directors  

Under Delaware law, the business and affairs of a corporation are managed by or under the direction of its board of directors. In exercising their powers, directors are charged with a fiduciary duty of care to protect the interests of the corporation and a fiduciary duty of loyalty to act in the best interests of its shareholders. The duty of care requires that directors act in an informed and deliberative manner and inform themselves, prior to making a business decision, of all material information reasonably available to them. The duty of care also requires that directors exercise care in overseeing and investigating the conduct of the corporation’s employees. The duty of loyalty may be summarized as the duty to act in good faith, not out of self-interest, and in a manner which the director reasonably believes to be in the best interests of the shareholders. 

  Under the laws of the Cayman Islands, directors have a fiduciary duty to act honestly in good faith with a view to the company’s best interests. Our directors also have a duty to exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances. A shareholder has the right to seek damages if a duty owed by the directors is breached.
         
Limitations on Personal Liability of Directors   Subject to the limitations described below, a certificate of incorporation may provide for the elimination or limitation of the personal liability of a director to the corporation or its shareholders for monetary damages for a breach of fiduciary duty as a director. Such provision cannot limit liability for breach of loyalty, bad faith, intentional misconduct, unlawful payment of dividends or unlawful share purchase or redemption. In addition, the certificate of incorporation cannot limit liability for any act or omission occurring prior to the date when such provision becomes effective.   The Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of Officers and directors. However, as a matter of public policy, Cayman Islands law will not allow the limitation of a director’s liability to the extent that the liability is a consequence of the director committing a crime or of the director’s own fraud, dishonesty or wilful default.

 

100

 

 

    Delaware   Cayman Islands
Indemnification of Directors, Officers, Agents, and Others   A corporation has the power to indemnify any director, officer, employee, or agent of corporation who was, is, or is threatened to be made a party who acted in good faith and in a manner he believed to be in the best interests of the corporation, and if with respect to a criminal proceeding, had no reasonable cause to believe his conduct would be unlawful, against amounts actually and reasonably incurred.  

The ability of Cayman Islands companies to provide in their articles of association for indemnification of officers and directors is limited, insofar as it is not permissible for the directors to contract out of the core fiduciary duties they owe to the company, nor would any indemnity be effective if it were held by the Cayman Islands courts to be contrary to public policy, which would include any attempt to provide indemnification against civil fraud or the consequences of committing a crime. 

         
        Our articles of association provide to the extent permitted by law, the directors and officers for the time being of the Company and any trustee for the time being acting in relation to any of the affairs of the Company and their heirs, executors, administrators and personal representatives respectively shall be indemnified out of the assets of the Company from and against all actions, proceedings, costs, charges, losses, damages and expenses which they or any of them shall or may incur or sustain by reason of any act done or omitted in or about the execution of their duty in their respective offices or trusts, except such (if any) as they shall incur or sustain by or through their own wilful neglect or default respectively and no such director, officer or trustee shall be answerable for the acts, receipts, neglects or defaults of any other director, officer or trustee or for joining in any receipt for the sake of conformity or for the solvency or honesty of any banker or other persons with whom any monies or effects belonging to the Company may be lodged or deposited for safe custody or for any insufficiency of any security upon which any monies of the Company may be invested or for any other loss or damage due to any such cause as aforesaid or which may happen in or about the execution of his office or trust unless the same shall happen through the wilful neglect or default of such director, officer or trustee.

 

101

 

 

    Delaware   Cayman Islands
Interested Directors  

Under Delaware law, a transaction in which a director who has an interest in such transaction would not be voidable if (i) the material facts as to such interested director’s relationship or interests are disclosed or are known to the board of directors and the board in good faith authorizes the transaction by the affirmative vote of a majority of the disinterested directors, even though the disinterested directors are less than a quorum, (ii) such material facts are disclosed or are known to the shareholders entitled to vote on such transaction and the transaction is specifically approved in good faith by vote of the shareholders, or (iii) the transaction is fair as to the corporation as of the time it is authorized, approved or ratified. Under Delaware law, a director could be held liable for any transaction in which such director derived an improper personal benefit. 

  Interested director transactions are governed by the terms of a company’s Memorandum and Articles of Association.
         
Voting Requirements  

The certificate of incorporation may include a provision requiring supermajority approval by the directors or shareholders for any corporate action.

 

In addition, under Delaware law, certain business combinations involving interested shareholders require approval by a supermajority of the non-interested shareholders.

 

For the protection of shareholders, certain matters must be approved by special resolution of the shareholders as a matter of Cayman Islands law, including alteration of the memorandum or articles of association, appointment of inspectors to examine company affairs, reduction of share capital (subject, in relevant circumstances, to court approval), change of name, authorization of a plan of merger or transfer by way of continuation to another jurisdiction or consolidation or voluntary winding up of the company.

 

The Companies Act requires that a special resolution be passed by a majority of at least two-thirds or such higher percentage as set forth in the Memorandum and Articles of Association, of shareholders being entitled to vote and do vote in person or by proxy at a general meeting, or by unanimous written consent of shareholders entitled to vote at a general meeting. 

         
Voting for election of Directors  

Under Delaware law, unless otherwise specified in the certificate of incorporation or bylaws of the corporation, directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. 

  Directors are appointed in accordance with the terms of the Memorandum and Articles of Association of the company.
         
Cumulative Voting   No cumulative voting for the election of directors unless so provided in the certificate of incorporation.   Our currently effective articles of association do not provide for cumulative voting.

 

102

 

 

    Delaware   Cayman Islands
Directors’ Powers Regarding Bylaws   The certificate of incorporation may grant the directors the power to adopt, amend or repeal bylaws.  

The Memorandum and Articles of Association may only be amended by a special resolution of the shareholders. 

         
Nomination and Removal of Directors and Filling Vacancies on Board  

Shareholders may generally nominate directors if they comply with advance notice provisions and other procedural requirements in company bylaws. Holders of a majority of the shares may remove a director with or without cause, except in certain cases involving a classified board or if the company uses cumulative voting. Unless otherwise provided for in the certificate of incorporation, directorship vacancies are filled by a majority of the directors elected or then in office. 

  Nomination, appointment and removal of directors and filling of board vacancies are governed by the terms of the Memorandum and Articles of Association.
         
Mergers and Similar Arrangements  

Under Delaware law, with certain exceptions, a merger, consolidation, exchange or sale of all or substantially all the assets of a corporation must be approved by the board of directors and a majority of the outstanding shares entitled to vote thereon. Under Delaware law, a shareholder of a corporation participating in certain major corporate transactions may, under certain circumstances, be entitled to appraisal rights pursuant to which such shareholder may receive cash in the amount of the fair value of the shares held by such shareholder (as determined by a court) in lieu of the consideration such shareholder would otherwise receive in the transaction.

 

Delaware law also provides that a parent corporation, by resolution of its board of directors, may merge with any subsidiary, of which it owns at least 90% of each class of capital stock without a vote by shareholders of such subsidiary. Upon any such merger, dissenting shareholders of the subsidiary would have appraisal rights.

  The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (a) “merger” means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (b) a “consolidation” means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the shareholders and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.

 

103

 

 

    Delaware   Cayman Islands
       

Save in certain limited circumstances under the Companies Act of the Cayman Islands, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to the merger or consolidation, provide the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful. 

         
       

Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of schemes of arrangement; provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. Dissentient members/creditors are entitled to appear and be heard. At the hearing, the Grand Court considers (in light of any opposition) whether:

 

● approval of the scheme was reasonable (whether a reasonable member would have approved it);

 

● each class was fairly represented at the meeting;

 

●  the majority acted bona fide without coercion of the minority to promote interests adverse to those of the class;

 

●   all notice periods were complied with;

 

● the resolutions carried by the requisite majority.

 

104

 

 

    Delaware   Cayman Islands
Shareholder Suits   Class actions and derivative actions generally are available to shareholders under Delaware law for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. In such actions, the court generally has discretion to permit the winning party to recover attorneys’ fees incurred in connection with such action.  

In principle, we will normally be the proper plaintiff and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, there are exceptions to the foregoing principle, including when:

 

● a company acts or proposes to act illegally or ultra vires;

 

● the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and

 

●  those who control the company are perpetrating a “fraud on the minority.” 

         
Inspection of Corporate Records   Under Delaware law, shareholders of a Delaware corporation have the right during normal business hours to inspect for any proper purpose, and to obtain copies of list(s) of shareholders and other books and records of the corporation and its subsidiaries, if any, to the extent the books and records of such subsidiaries are available to the corporation.  

Shareholders of a Cayman Islands exempted company have no general right under Cayman Islands law to inspect or obtain copies of a list of shareholders or other corporate records (other than the copies of Memorandum and Articles of Association and any special resolutions passed by such companies, and the registers of mortgages and charges of such companies) of the company. However, these rights may be provided in the company’s Memorandum and Articles of Association. 

         
Shareholder Proposals   Unless provided in the corporation’s certificate of incorporation or bylaws, Delaware law does not include a provision restricting the manner in which shareholders may bring business before a meeting.   Cayman Islands law provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to table resolutions at a general meeting. However, these rights may be provided in a company’s articles of association. Our articles provide that the directors may whenever they think fit, and they shall on the requisition of Members of the Company holding at the date of the deposit of the requisition not less than one-tenth of such of the paid-up capital of the Company as at the date of the deposit carries the right of voting at general meetings of the Company, proceed to convene a general meeting of the Company. If the directors do not within 21 days from the date of the deposit of the requisition duly proceed to convene a general meeting, the requisitionists, or any of them representing more than one-half of the total voting rights of all of them, may themselves convene a general meeting, but any meeting so convened shall not be held after the expiration of three months after the expiration of the said 21 days.

 

105

 

 

    Delaware   Cayman Islands
Approval of Corporate Matters by Written Consent  

Delaware law permits shareholders to take action by written consent signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting of shareholders. 

  The Companies Act allows a special resolution to be passed in writing if signed by all the voting shareholders (if authorized by the Memorandum and Articles of Association).
         
Calling of Special Shareholders Meetings  

Delaware law permits the board of directors or any person who is authorized under a corporation’s certificate of incorporation or bylaws to call a special meeting of shareholders. 

  The Companies Act does not have provisions governing the proceedings of shareholders meetings which are usually provided in the Memorandum and Articles of Association.
         
Dissolution; Winding Up   Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board of directors.   Under the Companies Act and our articles, the Company may be wound up by a special resolution of our shareholders, or if the winding up is initiated by our board of directors, by either a special resolution of our members or, if our company is unable to pay its debts as they fall due, by an ordinary resolution of our members. In addition, a company may be wound up by an order of the courts of the Cayman Islands. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so.

 

106

 

 

SHARES ELIGIBLE FOR FUTURE SALE

 

Rule 144

 

In general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for at least 90 days, a person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least six months, including the holding period of any prior owner other than our affiliates, is entitled to sell those shares without complying with the manner of sale, volume limitation or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then that person is entitled to sell those shares without complying with any of the requirements of Rule 144.

 

In general, under Rule 144, as currently in effect, our affiliates or persons selling shares on behalf of our affiliates are entitled to sell within any three-month period beginning 90 days after the date of this prospectus, a number of shares that does not exceed the greater of:

 

1% of the number of ordinary shares; or

 

the average weekly trading volume of the ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.

 

Sales under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us.

 

Options Grants

 

Effective on August 1, 2022, Top Wealth (International) Limited (“TW HK”), the Operating Subsidiary, entered into a Corporate Development Consultant Appointment Agreement with Mr. Haitong, CHEN (the “Consultancy Agreement”), in which TW HK appointed Mr. Chen for a term of 10 months commencing from August 1, 2022 to June 30, 2023, subject to extension or early termination, to provide corporate development, project management, and capital financing consultancy services in connection to the Company’s IPO in the United States. Pursuant to the Consultancy Agreement, in addition to a fixed cash remuneration to Mr. Chen, TW HK will also cause TW Cayman to grant stock options to Mr. Chen to acquire an aggregate of 1,080,000 Ordinary Shares of TW Cayman after the Company’s IPO, representing 4% of the Ordinary Shares of TW Cayman issued and outstanding prior to the Offering (the “Consultancy Stock Option”). The options granted to Mr. Chen will vest and become exercisable over a period of three years in three equal tranches, on the first, second, and third anniversary of the date of Company’s listing on Nasdaq capital market. All options shall be exercised after three anniversaries and within 60 months of Company’s listing, otherwise the unexercised options will be null and void. The applicable exercise price for the Consultancy Stock Option that to be granted to Mr. Chen is fifty percent (50%) of the Offering Price per Ordinary Shares offered by the Company.

 

Upon the expiration of the term of the Consultancy Agreement, Mr. Chen and the Company mutually agreed not to extend Consultancy Agreement.

 

107

 

 

TAXATION

 

The following summary of material Cayman Islands, Hong Kong, and United States federal income tax consequences of an investment in our Ordinary Shares is based upon laws and relevant interpretations thereof in effect as of the date of this prospectus, all of which are subject to change. This summary does not deal with all possible tax consequences relating to an investment in our Ordinary Shares, such as the tax consequences under state, local and other tax laws.

 

Cayman Islands Taxation

 

The Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or after execution brought within the jurisdiction of the Cayman Islands. The Cayman Islands is a party to a double tax treaty entered with the United Kingdom in 2010 but is otherwise not party to any double tax treaties that are applicable to any payments made to or by our company. There are no exchange control regulations or currency restrictions in the Cayman Islands.

 

Payments of dividends and capital in respect of the shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of a dividend or capital to any holder of our Ordinary Shares, nor will gains derived from the disposal of our Ordinary Shares be subject to Cayman Islands income or corporation tax.

 

The Cayman Islands enacted the International Tax Co-operation (Economic Substance) Act (2021 Revision) together with the Guidance Notes published by the Cayman Islands Tax Information Authority from time to time. The Company is required to comply with the economic substance requirements from July 1, 2019 and make an annual report in the Cayman Islands as to whether or not it is carrying on any relevant activities and if it is, it must satisfy an economic substance test.

 

Hong Kong Taxation

 

The following summary of certain relevant taxation provisions under the laws of Hong Kong is based on current law and practice and is subject to changes therein. This summary does not purport to address all possible tax consequences relating to purchasing, holding or selling our Ordinary Shares, and does not take into account the specific circumstances of any particular investors, some of whom may be subject to special rules. Accordingly, holders or prospective purchasers (particularly those subject to special tax rules, such as banks, dealers, insurance companies and tax-exempt entities) should consult their own tax advisers regarding the tax consequences of purchasing, holding or selling our Ordinary Shares. Under the current laws of Hong Kong:

 

No profit tax is imposed in Hong Kong in respect of capital gains from the sale of the Ordinary Shares.

 

Revenues gains from the sale of our Ordinary Shares by persons carrying on a trade, profession or business in Hong Kong where the gains are derived from or arise in Hong Kong from the trade, profession or business will be chargeable to Hong Kong profits tax, which is currently imposed at the rate of 16.5% on corporations and at a maximum rate of 15% on individuals and unincorporated businesses.

 

Gains arising from the sale of Ordinary Shares, where the purchases and sales of the Ordinary Shares are effected outside of Hong Kong such as, for example, on Cayman Islands, should not be subject to Hong Kong profits tax.

 

According to the current tax practice of the Hong Kong Inland Revenue Department, dividends paid on the Ordinary Shares would not be subject to any Hong Kong tax.

 

No Hong Kong stamp duty is payable on the purchase and sale of the Ordinary Shares.

 

108

 

 

United States Federal Income Tax Considerations

 

The following discussion is a summary of U.S. federal income tax considerations generally applicable to the ownership and disposition of our Ordinary Shares by a U.S. Holder (as defined below) that acquires our Ordinary Shares in this offering and holds our Ordinary Shares as “capital assets” (generally, property held for investment) under the U.S. Internal Revenue Code of 1986, as amended, or the Code. This discussion is based upon existing U.S. federal tax law, which is subject to differing interpretations or change, possibly with retroactive effect. No ruling has been sought from the Internal Revenue Service, or the IRS, with respect to any U.S. federal income tax considerations described below, and there can be no assurance that the IRS or a court will not take a contrary position. This discussion, moreover, does not address the U.S. federal estate, gift, and alternative minimum tax considerations, the Medicare tax on certain net investment income, information reporting or backup withholding or any state, local, and non-U.S. tax considerations, relating to the ownership or disposition of our Ordinary Shares. The following summary does not address all aspects of U.S. federal income taxation that may be important to particular investors in light of their individual circumstances or to persons in special tax situations such as:

 

banks and other financial institutions;

 

insurance companies;

 

pension plans;

 

cooperatives;

 

regulated investment companies;

 

real estate investment trusts;

 

broker-dealers;

 

traders that elect to use a mark-to-market method of accounting;

 

certain former U.S. citizens or long-term residents;

 

tax-exempt entities (including private foundations);

 

individual retirement accounts or other tax-deferred accounts;

 

persons liable for alternative minimum tax;

 

persons who acquire their Ordinary Shares pursuant to any employee share option or otherwise as compensation;

 

investors that will hold their Ordinary Shares as part of a straddle, hedge, conversion, constructive sale or other integrated transaction for U.S. federal income tax purposes;

 

investors that have a functional currency other than the U.S. dollar;

 

persons that actually or constructively own 10% or more of our Ordinary Shares (by vote or value); or

 

partnerships or other entities taxable as partnerships for U.S. federal income tax purposes, or persons holding the Ordinary Shares through such entities,

 

all of whom may be subject to tax rules that differ significantly from those discussed below.

 

Each U.S. Holder is urged to consult its tax advisor regarding the application of U.S. federal taxation to its particular circumstances, and the state, local, non-U.S., and other tax considerations of the ownership and disposition of our Ordinary Shares.

 

109

 

 

General

 

For purposes of this discussion, a “U.S. Holder” is a beneficial owner of our Ordinary Shares that is, for U.S. federal income tax purposes:

 

an individual who is a citizen or resident of the United States;

 

a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in, or organized under the laws of the United States or any state thereof or the District of Columbia;

 

an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or

 

a trust (i) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or (ii) that has otherwise validly elected to be treated as a U.S. person under the Code.

 

If a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of our Ordinary Shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships holding our Ordinary Shares and their partners are urged to consult their tax advisors regarding an investment in our Ordinary Shares.

 

Passive Foreign Investment Company Considerations

 

A non-U.S. corporation, such as our company, will be classified as a PFIC for U.S. federal income tax purposes for any taxable year if either (i) 75% or more of its gross income for such year consists of certain types of “passive” income or (ii) 50% or more of the value of its assets (determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income, or the asset test. Passive income generally includes, among other things, dividends, interest, rents, royalties, and gains from the disposition of passive assets. Passive assets are those which give rise to passive income, and include assets held for investment, as well as cash, assets readily convertible into cash, and working capital. The company’s goodwill and other unbooked intangibles are taken into account and may be classified as active or passive depending upon the relative amounts of income generated by the company in each category. We will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation in which we own, directly or indirectly, 25% or more (by value) of the stock.

 

Based upon our current and projected income and assets, the expected proceeds from this offering, and projections as to the market price of our Ordinary Shares immediately following this offering, we do not expect to be a PFIC for the current taxable year or the foreseeable future. However, no assurance can be given in this regard because the determination of whether we are or will become a PFIC is a factual determination made annually that will depend, in part, upon the composition and classification of our income and assets, including the relative amounts of income generated by our strategic investment business as compared to our other businesses, and the value of the assets held by our strategic investment business as compared to our other businesses. Because there are uncertainties in the application of the relevant rules, it is possible that the IRS may challenge our classification of certain income and assets as non-passive, which may result in our being or becoming classified as a PFIC in the current or subsequent years. Furthermore fluctuations in the market price of our Ordinary Shares may cause us to be a PFIC for the current or future taxable years because the value of our assets for purposes of the asset test, including the value of our goodwill and unbooked intangibles, may be determined by reference to the market price of our Ordinary Shares from time to time (which may be volatile). In estimating the value of our goodwill and other unbooked intangibles, we have taken into account our anticipated market capitalization immediately following the close of this offering. Among other matters, if our market capitalization is less than anticipated or subsequently declines, we may be or become a PFIC for the current or future taxable years. The composition of our income and assets may also be affected by how, and how quickly, we use our liquid assets and the cash raised in this offering. Under circumstances where our revenues from activities that produce passive income significantly increases relative to our revenues from activities that produce non-passive income, or where we determine not to deploy significant amounts of cash for active purposes, our risk of becoming a PFIC may substantially increase.

 

If we are a PFIC for any year during which a U.S. Holder holds our Ordinary Shares, we generally will continue to be treated as a PFIC for all succeeding years during which such U.S. Holder holds our Ordinary Shares unless, in such case, we cease to be treated as a PFIC and such U.S. Holder makes a deemed sole election.

 

The discussion below under “— Dividends” and “— Sale or Other Disposition” is written on the basis that we will not be or become classified as a PFIC for U.S. federal income tax purposes. The U.S. federal income tax rules that apply generally if we are treated as a PFIC are discussed below under “— Passive Foreign Investment Company Rules.”

 

110

 

 

Dividends

 

Any cash distributions paid on our Ordinary Shares out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, will generally be includible in the gross income of a U.S. Holder as dividend income on the day actually or constructively received by the U.S. Holder. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles, any distribution we pay will generally be treated as a “dividend” for U.S. federal income tax purposes. Dividends received on our Ordinary Shares will not be eligible for the dividends received deduction allowed to corporations in respect of dividends-received from U.S. corporations.

 

Individuals and other non-corporate U.S. Holders may be subject to tax on any such dividends at the lower capital gain tax rate applicable to “qualified dividend income,” provided that certain conditions are satisfied, including that (i) our Ordinary Shares on which the dividends are paid are readily tradable on an established securities market in the United States, (ii) we are neither a PFIC nor treated as such with respect to a U.S. Holder for the taxable year in which the dividend is paid and the preceding taxable year, and (iii) certain holding period requirements are met. We intend to list the Ordinary Shares on Nasdaq Capital Market. Provided that this listing is approved, we believe that the ordinary should generally be considered to be readily tradeable on an established securities market in the United States. There can be no assurance that the Ordinary Shares will continue to be considered readily tradable on an established securities market in later years. U.S. Holders are urged to consult their tax advisors regarding the availability of the lower rate for dividends paid with respect to the Ordinary Shares.

 

For U.S. foreign tax credit purposes, dividends paid on our Ordinary Shares will generally be treated as income from foreign sources and will generally constitute passive category income. The rules governing the foreign tax credit are complex and U.S. Holders are urged to consult their tax advisors regarding the availability of the foreign tax credit under their particular circumstances.

 

Sale or Other Disposition

 

A U.S. Holder will generally recognize gain or loss upon the sale or other disposition of Ordinary Shares in an amount equal to the difference between the amount realized upon the disposition and the holder’s adjusted tax basis in such Ordinary Shares. Such gain or loss will generally be capital gain or loss. Any such capital gain or loss will be long term if the Ordinary Shares have been held for more than one year. Non-corporate U.S. Holders (including individuals) generally will be subject to United States federal income tax on long-term capital gain at preferential rates. The deductibility of a capital loss may be subject to limitations. Any such gain or loss that the U.S. Holder recognizes will generally be treated as U.S. source income or loss for foreign tax credit limitation purposes, which could limit the availability of foreign tax credits. Each U.S. Holder is advised to consult its tax advisor regarding the tax consequences if a foreign tax is imposed on a disposition of our Ordinary Shares, including the applicability of any tax treaty and the availability of the foreign tax credit under its particular circumstances.

 

Passive Foreign Investment Company Rules

 

If we are classified as a PFIC for any taxable year during which a U.S. Holder holds our Ordinary Shares, and unless the U.S. Holder makes a mark-to-market election (as described below), the U.S. Holder will generally be subject to special tax rules on (i) any excess distribution that we make to the U.S. Holder (which generally means any distribution paid during a taxable year to a U.S. Holder that is greater than 125 percent of the average annual distributions paid in the three preceding taxable years or, if shorter, the U.S. Holder’s holding period for the Ordinary Shares), and (ii) any gain realized on the sale or other disposition, including, under certain circumstances, a pledge, Ordinary Shares. Under the PFIC rules:

 

the excess distribution or gain will be allocated ratably over the U.S. Holder’s holding period for the Ordinary Shares;

 

the amount allocated to the current taxable year and any taxable years in the U.S. Holder’s holding period prior to the first taxable year in which we are classified as a PFIC (each, a “pre-PFIC year”), will be taxable as ordinary income; and

 

the amount allocated to each prior taxable year, other than a pre-PFIC year, will be subject to tax at the highest tax rate in effect for individuals or corporations, as appropriate, for that year, increased by an additional tax equal to the interest on the resulting tax deemed deferred with respect to each such taxable year.

 

111

 

 

As an alternative to the foregoing rules, a U.S. Holder of “marketable stock” (as defined below) in a PFIC may make a mark-to-market election with respect to such stock. If a U.S. Holder makes this election with respect to our Ordinary Shares, the holder will generally(i) include as ordinary income for each taxable year that we are a PFIC the excess, if any, of the fair market value of Ordinary Shares held at the end of the taxable year over the adjusted tax basis of such Ordinary Shares and (ii) deduct as an ordinary loss the excess, if any, of the adjusted tax basis of the Ordinary Shares over the fair market value of such Ordinary Shares held at the end of the taxable year, but such deduction will only be allowed to the extent of the net amount previously included in income as a result of the mark-to-market election. The U.S. Holder’s adjusted tax basis in the Ordinary Shares would be adjusted to reflect any income or loss resulting from the mark-to-market election. If a U.S. Holder makes a mark-to- market election in respect of our Ordinary Shares and we cease to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that we are not classified as a PFIC. If a U.S. Holder makes a mark-to-market election, any gain such U.S. Holder recognizes upon the sale or other disposition of our Ordinary Shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as ordinary loss, but such loss will only be treated as ordinary loss to the extent of the net amount previously included in income as a result of the mark-to-market election.

 

The mark-to-market election is available only for “marketable stock,” which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter, or regularly traded, on a qualified exchange or other market, as defined in applicable United States Treasury regulations. Our Ordinary Shares will be treated as marketable stock upon their listing on Nasdaq Capital Market. We anticipate that our Ordinary Shares should qualify as being regularly traded, but no assurances may be given in this regard.

 

Because a mark-to-market election cannot technically be made for any lower-tier PFICs that we may own, a U.S. Holder may continue to be subject to the PFIC rules with respect to such U.S. Holder’s indirect interest in any investments held by us that are treated as an equity interest in a PFIC for U.S. federal income tax purposes.

 

We do not intend to provide information necessary for U.S. Holders to make qualified electing fund elections which, if available, would result in tax treatment different from (and generally less adverse than) the general tax treatment for PFICs described above.

 

If a U.S. Holder owns our Ordinary Shares during any taxable year that we are a PFIC, the holder must generally file an annual IRS Form 8621. You should consult your tax advisor regarding the U.S. federal income tax consequences of owning and disposing of our Ordinary Shares if we are or become a PFIC.

 

112

 

 

PLAN OF DISTRIBUTION

 

Placement Agent Fees and Expenses; Other Fees

 

Upon the closing of this offering, will pay AC Sunshine Securities, LLC (the “Placement Agent”) a commission of 4.0% of the aggregate gross proceeds raised in this offering. We have also agreed to (i) reimburse the Placement Agent for certain expenses; and (ii) provide a non-accountable expense allowance equal to 1% of the gross proceeds of this offering payable to the Placement Agent.

 

The following table shows the public offering price, Placement Agent fees, other fees, and proceeds, before expenses, to us, assuming the purchase of all the shares of Class A common stock we are offering.

  

   Per Share
of Ordinary
Share
   Total 
Public offering price  $               $              
Placement agent fees  $    $  
Other Fees  $    $  
Proceeds to our company before expenses  $    $  

 

We estimate that the total expenses of the offering, including registration, filing, and listing fees, printing fees, and legal and accounting expenses, but excluding Placement Agent fees and other fees, will be approximately $[], all of which are payable by us.

 

Indemnification

 

We have agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the Placement Agent may be required to make for these liabilities.

 

Regulation M

 

The Placement Agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale of the securities sold by it while acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, each Placement Agent would be required to comply with the requirements of the Securities Act and the Exchange Act, including, without limitation, Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities by the Placement Agent acting as principal. Under these rules and regulations, the Placement Agent (i) may not engage in any stabilization activity in connection with our securities and (ii) may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted under the Exchange Act, until it has completed its participation in the distribution.

 

Determination of Offering Price

 

The actual offering price of the securities will be negotiated between us, the Placement Agent, and the prospective investors in the offering based on the trading of our ordinary shares prior to the offering, among other things. Other factors considered in determining the public offering price of the securities we are offering, include our history and prospects, the stage of development of our business, our business plans for the future and the extent to which they have been implemented, an assessment of our management, the general conditions of the securities markets at the time of the offering and such other factors as were deemed relevant.

 

113

 

 

Electronic Distribution

 

A prospectus in electronic format may be made available on a website maintained by the Placement Agent. In connection with the offering, the Placement Agent or selected dealers may distribute prospectuses electronically. No forms of electronic prospectus other than prospectuses that are printable as Adobe® PDF will be used in connection with this offering.

 

Other than the prospectus in electronic format, the information on the Placement Agent’s website and any information contained in any other website maintained by the Placement Agent is not part of the prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the Placement Agent in its capacity as placement agent and should not be relied upon by investors.

 

Certain Relationships

 

The Placement Agent and its affiliates may in the future provide, from time to time, investment banking and financial advisory services to us in the ordinary course of business, for which they may receive customary fees and commissions.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for the Ordinary Shares is VStock Transfer, LLC. The transfer agent and registrar’s address is 18 Lafayette Place, Woodmere, NY 11598. 

 

Listing

 

Our Ordinary Shares are listed on the Nasdaq Capital Market under the trading symbol “TWG.”

 

Selling Restrictions

 

Other than in the United States of America, no action has been taken by us or the Placement Agent that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.

 

114

 

 

ENFORCEABILITY OF CIVIL LIABILITIES

 

We are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We are incorporated in the Cayman Islands because of certain benefits associated with being a Cayman Islands exempted company, such as political and economic stability, an effective judicial system, a favorable tax system, the absence of foreign exchange control or currency restrictions and the availability of professional and support services. However, the Cayman Islands has a less developed body of securities laws than the United States and provides less protection for investors. In addition, Cayman Islands companies may not have standing to sue before the federal courts of the United States.

 

Our constitutional documents do not contain provisions requiring that disputes, including those arising under the securities laws of the United States, among us, our officers, directors and shareholders, be arbitrated.

 

Substantially all of our assets are located outside the United States. In addition, all of our directors and officers are nationals or residents of jurisdictions other than the United States and all or a substantial portion of their assets are located outside the United States. As a result, it may be difficult for investors to effect service of process within the United States upon us or these persons, or to enforce judgments obtained in U.S. courts against us or them, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States. It may also be difficult for you to enforce judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against us and our officers and directors.

 

We have appointed Cogency Global Inc. as our agent upon whom process may be served in any action brought against us under the securities laws of the United States.

 

Cayman Islands

 

We have been advised by Ogier, our counsel as to Cayman Islands laws, that it is uncertain whether the courts of the Cayman Islands will (i) recognize or enforce against us judgments of courts of the United States based on certain civil liability provisions of U.S. securities laws; and (ii) entertain original actions brought in the Cayman Islands against us or our directors or officers predicted upon the securities laws of the United States or any state in the United States. In addition, there is uncertainty with regard to Cayman Islands law related to whether a judgment obtained from the U.S. courts under civil liability provisions of U.S. securities laws will be determined by the courts of the Cayman Islands as penal or punitive in nature. If such determination is made, the courts of the Cayman Islands will not recognize or enforce the judgment against a Cayman Islands company, such as our company. As the courts of the Cayman Islands have yet to rule on making such a determination in relation to judgments obtained from U.S. courts under civil liability provisions of U.S. securities laws, it is uncertain whether such judgments would be enforceable in the Cayman Islands. We have been further advised by Ogier, our counsel as to Cayman Islands laws, that although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, in certain circumstances a judgment obtained in such jurisdiction will be recognized and enforced in the courts of the Cayman Islands at common law, without any re-examination or re-litigation of matters adjudicated upon, provided such judgment:

 

  (a) is given by a foreign court of competent jurisdiction;

 

  (b) imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given;

 

  (c) is final;

 

  (d) is not in respect of taxes, a fine or a penalty;

 

  (e) was not obtained by fraud; and

 

  (f) is not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands.

 

Subject to the above limitations, in appropriate circumstances, a Cayman Islands court may give effect in the Cayman Islands to other kinds of final foreign judgments such as declaratory orders, orders for performance of contracts and injunctions.

 

115

 

 

British Virgin Islands

 

In addition, there is uncertainty as to whether the courts of the British Virgin Islands would (i) recognize or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States or (ii) entertain original actions brought in the British Virgin Islands against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.

 

There is uncertainty with regard to British Virgin Islands law as to whether a judgment obtained from the United States courts under civil liability provisions of the securities laws will be determined by the courts of the British Virgin Islands as penal or punitive in nature. If such a determination is made, the courts of the British Virgin Islands are also unlikely to recognize or enforce the judgment against a British Virgin Islands company. Because the courts of the British Virgin Islands have yet to rule on whether such judgments are penal or punitive in nature, it is uncertain whether they would be enforceable in the British Virgin Islands. Although there is no statutory enforcement in the British Virgin Islands of judgments obtained in the federal or state courts of the United States, in certain circumstances a judgment obtained in such jurisdiction may be recognized and enforced in the courts of the British Virgin Islands at common law, without any re-examination of the merits of the underlying dispute, by an action commenced on the foreign judgment debt in the High Court of the British Virgin Islands, provided such judgment:

 

  is given by a foreign court of competent jurisdiction and such foreign court had proper jurisdiction over the parties subject to such judgment;

 

  imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given;

 

  is final;

 

  no new admissible evidence relevant to the action is submitted prior to the rendering of the judgment by the courts of the British Virgin Islands;

 

  is not in respect of taxes, a fine, a penalty or similar fiscal or revenue obligations of the company;

 

  was not obtained in a fraudulent manner and is not of a kind the enforcement of which is contrary to natural justice or the public policy of the British Virgin Islands.

 

In appropriate circumstances, a BVI Court may give effect in the British Virgin Islands to other kinds of final foreign judgments such as declaratory orders, orders for performance of contracts and injunctions.

 

Original action in the British Virgin Islands based upon the U.S. federal securities laws

 

If an action is capable of amounting to a cause of action under common law and thus capable of being sustained as a cause of action in itself under English law then it may be possible for such action to be brought in the British Virgin Islands. For example, if the action to be brought in the British Virgin Islands is based on a provision within the U.S. federal securities laws which prohibits fraud, deceit or misrepresentation in the sale of securities, an investor may be able to bring an original action in the British Virgin Islands if the facts and circumstances of their case amount to an action for fraud, misrepresentation or deceit based solely on the common law without reference to or independent of the U.S. federal securities laws.

 

However, where such action can only be based on a particular provision within the U.S. federal securities laws, for example, such action that may relate to strict reporting or registration requirements to particular bodies established under or recognized by such law (such as the SEC); it is very unlikely that such action would have extra-territorial effect unless specifically stated within that law and recognized as having such effect under British Virgin Islands law. Consequently, an investor would not be able to bring such an action in the British Virgin Islands in those circumstances.

 

Hong Kong

 

The judgment of United States courts will not be directly enforced in Hong Kong. There are currently no treaties or other arrangements providing for reciprocal enforcement of foreign judgments between Hong Kong and the United States. However, the common law permits an action to be brought upon a foreign judgment. That is to say, a foreign judgment itself may form the basis of a cause of action since the judgment may be regarded as creating a debt between the parties to it. In a common law action for enforcement of a foreign judgment in Hong Kong, the enforcement is subject to various conditions, including but not limited to, that the foreign judgment is a final judgment conclusive upon the merits of the claim, the judgment is for a liquidated amount in a civil matter and not in respect of taxes, fines, penalties, or similar charges, the proceedings in which the judgment was obtained were not contrary to natural justice, and the enforcement of the judgment is not contrary to public policy of Hong Kong. Such a judgment must be for a fixed sum and must also come from a “competent” court as determined by the private international law rules applied by the Hong Kong courts. The defenses that are available to a defendant in a common law action brought on the basis of a foreign judgment include lack of jurisdiction, breach of natural justice, fraud, and contrary to public policy. However, a separate legal action for debt must be commenced in Hong Kong in order to recover such debt from the judgment debtor.

 

116

 

 

EXPENSES RELATED TO THIS OFFERING

 

Set forth below is an itemization of the total expenses, excluding placement agent’s fees, expected to be incurred in connection with the offer and sale of our securities. Except for the SEC registration fee and the Financial Industry Regulatory Authority Inc. filing fee, all amounts are estimates.

 

SEC Registration Fee  $3,946 
FINRA Filing Fee  $5,000 
Legal Fees and Expenses  $135,000 
Accounting Fees and Expenses  $10,000 
Miscellaneous Expenses  $240,000 
Total Expenses  $393,946 

 

These expenses will be borne by us. Placement agent fees and the non-accountable expense allowance will be borne by us in proportion to the numbers of Ordinary Shares sold in the offering.

 

LEGAL MATTERS

 

We are being represented by Ortoli Rosenstadt LLP with respect to certain legal matters as to U.S. federal securities law. The validity of the Ordinary Shares offered hereby and certain legal matters as to Cayman Islands law will be passed upon for us by Ogier, our counsel as to Cayman Islands law. iTKG Law LLC is acting as U.S. securities counsel to AC Sunshine Securities LLC. Certain legal matters as to Hong Kong law will be passed upon for the Company by David Fong & Co. Ortoli Rosenstadt LLP may rely upon Ogier with respect to matters governed by the law of the Cayman Islands. Certain matters as to Hong Kong law will be passed for AC Sunshine Securities LLC by CFN Lawyers. iTKG Law LLC may rely upon CFN Lawyers with respect to matters governed by Hong Kong law.

 

EXPERTS

 

The consolidated financial statements of Top Wealth Group Holding Limited at December 31, 2023 and 2022, appearing in this prospectus have been audited by OneStop Assurance PAC, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The offices of OneStop Assurance PAC are located at 10 Anson Road, #13-09 International Plaza, Singapore 079903.

 

117

 

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We have filed with the SEC an annual report and registration statement on Form F-1 (including amendments and exhibits to the registration statement) under the Securities Act with respect to the Ordinary Shares offered hereby. Our SEC filings are available to the public over the Internet at the SEC’s website at http://www.sec.gov. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits filed therewith. For further information about us and the Ordinary Shares offered hereby, reference is made to the registration statement and the exhibits filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and in each instance we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. However, statements in the prospectus contain the material provisions of such contracts, agreements and other documents.

 

We are subject to periodic reporting and other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, we will be required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in Sections 14(a), (b), and (c) of the Exchange Act, and our executive officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.

 

In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. A copy of the registration statement and the exhibits filed therewith may be inspected without charge at the public reference room maintained by the SEC, located at 100 F Street, NE, Washington, DC 20549, and copies of all or any part of the registration statement may be obtained from that office. Please call the SEC at 1-800-SEC-0330 for further information about the public reference room. The SEC also maintains a website that contains reports, information statements and other information regarding registrants that file electronically with the SEC. The address of the website is www.sec.gov.

 

We have maintained our website at https://www.imperialcristalcaviar.com/ and https://ir.imperialcristalcaviar.com. The registration statement and the documents referred to under “Incorporation of Certain Information by Reference” are also available on our website. Information contained on, or that can be accessed through, our website is not a part of, and shall not be incorporated by reference into, this prospectus.

 

No dealers, salesperson, or other person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.

 

118

 

 

Top Wealth Group Holding Limited

 

Reports and Financial Statements

For the years ended December 31, 2023 and 2022

 

Top Wealth Group Holding Limited

 

Reports and Index to Consolidated Financial Information

For the years ended December 31, 2023, 2022 and 2021

 

  Page
   
Report of independent registered public accounting firm (PCAOB ID: 6732) F-2
Consolidated balance sheets as of December 31, 202 and 2022 F-3
Consolidated statements of operation and other comprehensive income(loss) for the financial years ended December 31, 2023, 2022 and 2021 F-4
Consolidated statements of changes in shareholders’ equity for the financial years ended December 31, 2023 , 2022 and 2021 F-5
Consolidated statements of cash flows for the financial years ended December 31, 2023, 2022 and 2021 F-6
Notes to the consolidated financial statements for the financial years ended December 31, 2023, 2022 and 2021 F-7 - F-19

 

F-1

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of Top Wealth Group Holding Limited:

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Top Wealth Group Holding Limited together with its subsidiaries (“the Company”) as of December 31, 2023 and 2022, and related consolidated statements of operations and comprehensive income(loss), stockholders’ equity, and cash flows, for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial positions of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. 

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Emphasis of Matter

 

The Company has significant transactions with related parties, which are described in Note 10 to the financial statements. Transactions involving related party cannot be presumed to be carried out on an arm’s length basis, as the requisite conditions of competitive, free market dealings may not exist.

 

/s/ Onestop Assurance PAC

 

We have served as the Company’s auditor since 2022.

 

Singapore

May 29, 2024

 

F-2

 

Top Wealth Group Holding Limited

Consolidated balance sheets

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

 

   As of December 31 
   2023   2022 
         
Assets        
Current assets        
Cash and cash equivalents  $134,350   $217,384 
Accounts receivable   5,972,736    33,382 
Accounts receivable from related parties   
-
    6,866 
Inventories   153,209    2,071,708 
Prepayments   274,417    
-
 
Deposits paid   595,063    586,096 
Amount due from a related party   
-
    63,735 
           
    7,129,775    2,979,171 
           
Non-current assets          
Property, plant and equipment, net   134,538    368,197 
Right-of-use assets – operating lease   40,421    71,076 
Deferred tax assets    44,248    13,725 
           
Total non-current assets   219,207    452,998 
           
Total assets  $7,348,982   $3,432,169 
           
Current liabilities          
Accounts payable   
-
    200,608 
Accrued expenses and other payables   425,673    60,435 
Operating lease liabilities - current   40,421    53,313 
Amount due to a related party   160,089    217,779 
Borrowings   777,893    
-
 
Current income tax payable   992,270    370,419 
           
Total current liabilities   2,396,346    902,554 
           
Non-current liabilities          
Operating lease liabilities – non-current   
-
    17,763 
           
Total liabilities  $2,396,346   $920,317 
           
Commitments and contingencies   
 
    
 
 
           
Shareholders’ equity          
Common stock, $0.0001 par value; 500,000,000 shares authorized, 27,000,000 (2022: 27,000,000)* shares issued and outstanding   2,700    2,700 
Additional paid-in capital   641,015    638,326 
Retained earnings   4,308,921    1,870,826 
           
Total shareholders’ equity   4,952,636    2,511,852 
           
Total liabilities and equity  $7,348,982   $3,432,169 

 

*Giving retroactive effect to all the 27,000,000 shares issued and outstanding after the Pro Rata Share Issuance on October 12, 2023, which has been treated as share split, from the earliest period presented.

 

The accompany notes form an integral part of these consolidated financial statements.

 

F-3

 

Top Wealth Group Holding Limited

Consolidated statements of operation and other comprehensive income/(loss)

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

 

   For the year ended December 31, 
   2023   2022   2021 
             
Sales (including sales to related parties of nil for 2023, $3,142,283 for 2022 and nil for 2021)  $16,943,287   $8,512,929   $19,615 
Cost of sales   (11,556,006)   (4,309,747)   (4,313)
                
Gross profit   5,387,281    4,203,182    15,302 
                
Other income   2    
-
    
-
 
                
Selling expenses (including marketing expenses to a related party of nil for 2023, $1,418,141 for 2022 and nil for 2021)   (495,276)   (1,456,347)   (11,186)
Administrative expense   (1,846,759)   (466,477)   (21,004)
                
Profit (loss) before income tax   3,045,248    2,280,358    (16,888)
Income tax (expense) credit   (607,153)   (362,587)   5,893 
                
Profit and total comprehensive income for the year  $2,438,095   $1,917,771   $(10,995)
Earnings per share:               
                
Ordinary shares, - basic and diluted
  $0.090   $0.071   $(0.001)
                
Weighted average shares outstanding used in calculating basic and diluted earnings per share               
Ordinary shares, - basic and diluted*
   27,000,000    27,000,000    27,000,000 

 

*Giving retroactive effect to all the 27,000,000 shares issued and outstanding after the Pro Rata Share Issuance on October 12, 2023, which has been treated as share split, from the earliest period presented.

 

The accompany notes form an integral part of these consolidated financial statements.

 

F-4

 

Top Wealth Group Holding Limited

Consolidated statements of changes in equity

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

 

   Common
stock
outstanding*
   Amount   Additional
paid-in
capital
   (Accumulated
losses)
retained
earnings
   Total 
                     
Balance as of January 1, 2021   27,000,000   $2,700   $(2,699)  $(35,950)  $(35,949)
                          
Issuance of common stock of Top Wealth International   -    
-
    12    
-
    12 
                          
Loss and total comprehensive loss for the year   -    
-
    
-
    (10,995)   (10,995)
                          
Balance as of December 31, 2021   27,000,000   $2,700   $(2,687)  $(46,945)  $(46,932)
                          
Issuance of common stock of Top Wealth International   -    
-
    641,013    
-
    641,013 
                          
Profit and total comprehensive income for the year   -    
-
    
-
    1,917,771    1,917,771 
                          
Balance as of December 31, 2022   27,000,000   $2,700   $638,326   $1,870,826   $2,511,852 
                          
Pro Rata Share Issuance deemed as share split   -    
-
    2,699    
-
    2,699 
                          
Deemed capital reduction in reorganisation   -    
-
    (10)   
-
    (10)
                          
Profit and total comprehensive income for the year   -    
-
    
-
    2,438,095    2,438,095 
                          
Balance as of December 31, 2023   27,000,000   $2,700   $641,015   $4,308,921   $4,952,636 

 

*Giving retroactive effect to all the 27,000,000 shares issued and outstanding after the Pro Rata Share Issuance on October 12, 2023, which has been treated as share split, from the earliest period presented.

 

The accompany notes form an integral part of the consolidated financial statements.

 

F-5

 

Top Wealth Group Holding Limited

Consolidated statements of cash flows

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

 

   For the years ended December 31, 
   2023   2022   2021 
Cash flows from operating activities            
Net profit (loss)  $2,438,095   $1,917,771   $(10,995)
Adjustments for:-               
Depreciation of property, plant and equipment   233,659    173,215    2,484 
Deferred tax credit   (30,523)   (7,832)   (5,893)
Changes in operating assets and liabilities:               
Accounts receivable   (5,932,488)   (40,219)   (29)
Inventories   1,918,499    (1,822,381)   (249,327)
Prepayments   (274,417)   
-
    
-
 
Deposits paid   (8,967)   (586,096)   
-
 
Accounts payable   (200,608)   200,608    
-
 
Accrued expenses and other payables   365,238    23,474    34,397 
Amounts due with related parties   6,045    (108,699)   292,878 
Current income tax payable   621,851    370,419    
-
 
                
Net cash (used in) provided by operating activities   (863,616)   120,260    63,515 
                
Cash flows from investing activities               
Acquisition of property, plant and equipment   
-
    (481,173)   (62,723)
                
Net cash used in investing activities   
-
    (481,173)   (62,723)
                
Cash flows from financing activities               
Proceeds from borrowings   777,893    
-
    
-
 
Deemed capital reduction on reorganization   (10)   
-
    
-
 
Proceeds from Pro Rata Share Issuance deemed as share split   2,699    
-
    
-
 
Proceeds from issuance of shares of Top Wealth International   
-
    576,912    12 
                
Net cash provided by financing activities   780,582    576,912    12 
                
(Decease) increase in cash and cash equivalents   (83,034)   215,999    804 
                
Cash and cash equivalents at beginning of year   217,384    1,385    581 
                
Cash and cash equivalents at end of year  $134,350   $217,384   $1,385 
                
Analysis of the balance of cash and cash equivalents               
Bank balances  $134,350   $217,384   $1,385 

 

The accompany notes form an integral part of the consolidated financial statements.

 

F-6

 

Top Wealth Group Holding Limited

Notes to the consolidated financial statements

For the years ended December 31, 2023 and 2022

 

1. General information and basis of operation

 

Top Wealth Group Holding Limited is a limited liability company incorporated in incorporated in the Cayman Islands. Top Wealth Group Holding Limited together with its subsidiaries are defined as the “Company”. As of the date of this report, the Company immediate and ultimate parent company is Winwin Development Group Limited (“Winwin”). As of the date of this report, Winwin is 90% owned by Mr. Wong Kim Kwan Kings and 10% owned by Mr. Chong Kin Fai. As of the date of this report, details of the Company and its subsidiaries are as follows:

 

Name of entity  Date of incorporation  Holding company  Nature of business
Top Wealth Group Holding Limited  February 1, 2023  Winwin Development Group Limited  Investment holding
Top Wealth (BVI) Group Limited  January 18, 2023  Top Wealth Group Holding Limited  Investment holding
Top Wealth Group (International) Limited  September 22, 2009  Top Wealth (BVI) Group Limited  Trading of caviar

 

On March 21, 2023, the Company acquired 100% interest in Top Wealth (BVI) Group Limited (“Top Wealth BVI”), a company incorporated in the British Virgin Islands, at a nominal value of US$10 from the shareholders of Winwin. On March 24, 2023, the Company, through Top Wealth BVI, acquired 100% interest in the Top Wealth Group (International) Limited (“Top Wealth International”), a company incorporated and operating in Hong Kong, at a nominal consideration of US$10 from the shareholders of Winwin.

 

On April 28, 2023, 650 ordinary shares were issued at par value.

 

On October 12, 2023, in contemplation of Company’s initial public offering, the Company further issued 26,999,250 ordinary shares in aggregate to its shareholders at par value, on a pro rata basis proportional to the shareholders’ existing equity interests (collectively refers as the “Pro Rata Share Issuance”), which have been treated as share split. After the Pro Rata Share Issuance, 27,000,000 Ordinary Shares are issued and outstanding.

 

As of December 31, 2023, the Company’s shareholders were as follows:

 

Name of shareholder  Percentage
of interest
 
Winwin Development Group Limited   74.67 
Beyond Glory Worldwide Limited   4.40 
Keen Sky Global Limited   4.93 
State Wisdom Holdings Limited   4.93 
Snow Bear Capital Limited   3.33 
Mercury Universal Investment Limited   4.54 
Greet Harmony Global Limited   3.20 

 

Top Wealth International have been trading Caviar. During the periods covered in these consolidated financial statements, the control of the entities has remained consistent, with Top Wealth Group Holding Limited always exercising control. Consequently, the combination has been considered as a corporate restructuring (“Reorganization”) of entities under common control. In compliance with ASC 805-50-45-5, the entities under common control are presented on a combined basis for all periods during which they were under common control. The current capital structure is retroactively reflected in prior periods as if it had existed at that time.

 

The consolidation of Top Wealth Group Holding Limited and its subsidiaries has been accounted for at historical cost and prepared as if the aforementioned transactions had been effective from the beginning of the first period presented in the accompanying consolidated financial statements.

 

F-7

 

2. Significant accounting policies

 

Basis of Presentation and Consolidation —The consolidated financial statements are prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the regulations of the Securities and Exchange Commission (“SEC”), and include the accounts of the Company and its consolidated and wholly owned subsidiaries. The consolidated financial statements reflect the elimination of all significant inter-company accounts and transactions.

 

Use of Estimates—The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the recorded amounts of assets, liabilities, shareholders’ equity, revenues and expenses during the reporting period, and the disclosure of contingent liabilities at the date of the consolidated financial statements.

 

On an ongoing basis, management reviews its estimates and if deemed appropriate, those estimates are adjusted. The most significant estimates include allowance for uncollectible accounts receivable, inventory valuation, useful lives and impairment for property and equipment, valuation allowance for deferred tax assets, accruals for potential liabilities and contingencies. Actual results could vary from the estimates and assumptions that were used.

 

Cash and Cash Equivalents— Cash and cash equivalents consist of the Company’s demand deposit placed with financial institutions, which have original maturities of less than three months and unrestricted as to withdrawal and use. The Hong Kong government provides a guarantee for deposits held in each bank up to HK$500,000 (approximately $64,000). As a result, an amount of $70,350 is not covered by this guarantee.

 

Property and Equipment— Property and equipment included equipment and leasehold improvement and are stated at cost less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of depreciable assets at the following rate:

 

Equipment  5 to 10 years
Leasehold improvement  Over the lease term

 

Cost and accumulated depreciation for property retired or disposed of are removed from the accounts, and any resulting gain or loss is included in earnings. Expenditures for maintenance and repairs are charged to expense as incurred.

 

Impairment of Long-Lived Assets— We evaluate our long-lived assets, including property, plant and equipment and right-of-use assets – operating lease  with finite lives, for impairment whenever events or changes in circumstances, such as a significant adverse change to market conditions that will impact the future use of the assets, indicate that the carrying amount of an asset may not be fully recoverable. When these events occur, we evaluate the recoverability of long-lived assets by comparing the carrying amount of the assets to the future undiscounted cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flows is less than the carrying amount of the assets, we recognize an impairment loss based on the excess of the carrying amount of the assets over their fair value. There were no impairment recognised for the years ended December 2023 and 2022.

 

Accounts Receivable and Allowance for Doubtful Accounts— Accounts receivable are carried at the original invoiced amount. Accounts receivable are reviewed for impairment on a quarterly basis and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company’s analysis of amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions. The allowance for expected credit losses is recognized in net income (loss) and any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of accounts receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs. As of December 31, 2023 and 2022, the total allowance for expected credit losses on the Company’s accounts receivable were Nil and Nil.

 

Income Taxes— Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss, capital loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

F-8

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits as a component of general and administrative expenses.

 

Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

Revenue Recognition—The Company recognizes revenue in accordance with Accounting Standards Update 2014-09, “Revenue from contracts with customers,” (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company’s revenue is from sales of products. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied. Generally, the Company’s performance obligations are transfer of products title to customers at a point in time, typically upon delivery.

 

The Company has two streams of revenue:

 

1. the sale of caviar products in Hong Kong.

 

2. the sale of wine in Hong Kong

 

An analysis of their revenue is set out below:

 

   Years ended December 31, 
   2023   2022   2021 
             
Sale of caviar products  $12,483,195   $8,512,929   $19,615 
Sale of wine   4,460,092    
-
    
-
 
                
Total  $16,943,287   $8,512,929   $19,615 

 

Inventories - The cost of inventories is computed according to the weighted average method. Cost includes the costs of purchases and materials. Inventories are evaluated based on individual inventory items. Reserves are established to reduce the value of inventories to the lower of cost or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Excess inventories are quantities of items that exceed anticipated sales or usage for a reasonable period. The Company calculates provisions based on the expiry date. Management provides full provision of for those inventories that would expire within 6 months. There can be no assurance that the amount ultimately realized for inventories will not be materially different than that assumed in the calculation of the provisions. There were no provision recognised for the years ended December 2023 and 2022.

 

Leases— Under ASC Top 842, “Leases”, the Company determines if an agreement is a lease at inception. Operating leases are included in operating lease – right to use, current portion of operating lease liability, and operating lease liability, less current portion in the Company’s consolidated balance sheets.

 

As permitted under ASU Topic 842, the Company has made an accounting policy election not to apply the recognition provisions of ASU 2016-02 to short term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term.

 

F-9

 

Foreign Currency Translation - The Company’s principal country of operations is Hong Kong. The financial position and results of its operation are determined using Hong Kong Dollars (“HK$”), the local currency, as the functional currency. The Company’s consolidated financial statements are reported using U.S. Dollar (“US$” or “$”).

 

The consolidated statements of income and the consolidated statements of cash flows denominated in foreign currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in currencies other than the reporting currency are translated into the reporting currency at the rates of exchange prevailing at the balance sheet date. The equity denominated in the functional currency is translated at the historical rate of exchange at the time of capital contribution. As the cash flows are translated based on the average translation rate, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

The following table outlines the currency exchange rates that were used in preparing the accompanying consolidated financial statements:

 

   December 31, 
   2023   2022   2021 
             
USD to HK$ Year End   7.8    7.8    7.8 
USD to HK$ Average Rate   7.8    7.8    7.8 

 

Pension Obligations - The Company provides for defined contribution plan in accordance with the Mandatory Provident Fund Schemes Ordinance in Hong Kong. A defined contribution plan generally specifies the periodic amount that the employer must contribute to the plan and how that amount will be allocated to the eligible employees who perform services during the same period.

 

Segment Reporting and Reporting Units - As of December 31, 2023, the Company operated in Hong Kong through its subsidiaries, which primarily engaged in trading of caviars.

 

Management determined that the Company functions as a single operating segment, and thus reports as a single reportable segment. This determination is based on rules prescribed by GAAP applied to the manner in which management operates the Company. The chief operating decision maker is responsible for allocating resources to its operations and assessing performance and obtains financial information, being the consolidated balance sheets, consolidated statements of operations, and consolidated statements of cash flows, about the Company as a whole.

 

Fair Value Measurements - Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Inputs used to measure fair value are classified using the following hierarchy:

 

  Level 1. Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

  Level 2. Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly through corroboration with observable market data.

 

  Level 3. Inputs are unobservable for the asset or liability and include situations in which there is little, if any, market activity for the asset or liability. The inputs used in the determination of fair value are based on the best information available under the circumstances and may require significant management judgment or estimation.

 

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses reflected as current assets and current liabilities. Due to the short-term nature of these instruments, management considers their carrying value to approximate their fair value.

 

F-10

 

Related parties – We adopted ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of their immediate families and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

 

New accounting standards

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 (Topic 326), Financial Instruments — Credit Losses: Measurement of Credit Losses on Financial Instruments, which replaces the existing incurred loss impairment model with an expected credit loss model and requires an asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance became effective for the Company beginning January 1, 2023. The adoption did not have a material impact on the Company’s consolidated financial statements.

 

 

On December 14, 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” to enhance the transparency and decision usefulness of income tax disclosures. The amendments require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). In addition, public business entities are required to provide certain qualitative disclosures about the rate reconciliation and the amount of income taxes paid (net of refunds received) disaggregated (1) by federal (national), state, and foreign taxes and (2) by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). For public business entities, the standard is effective for annual periods beginning after December 15, 2024. The amendments in this ASU require a cumulative effect adjustment to the opening balance of retained earnings (or other appropriate components of equity or net assets) as of the beginning of the annual reporting period in which an entity adopts the amendments. The Company is evaluating the impact of this standard on the Company’s consolidated financial statements.

 

We have evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the Financial Accounting Standards Board or other standards-setting bodies through the date of this report and do not believe the future adoption of any such standards will have a material impact on our consolidated financial statements.

 

3. Accounts receivable

 

   At December 31, 
   2023   2022 
         
Accounts receivable from third parties  $5,972,736   $33,382 
Accounts receivable from related parties   
-
    6,866 
           
Total accounts receivable   5,972,736    40,248 
Allowance   
-
    
-
 
           
   $5,972,736   $40,248 

 

Accounts receivable increase significantly as there was $5,390,276 revenue in December 2023. As of the date of this report, US$5,432,603 has been collected.

 

F-11

 

4. Inventories

 

   At December 31, 
   2023   2022 
         
Finished products  $153,209   $2,071,708 
Allowance   
-
    
-
 
           
   $153,209   $2,071,708 

 

5. Deposits paid

 

The deposits mainly related to refundable security deposit to supplier of sturgeon farm and lease agreement of officers and processing factory in Hong Kong. Deposits are to be recovered when the Company terminated the supplier agreement and upon the expiry of the leases respectively.

 

6. Property, plant and equipment

 

   At December 31, 
   2023   2022 
         
Equipment  $104,294   $104,294 
Leasehold improvement   439,602    439,602 
           
Property, plant and equipment   543,896    543,896 
Accumulated depreciation   (409,358)   (175,699)
           
   $134,538   $368,197 

 

Depreciation included in:

 

   Years ended December 31, 
   2023   2022 
           
Administrative expense  $233,659   $173,215 

 

7. Accrued expenses and other payables

 

Accrued expenses and other payables mainly represents accrued salaries and other payables for professional fees.

 

8. Borrowings

 

During the year ended December 31, 2023, the Company has established two unsecured, interest-free standby bridging loan facilities. One, obtained from a minority shareholder, has a facility limit of US$1,000,000, of which US$429,065 has been drawn down to date and the other, from an independent third party, is set at US$500,000, of which US$348,828 has been drawn down. Both facilities are due for repayment within one year from the date of the initial drawdown.

 

F-12

 

6. Leases

 

The Company has operating leases for office and warehouse storage. The Company’s leases have remaining lease terms of 1 to 2 years.

 

As of December 31, 2022, the Company has no additional material operating leases that have not yet commenced.

 

The following tables provide information about the Company’s operating leases.

 

   As of December 31, 
Right-of-use asset – operating lease  2023   2022 
         
Cost  $147,539   $131,138 
Accumulated amortisation   (107,118)   (60,062)
           
Total lease cost  $40,421   $71,076 

 

Other information  Years ended December 31, 
   2023   2022 
         
New right-of-uses asset – operating lease and lease liabilities recognized  $45,992   $102,280 
Cash paid for amounts included in the measurement of operating lease liabilities   79,769    57,128 
Weighted-average remaining lease term - operating leases   0.5 years    1.5 years 
Weighted-average discount rate - operating leases   5.625%   5%

 

Maturities of operating lease liabilities (undiscounted cash flows) are as follows:

 

   Maturities 
     
2024  $41,141 
      
Total operating lease payments   41,141 
Less imputed interest   (720)
      
Total operating lease liabilities  $40,421 

 

7. Income tax

 

The Company and its subsidiaries are subject to income taxes on an entity basis on income derived from the location in which each entity is domiciled.

 

The Company and its subsidiary, Top Wealth BVI, are domiciled in the Cayman Islands and the British Virgin Islands respectively. Both companies currently enjoy permanent income tax holidays; accordingly, both companies do not accrue for income taxes.

 

F-13

 

The Company’s operating subsidiary, Top Wealth International incorporated in Hong Kong is subject to an income tax rate of 8.25% for first HK$2,000,000 assessable profits and 16.5% for the assessable profits thereafter.

 

   Years ended December 31, 
Provision for income tax  2023   2022   2021 
             
Current            
Hong Kong  $669,016   $370,419   $
-
 
Over provision in previous years   (31,340)   
-
    
-
 
                
    637,676    370,419    
-
 
                
Deferred               
Hong Kong   (34,998)   (7,832)   (5,893)
Under provision in previous years   4,475    
-
    
-
 
                
    (30,523)   (7,832)   (5,893)
                
Total  $607,153   $362,587   $(5,893)

 

Numerical reconciliation of income tax expenses to prima facie tax payable:

 

   Years ended December 31, 
   2023   2022   2021 
             
Profit (loss) before income tax  $3,045,248   $2,280,358   $(16,888)
                
Tax effect at the Hong Kong profits tax rate of 16.5%   502,466    376,259    (2,787)
Tax effect of preferential tax rate   (21,154)   (21,154)   
-
 
Tax effect of tax loss not previously recognized   
-
    
-
    (3,106)
Non-deductible expenditure   153,475    8,251    
-
 
Over provision in previous years   (26,865)   
-
    
-
 
Tax effect of tax reduction   (769)   (769)   
-
 
                
Total  $607,153   $362,587    (5,893)

 

Effective income tax rate (%)

 

   Years ended December 31, 
   2023   2022   2021 
             
Effective income tax rate – Hong Kong   19.94%   15.9%   14.9%

 

There were no material unrecognised temporary differences.

 

F-14

 

The components of deferred tax assets and liabilities and their movements were as follows:

 

   Tax losses   Depreciation
allowance
   Total 
             
Balance as of January 1, 2022  $(12,521)  $6,628   $(5,893)
                
Charged (credited) to statement of operations   12,521    (20,353)   (7,832)
                
Balance as of December 31, 2022  $
-
   $(13,725)  $(13,725)
                
Credited to statement of operations   
-
    (30,523)   (30,523)
                
Balance as of December 31, 2023  $
-
   $(44,248)  $(44,248)

 

8. Commitments and contingencies

 

In the ordinary course of business, the Company may be subject to legal proceedings regarding contractual and employment relationships and a variety of other matters. The Company records contingent liabilities resulting from such claims, when a loss is assessed to be probable, and the amount of the loss is reasonably estimable.

 

The Company entered into a 10-month consultant agreement with a third party on August 1, 2022 to assist the Company in planning, coordination and implementation of corporate development as well as capital financing strategies. There are two components of this service agreement, first component is fixed fee amounted HKD 1,000,000 (US$128,205), payable with 5 working days upon successful listing. This amount has been accrued during six months period ended June 30, 2023, and the second component is stock option. The option is contingent upon the occurrence of a future event, i.e., successful initial public offering. The Company will grant   the consultant stock option equivalent to 4% of total number of shares of the Company before public offering with the exercise price at 50% discount of the public offering price.

 

As the compensation cost is contingent upon the occurrence of a performance condition (i.e., the successful initial public offering), the compensation cost shall not be recognized until the performance condition becomes probable in accordance with ASC 718-10-30-28.

 

Upon the initial public offering completed on April 18, 2024, the Company paid up the fixed fee of US$128,205 and the stock option was vested to the consultant. The fair value of this stock option recognised on April 18, 2024 is US$470,148.

 

In the opinion of management, there were no pending or threatened claims and litigation as of December 31, 2023 and through the issuance date of these consolidated financial statements.

 

9. Supplemental Cash Flow Information

 

Payments for interest and income taxes were as follows:

 

   Years ended December 31, 
   2023   2022   2021 
             
Interest  $
-
   $
     -
   $
    -
 
Income taxes  $15,825   $
-
   $
-
 

 

F-15

 

10. Related party transactions

 

During 2023, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Chong Kin Fai  $63,735   A former director and principal owner of the Company  Repayment of unsecured interest free loan payable, repayable on demand
Wong Kim Kwan Kings  $57,690   Director and controlling shareholder of the Company  Repayment of unsecured interest free loan payable, repayable on demand
Snow Bear Capital Limited  $429,065   Shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable within one year from drawdown.

 

During 2022, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Beauty & Health International Company Limited (Customer B) (note a)  $1,281,077   A company under common control  Revenue - sale of caviar
Beauty & Health International E-Commerce Limited (Customer C) (note b)   1,063,334   A company under common control  Revenue - sale of caviar
Mother Nature Health (HK) Limited (Customer E) (note b)   797,872   The Company’s former director  was also this related company’s former director  Revenue - sale of caviar
Sky Channel Management Limited (note d)   1,418,141   The Company’s principal owner was a former director of this related company  Marketing expense
Chong Kin Fai   (898)  A former director and principal owner of the Company  Proceeds from unsecured interest free loan payable, repayable on demand
Chong Kin Fai   64,101   A former director and principal owner of the Company  Amount receivable for issuance of common stock in Top Wealth International as of December 31, 2022. The amount was paid on May 13, 2023.
Wong Kim Kwan Kings   (467,315)  Director and controlling shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable on demand
Wong Kim Kwan Kings   576,912   Director and controlling shareholder of the Company  Conversion of unsecured interest free loan payable, repayable on demand into common stock in Top Wealth International

 

During 2021, the Company had following related party transactions:

 

Name  Amount   Relationship  Note
Chong Kin Fai   532   A former director and principal owner of the Company  Cash advanced for unsecured interest free loan receivable, repayable on demand
Wong Kim Kwan Kings   (293,410)  Director and controlling shareholder of the Company  Proceeds from unsecured interest free loan payable, repayable on demand

 

F-16

 

As of December 31, 2023, the Company had the following balances due with related parties:

 

Name   Amount     Relationship   Note
Wong Kim Kwan Kings   $ 160,089     Director and controlling shareholder of the Company   Unsecured interest free loan payable, repayable on demand
Snow Bear Capital Limited   $ 429,065     Shareholder of the Company   Unsecured interest free loan payable, repayable within one year from draw down

 

As of December 31, 2022, the Company had the following balances due with related parties:

 

Name  Amount   Relationship  Note
Mother Nature Health (HK) Limited (Customer E) (note c)  $5,436   The Company’s former director was also this related company’s former director  Account receivable
            
Chong Kin Fai  $63,735   A former director and principal owner of the Company  Unsecured interest free loan receivable, repayable on demand
            
Wong Kim Kwan Kings  $(217,779)  Director and controlling shareholder of the Company  Unsecured interest free loan payable, repayable on demand

 

Note:

 

(a) The transaction with this related party was ceased after August 31, 2022.

 

(b) The transaction with this related party started on September 3, 2022. The controlling shareholder disposed all of his interest in this related party on 28 August 2022. These transactions were not considered as related party transactions in the year ended December 31, 2023

 

(c) The transaction with this related party started on January 27, 2022. The former director of the Company resigned on February 10, 2022. These transactions were not considered as related party transactions in the year ended December 31, 2023.

 

(d) The transaction with this related party was ceased after December 31, 2022.

 

11. Concentration and risks

 

The Company is not exposed to significant financial risks other than the concentration risk, which is analysed as follows:

 

Customers

 

Customers who accounted for 10% or more of the Company’s revenues or with significant outstanding receivables are analysed as follows:

 

   Revenue for years ended
December 31,
   Balance as of
December 31,
 
   2023   2022   2021   2023   2022 
                     
Customer A   25%   37%   
-
%   8%   46%
Customer B   
-
    15    
-
    
-
    
-
 
Customer C   
-
    12    
-
    
-
    4 
Customer D   
-
    18    
-
    
-
    22 
Customer E   35    9    
-
    40    13 
Customer F   
-
    4    
-
    
-
    15 
Customer G   16    
-
    
-
    9    
-
 
Customer H   8    
-
    
-
    14    
-
 
Customer I   5    
-
    
-
    13    
-
 
Customer J   8    
-
    
-
    16    
-
 
                          
    97%   95%   
-
%   100%   100%

 

F-17

 

Major suppliers

 

Suppliers who accounted for 10% or more of the Company’s purchase or with significant outstanding payable are analysed as follows:

 

   Purchase for years ended
December 31,
   Balance as of
December 31,
 
   2023   2022   2021   2023   2022 
                     
Supplier A   64%   90%   100%   100%   100%
Supplier B   36    10    
-
    
-
    
-
 
                          
    100%   100%   100%   100%   100%

 

The Company has an exclusive supply agreement with a sturgeon farm and all purchases of caviar were made from the this supplier.

 

The Company recognizes that its dependence on a single supplier for caviar represents a significant business risk. The Company closely monitors its relationship with the exclusive supplier to ensure that the quality of products received remains high and that the risk of supply disruptions is minimized.

 

The Company has significant trading in wine, which is currently sourced from a single supplier. However, wine could be sourced from many channels. Also, the trading of wine is not our major business. The management believe the risk to the Company is not significant.

 

12. Equity

 

Ordinary Shares

 

The Company is authorized to issue one class of ordinary share. The Company was established under the laws of Cayman Islands (the Cayman law) on February 1, 2023 with authorized share of 500,000,000 ordinary shares of par value US$0.0001 each.

 

Upon incorporation, 1 ordinary share of US$0.0001 was issued a par.

 

On March 1, 2023, 99 ordinary shares of US$0.0001 each were issued at par. All these ordinary shares rank pari-passu with the exiting share in all respect.

 

On April 28, 2023, 650 ordinary shares of US$0.0001 each were issued at par. All these ordinary shares rank pari-passu with the exiting shares in all respect.

 

On October 12, 2023, in contemplation of Company’s initial public offering, the Company further issued 26,999,250 ordinary shares in aggregate to its shareholders at par value, on a pro rata basis proportional to the shareholders’ existing equity interests (collectively refers as the “Pro Rata Share Issuance”). After the Pro Rata Share Issuance, 27,000,000 Ordinary Shares are issued and outstanding. All these ordinary shares rank pari-passu with the exiting shares in all respect. This Pro Rata Share Issuance has treated as share split.

 

As of the December 31, 2023, 27,000,000 ordinary shares were issued and outstanding.

 

F-18

 

The Company is authorized to issue one class of ordinary share.

 

The holders of the Company’s ordinary share are entitled to the following rights:

 

Voting Rights: Each share of the Company’s ordinary share entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders. Holders of the Company’s ordinary shares are not entitled to cumulative voting rights with respect to the election of directors.

 

Dividend Right: Subject to limitations under the Cayman law and preferences that may apply to any shares of preferred stock that the Company may decide to issue in the future, holders of the Company’s ordinary share are entitled to receive rateably such dividends or other distributions, if any, as may be declared by the Board of the Company out of funds legally available therefor.

 

Liquidation Right: In the event of the liquidation, dissolution or winding up of our business, the holders of the Company’s ordinary share are entitled to share rateably in the assets available for distribution after the payment of all of the debts and other liabilities of the Company, subject to the prior rights of the holders of the Company’s preferred stock.

 

Other Matters: The holders of the Company’s ordinary share have no subscription, redemption or conversion privileges. The Company’s ordinary share does not entitle its holders to pre-emptive rights. All of the outstanding shares of the Company’s ordinary share are fully paid and non-assessable. The rights, preferences and privileges of the holders of the Company’s ordinary share are subject to the rights of the holders of shares of any series of preferred stock which the Company may issue in the future.

 

13. Subsequent event

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that these consolidated financial statements were available to be issued, there was no other subsequent event that required recognition or disclosure.

 

F-19

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 6. Indemnification of Directors and Officers

 

Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.

 

Our memorandum and articles of association provide that we shall indemnify our officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such person’s dishonesty, willful default or fraud, in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Item 7. Recent Sales of Unregistered Securities

 

Founding Transactions and Shares Issuances

 

On February 1, 2023, the date of the incorporation of Top Wealth Group Holding Limited, 1 Ordinary Share was issued to Ogier Global Subscriber (Cayman) Limited. On March 1, 2023, the 1 Ordinary Share was transferred from Ogier Global Subscriber (Cayman) Limited to Winwin Development Group Limited and the Top Wealth Group Holding Limited further issued 99 Ordinary Shares to Winwin Development Group Limited on the same date.

 

On April 18, 2023, 650 Ordinary Shares were further issued to Winwin Development Group Limited, whereby Top Wealth Group Holding Limited then became solely owned by Winwin Development Group Limited as to 750 Ordinary Shares. Furthermore, on the same date, April 18, 2023, Winwin Development Group Limited executed the instrument of transfers whereby Winwin Development Group Limited transferred 48, 49, 49, 25, and 19 Ordinary Shares, out of its 750 Ordinary Shares, to Beyond Glory Worldwide Limited, Keen Sky Global Limited, State Wisdom Holdings Limited, Snow Bear Capital Limited and Mercury Universal Investment Limited, respectively, at the respective consideration of HK$1,424,000 (approximately US$182,564), HK$1,453,000 (approximately US$186,282), HK$1,453,000 (approximately US$186,282), HK$742,000 (approximately US$95,128), and HK$565,000 (approximately US$72,436).

 

On October 12, 2023, in contemplation of Company’s initial public offering, Top Wealth Group Holding Limited further issued 26,999,250 Ordinary Shares in aggregate to its shareholders at par value, on a pro rata basis proportional to the shareholders’ existing equity interests (collectively refers as the “Pro Rata Share Issuance”). After the Pro Rata Share Issuance, 27,000,000 Ordinary Shares were issued and outstanding. The following table sets forth the breakdown of the Pro Rata Share Issuance to each then shareholder:

 

Shareholders  Number of
Ordinary
Shares
Issued
 
Winwin Development Group Limited   20,159,440 
Beyond Glory Worldwide Limited   1,727,952 
Keen Sky Global Limited   1,763,951 
State Wisdom Holdings Limited   1,763,951 
Snow Bear Capital Limited   899,975 
Mercury Universal Investment Limited   683,981 

 

II-1

 

Subsequent to the Pro Rata Share Issuance, Top Wealth Group Holding Limited was 74.67% (representing 20,160,000 Ordinary Shares) owned by Winwin Development Group Limited, 6.40% (representing 1,728,000 Ordinary Shares) owned by Beyond Glory Worldwide Limited, 6.53% (representing 1,764,000 Ordinary Shares) owned by Keen Sky Global Limited, 6.53% (representing 1,764,000 Ordinary Shares) owned by State Wisdom Holdings Limited, 3.33% (representing 900,000 Ordinary Shares) owned by Snow Bear Capital Limited, and 2.53% (representing 684,000 Ordinary Shares) owned by Mercury Universal Investment Limited, respectively. The percentage of the ownership of equity interests held by the shareholders remained the same before and after the Pro Rata Share Issuance.

 

On October 16, 2023, State Wisdom Holdings Limited and Keen Sky Global Limited transferred 432,000 and 432,000 Ordinary Shares to Greet Harmony Global Limited at the consideration of HK$314,685 (approximately US$40,344) and HK$314,685 (approximately US$40,344), respectively. On the same day, Beyond Global Worldwide Limited transferred 540,000 Ordinary Shares to Mercury Universal Investment Limited at the consideration of HK$393,356 (approximately US$50,430).

 

Consultancy Stock Option

 

Top Wealth Group (International) Limited, the Operating Subsidiary, entered into a Corporate Development Consultant Appointment Agreement with Mr. Haitong, CHEN (the “Consultancy Agreement”), in which Top Wealth Group (International) Limited appointed Mr. Chen for a term of 10 months, effective from August 1, 2022 to June 30, 2023, to provide corporate development, project management, and capital financing consultancy services in connection to the Company’s IPO in the United States. Pursuant to the Consultancy Agreement, Top Wealth Group (International) Limited will also cause Top Wealth Group Holding Limited to grant stock options to Mr. Chen to acquire an aggregate of 1,080,000 Ordinary Shares of Top Wealth Group Holding Limited after the Company’s IPO, representing 4% of the Ordinary Shares of Top Wealth Group Holding Limited issued and outstanding prior to the IPO (the “Consultancy Stock Option”). The options granted to Mr. Chen will vest and become exercisable over a period of three years in three equal tranches, on the first, second, and third anniversary of the date of Company’s listing on the Nasdaq Capital Market. All options shall be exercised after three anniversaries and within 60 months of Company’s listing, otherwise the unexercised options will be null and void. The applicable exercise price for the Consultancy Stock Option that to be granted to Mr. Chen is fifty percent (50%) of the IPO Price per Ordinary Shares offered by the Company.

 

We believe that each of the issuance and transaction above was exempt from registration under the Securities Act in reliance on Regulation D under the Securities Act or pursuant to Section 4(2) of the Securities Act regarding transactions not involving a public offering or in reliance on Regulation S under the Securities Act regarding sales by an issuer in offshore transactions. No underwriters were involved in these issuances of securities.

 

Item 8. Exhibits and Financial Statement Schedules

 

(a) Exhibits.

 

Exhibit No.   Description
1.1†   Form of Placement Agency Agreement
3.1   Articles of Association (incorporated herein by reference to Exhibit 3.1 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
4.1†   Form of Securities Purchase Agreement
5.1†   Opinion of Ogier regarding the validity of the securities being registered
10.1   English Translation of Sales Agreement between the Top Wealth Group (International) Limited and Sunfun (China) Ltd., dated December 30, 2021 (incorporated herein by reference to Exhibit 10.1 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.2   English Translation of Sales Agreement between the Top Wealth Group (International) Limited and Mother Nature Health (HK) Limited, dated December 30, 2021 (incorporated herein by reference to Exhibit 10.2 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.3   English Translation of Sales Agreement between Top Wealth Group (International) Limited and Channel Power Limited, dated December 19, 2021 (incorporated herein by reference to Exhibit 10.3 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)

 

II-2

 

Exhibit No.   Description
10.4   English Translation of Sales Agreement between Top Wealth Group (International) Limited and Beauty & Health International Company Limited, dated December 30, 2021 (incorporated herein by reference to Exhibit 10.4 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.5   English Translation of Sales Agreement between Top Wealth Group (International) Limited and Beauty & Health International E-Commerce Limited, dated September 1, 2022 (incorporated herein by reference to Exhibit 10.5 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.6   English Translation of Sales Agreement between Top Wealth Group (International) Limited and Healthkitpro International Limited, dated December 18, 2021 (incorporated herein by reference to Exhibit 10.6 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.7   Employment Agreement between Top Wealth Group (International) Limited and Kwok Kuen Yuen, Registrant’s Chief Financial Officer, dated 20 November 2022 (incorporated herein by reference to Exhibit 10.7 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.8   Employment Agreement between the Registrant and Kwok Kuen, YUEN, Registrant’s Chief Financial Officer, dated May 16, 2023 (incorporated herein by reference to Exhibit 10.8 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.9   English Translation of Appointment Letter of Kim Kwan Kings, WONG as the President of Top Wealth Group (International) Limited, dated September 1, 2022 (incorporated herein by reference to Exhibit 10.9 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.10   Director Agreement between the Registrant and Kim Kwan Kings, WONG, Registrant’s director, Chief Executive Officer and chairman of the Board, dated May 16, 2023 (incorporated herein by reference to Exhibit 10.10 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.11   English Translation of Corporate Development Consultant Appointment Agreement between the Company and Mr. Haitong, CHEN, dated August 1, 2022 (incorporated herein by reference to Exhibit 10.11 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.12   English Translation of Caviar Sales Agreement between the Top Wealth Group (International) Limited and Fujian Aoxuanlaisi Biotechnology Co. Ltd., dated April 30, 2022 (incorporated herein by reference to Exhibit 10.12 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.13   English Translation of Power of Attorney granted under the Caviar Sales Agreement by Fujian Aoxuanlaisi Biotechnology Co. Ltd. to Top Wealth Group (International) Limited, dated April 30, 2022 (incorporated herein by reference to Exhibit 10.13 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.14   English Translation of Food Processing Factory Leasing and Service Project Agreement between Top Wealth Group (International) Limited and Sunfun (China) Limited, dated February 11, 2023 (incorporated herein by reference to Exhibit 10.14 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.15   English Translation of Food Processing Factory Leasing and Service Project Agreement between the Top Wealth Group (International) Limited and Sunfun (China) Limited, dated July 31, 2021 (incorporated herein by reference to Exhibit 10.15 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.16   English Translation of the Form of Sales Agreement of Top Wealth Group (International) Limited for its distributors (incorporated herein by reference to Exhibit 10.16 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)

 

II-3

 

Exhibit No.   Description
10.17   English Translation of sales agreement for caviar between Fujian Longhuang Biotech Co. Limited and Fujian Aoxuanlaisi Biotechnology Co. Ltd., dated December 10, 2020 (incorporated herein by reference to Exhibit 10.17 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.18   English Translation of Power of Attorney granted under the sales agreement for caviar by Fujian Longhuang Biotech Co. Limited to Fujian Aoxuanlaisi Biotechnology Co. Ltd., dated December 10, 2020 (incorporated herein by reference to Exhibit 10.18 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.19   Director Agreement between the Registrant and Hung, CHEUNG, Registrant’s director, dated October 27, 2023 (incorporated herein by reference to Exhibit 10.19 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.20   English Translation of the Letter of Employment between Top Wealth Group (International) Limited and Hung, CHEUNG, dated June 25, 2022. (incorporated herein by reference to Exhibit 10.20 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
10.21†   English Translation of Food Processing Factory Leasing and Service Project Agreement between Top Wealth Group (International) Limited and Sunfun (China) Limited, dated September 10, 2024
14.1   Code of Business Conduct and Ethics of the Registrant (incorporated herein by reference to Exhibit 14.1 to the registration statement on Form F-1 (File No. 333-273053), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
14.2   Executive Compensation Recovery Policy (incorporated herein by reference to Exhibit 14.2 to the registration statement on Form F-1 (File No. 333-273053), as amended, initially filed with the U.S. Securities and Exchange Commission on December 18, 2023)
21.1   List of Subsidiaries (incorporated herein by reference to Exhibit 21.1 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
23.1†   Consent of Ogier (included in Exhibit 5.1)
23.2†   Consent of OneStop Assurance PAC
23.3†   Consent of David Fong & Co.
24.1*   Powers of Attorney (included on signature page)
99.1   Audit Committee Charter (incorporated herein by reference to Exhibit 99.1 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
99.2   Compensation Committee Charter (incorporated herein by reference to Exhibit 99.3 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
99.3   Nominating Committee Charter (incorporated herein by reference to Exhibit 99.2 to the registration statement on Form F-1 (File No. 333-275684), as amended, initially filed with the U.S. Securities and Exchange Commission on November 21, 2023)
107†   Filing Fee Table

 

 

* Filed herein
** To be filed via amendment
Previously filed

 

(b) Financial Statement Schedules

 

Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Consolidated Financial Statements or the Notes thereto.

 

II-4

 

Item 9. Undertakings.

 

The undersigned registrant hereby undertakes to provide to the placement agent at the closing specified in the placement agency agreement, certificates in such denominations and registered in such names as required by the placement agent to permit prompt delivery to each purchaser.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

The undersigned registrant hereby undertakes that:

 

(1)For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 

(2)For purposes of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

II-5

 

Signatures

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hong Kong, on September 27, 2024.

 

  Top Wealth Group Holding Limited
   
  By:  /s/ Kim Kwan Kings, WONG
  Name: Kim Kwan Kings, WONG
    Chief Executive Officer and Director
(Principal Executive Officer)

 

Power of Attorney

 

Each person whose signature appears below constitutes and appoints each of Kim Kwan Kings, WONG as attorneys-in-fact with full power of substitution, for him in any and all capacities, to do any and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable to enable the registrant to comply with the Securities Act, and any rules, regulations, and requirements of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities Act of the ordinary shares of the registrant, including, without limitation, the power and authority to sign the name of each of the undersigned in the capacities indicated below to the Registration Statement on Form F-1 (the “Registration Statement”) to be filed with the Securities and Exchange Commission with respect to such Shares, to any and all amendments or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective date of such Registration Statement, to any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and all amendments thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and each of the undersigned hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Name    Title    Date 
         
/s/ Kim Kwan Kings, WONG   Chief Executive Officer and Director    September 27, 2024 
Name: Kim Kwan Kings, WONG    (Principal Executive Officer)     
         
/s/ Kwok Kuen, YUEN    Chief Financial Officer    September 27, 2024 
Name: Kwok Kuen, YUEN    (Principal Financial and Accounting Officer)     
         
/s/ Hung, CHEUNG   Director    September 27, 2024 
Name: Hung, CHEUNG        
         
/s/ Feiyong, LI   Director    September 27, 2024 
Name: Feiyong, LI        
         
/s/ Phei Suan, HO   Director    September 27, 2024 
Name: Phei Suan, HO        
         
/s/ Wai Chun, CHIK   Director    September 27, 2024 
Name: Wai Chun, CHIK        

 

II-6

 

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

 

Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration statement thereto in New York, NY on September 27, 2024.

 

  Cogency Global Inc.
   
  Authorized U.S. Representative
   
  By:  /s/ Colleen A. De Vries
  Name:  Colleen A. De Vries
  Title: Senior Vice President

 

 

II-7

 

 

F-1/A 0.001 0.071 0.090 27000000 27000000 27000000 true 00000 0001978057 0001978057 2023-01-01 2023-12-31 0001978057 dei:BusinessContactMember 2023-01-01 2023-12-31 0001978057 2023-12-31 0001978057 2022-12-31 0001978057 us-gaap:RelatedPartyMember 2023-12-31 0001978057 us-gaap:RelatedPartyMember 2022-12-31 0001978057 2022-01-01 2022-12-31 0001978057 2021-01-01 2021-12-31 0001978057 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001978057 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001978057 us-gaap:RelatedPartyMember 2021-01-01 2021-12-31 0001978057 us-gaap:CommonStockMember 2020-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001978057 us-gaap:RetainedEarningsMember 2020-12-31 0001978057 2020-12-31 0001978057 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001978057 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001978057 us-gaap:CommonStockMember 2021-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001978057 us-gaap:RetainedEarningsMember 2021-12-31 0001978057 2021-12-31 0001978057 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001978057 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001978057 us-gaap:CommonStockMember 2022-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001978057 us-gaap:RetainedEarningsMember 2022-12-31 0001978057 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001978057 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001978057 us-gaap:CommonStockMember 2023-12-31 0001978057 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001978057 us-gaap:RetainedEarningsMember 2023-12-31 0001978057 twg:MrWongKimKwanKingsMember 2023-12-31 0001978057 twg:MrChongKinFaiMember 2023-12-31 0001978057 twg:TopWealthBVIGroupLimitedMember 2023-03-21 0001978057 2023-03-21 0001978057 twg:TopWealthGroupInternationalLimitedMember 2023-03-24 0001978057 2023-03-24 0001978057 us-gaap:IPOMember 2023-04-28 0001978057 us-gaap:IPOMember 2023-10-01 2023-10-12 0001978057 us-gaap:CommonStockMember us-gaap:IPOMember 2023-10-12 0001978057 twg:TopWealthGroupHoldingLimitedMember 2023-01-01 2023-12-31 0001978057 twg:TopWealthBVIGroupLimitedMember 2023-01-01 2023-12-31 0001978057 twg:TopWealthGroupInternationalLimitedMember 2023-01-01 2023-12-31 0001978057 twg:WinwinDevelopmentGroupLimitedMember 2023-01-01 2023-12-31 0001978057 twg:BeyondGloryWorldwideLimitedMember 2023-01-01 2023-12-31 0001978057 twg:KeenSkyGlobalLimitedMember 2023-01-01 2023-12-31 0001978057 twg:StateWisdomHoldingsLimitedMember 2023-01-01 2023-12-31 0001978057 twg:SnowBearCapitalLimitedMember 2023-01-01 2023-12-31 0001978057 twg:MercuryUniversalInvestmentLimitedMember 2023-01-01 2023-12-31 0001978057 twg:GreetHarmonyGlobalLimitedMember 2023-01-01 2023-12-31 0001978057 2023-12-14 2023-12-14 0001978057 srt:MinimumMember 2023-12-31 0001978057 srt:MaximumMember 2023-12-31 0001978057 twg:SaleOfCaviarProductsMember 2023-01-01 2023-12-31 0001978057 twg:SaleOfCaviarProductsMember 2022-01-01 2022-12-31 0001978057 twg:SaleOfCaviarProductsMember 2021-01-01 2021-12-31 0001978057 twg:SaleOfWineMember 2023-01-01 2023-12-31 0001978057 twg:SaleOfWineMember 2022-01-01 2022-12-31 0001978057 twg:SaleOfWineMember 2021-01-01 2021-12-31 0001978057 twg:USDToHKYearEndMember 2023-12-31 0001978057 twg:USDToHKYearEndMember 2022-12-31 0001978057 twg:USDToHKYearEndMember 2021-12-31 0001978057 twg:USDToHKAverageRateMember 2023-12-31 0001978057 twg:USDToHKAverageRateMember 2022-12-31 0001978057 twg:USDToHKAverageRateMember 2021-12-31 0001978057 twg:ThirdPartiesMember 2023-12-31 0001978057 twg:ThirdPartiesMember 2022-12-31 0001978057 us-gaap:RelatedPartyMember 2023-12-31 0001978057 us-gaap:RelatedPartyMember 2022-12-31 0001978057 us-gaap:EquipmentMember 2023-12-31 0001978057 us-gaap:EquipmentMember 2022-12-31 0001978057 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001978057 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001978057 twg:ThirdPartiesMember 2023-12-31 0001978057 srt:MinimumMember 2023-01-01 2023-12-31 0001978057 srt:MaximumMember 2023-01-01 2023-12-31 0001978057 country:HK 2023-01-01 2023-12-31 0001978057 twg:TopWealthGroupInternationalLimitedMember 2023-01-01 2023-12-31 0001978057 twg:HongKongMember 2023-01-01 2023-12-31 0001978057 twg:HongKongMember 2022-01-01 2022-12-31 0001978057 twg:HongKongMember 2021-01-01 2021-12-31 0001978057 twg:OverProvisionInPreviousYearsMember 2023-01-01 2023-12-31 0001978057 twg:OverProvisionInPreviousYearsMember 2022-01-01 2022-12-31 0001978057 twg:OverProvisionInPreviousYearsMember 2021-01-01 2021-12-31 0001978057 twg:UnderProvisionInPreviousYearsMember 2023-01-01 2023-12-31 0001978057 twg:UnderProvisionInPreviousYearsMember 2022-01-01 2022-12-31 0001978057 twg:UnderProvisionInPreviousYearsMember 2021-01-01 2021-12-31 0001978057 country:HK 2022-01-01 2022-12-31 0001978057 country:HK 2021-01-01 2021-12-31 0001978057 twg:TaxLossesMember 2021-12-31 0001978057 twg:DepreciationAllowanceMember 2021-12-31 0001978057 twg:TaxLossesMember 2022-01-01 2022-12-31 0001978057 twg:DepreciationAllowanceMember 2022-01-01 2022-12-31 0001978057 twg:TaxLossesMember 2022-12-31 0001978057 twg:DepreciationAllowanceMember 2022-12-31 0001978057 twg:TaxLossesMember 2023-01-01 2023-12-31 0001978057 twg:DepreciationAllowanceMember 2023-01-01 2023-12-31 0001978057 twg:TaxLossesMember 2023-12-31 0001978057 twg:DepreciationAllowanceMember 2023-12-31 0001978057 srt:ScenarioForecastMember 2024-04-18 2024-04-18 0001978057 twg:ChongKinFaiMember 2023-01-01 2023-12-31 0001978057 twg:WongKimKwanKingsMember 2023-01-01 2023-12-31 0001978057 twg:SnowBearCapitalLimitedMember 2023-01-01 2023-12-31 0001978057 twg:BeautyHealthInternationalCompanyLimitedCustomerBMember 2022-01-01 2022-12-31 0001978057 twg:BeautyHealthInternationalECommerceLimitedCustomerCMember 2022-01-01 2022-12-31 0001978057 twg:MotherNatureHealthHKLimitedCustomerEMember 2022-01-01 2022-12-31 0001978057 twg:SkyChannelManagementLimitedMember 2022-01-01 2022-12-31 0001978057 twg:ChongKinFaiMember 2022-01-01 2022-12-31 0001978057 twg:ChongKinFaiOneMember 2022-01-01 2022-12-31 0001978057 twg:WongKimKwanKingsMember 2022-01-01 2022-12-31 0001978057 twg:WongKimKwanKingsOneMember 2022-01-01 2022-12-31 0001978057 twg:ChongKinFaiMember 2021-01-01 2021-12-31 0001978057 twg:WongKimKwanKingsMember 2021-01-01 2021-12-31 0001978057 twg:WongKimKwanKingsMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001978057 twg:SnowBearCapitalLimitedMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001978057 twg:MotherNatureHealthHKLimitedCustomerEMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001978057 twg:ChongKinFaiMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001978057 twg:WongKimKwanKingsMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001978057 twg:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerGMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerJMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 twg:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001978057 twg:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001978057 twg:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001978057 twg:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 2023-12-31 0001978057 twg:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierAMember 2023-01-01 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierAMember 2022-01-01 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierAMember 2021-01-01 2021-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierAMember 2023-12-31 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierAMember 2022-12-31 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierBMember 2023-01-01 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierBMember 2022-01-01 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierBMember 2021-01-01 2021-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierBMember 2023-12-31 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierBMember 2022-12-31 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierMember 2023-01-01 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierMember 2022-01-01 2022-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierMember 2021-01-01 2021-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierMember 2023-12-31 2023-12-31 0001978057 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember twg:SupplierMember 2022-12-31 2022-12-31 0001978057 us-gaap:CommonStockMember 2023-02-01 0001978057 us-gaap:CommonStockMember 2023-03-01 0001978057 us-gaap:CommonStockMember 2023-04-28 0001978057 us-gaap:IPOMember 2023-10-12 0001978057 us-gaap:CommonStockMember us-gaap:IPOMember 2023-10-12 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:HKD